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Summary 
Linear DNA is packaged into higher-order structures termed chromatin, in which the 
majority of DNA sequences are structurally inaccessible and functionally inactive. 
Hence, chromatin must exist in a dynamic state to govern the accessibility of the DNA 
to various regulatory factors that control nuclear processes, such as transcription, DNA 
replication, and DNA repair. Accessibility in turn is mediated by post-translational 
modifications, histone variants, histone chaperones, and ATP-dependent chromatin 
remodelling complexes. In particular, these complexes, such as the multi-subunit 
INO80 complex, are characterized by their ability to utilise ATP hydrolysis to alter 
histone-DNA contact by the sliding, eviction, or exchange of histones or nucleosomes. 
Since its identification in 1999, many INO80 subunits have been purified and 
structurally characterized. Here, we structurally and biochemistry characterized the 
recently identified human INO80 YY1 subunit and demonstrated a role for YY1 
together with RUVBL2, another INO80 subunit, in promoting DNA repair by 
homologous recombination (HR). Consequential to its chromatin-remodelling activity, 
INO80 plays multiple roles in cellular metabolism including DNA repair and 
chromosomal stability. Although evidence from yeast and mammals has indicated the 
involvement of INO80 in HR repair, the exact mechanism affected by INO80 therein 
remained unclear. Through a combination of live cell imaging and in vivo techniques, 
we revealed that in human cells the histone variant H2AZ is rapidly removed from 
damaged chromatin by INO80. Furthermore, we found that INO80 together with the 
histone chaperone, ANP32E, promotes HR by removing H2AZ from damaged 
chromatin. Finally, we verified that INO80 is required for the maintenance of 
chromosomal stability and that loss of INO80 in CIN+ tumour cells induced cell death. 
Therefore, INO80 may serve as a therapeutic target for the selective elimination of 
CIN+ tumour cells. 
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1.1 General introduction to chromatin and its structure  
Within the nucleus, 2 meters of linear DNA are packaged into a higher-order structure 
termed chromatin. Chromatin consists of negatively charged DNA wound around 
positively charged protein complexes called nucleosomes, which allow the DNA to 
overcome the electrostatic repulsion that would occur if it were coiled around itself. In 
addition to serving the vital function of fitting long linear DNA molecules into the 
nucleus, chromatin also protects the DNA and plays important roles in mitosis, meiosis, 
gene expression, and DNA replication (Maeshima et al., 2014). 
The core unit of chromatin is the nucleosome, which consists of 146 base pairs of DNA 
wrapped tightly, in approximately 1.65 superhelical turns, around a histone octamer, 
composed of two H2A-H2B dimers and an (H3-H4)2 tetramer. The core histones 
display a highly conserved structure, the histone fold, in which three alpha helices 
(α1, α2, and α3) are connected with two short loops (L1 and L2). Each histone has a 
flexible tail that extends from the surface of the nucleosome and contains sites that can 
undergo covalent modification. These histone tails play vital roles in chromatin 
function. Histones H3 and H4 only have N-terminal tails, whereas histones H2A and 
H2B also have C-terminal tails. Histones H3 and H4 are among the most conserved 
proteins in eukaryotes. H2A and H2B are also conserved; however, they exhibit 
considerable species-specific variation, especially in their tails (Luger, 2001; Lewin et 
al., 2011). Nucleosomes are thought to be assembled in two steps: 1) the core (H3-H4)2 
tetramer is first connected through a strong 4-helix bundle (4-HB) between the two H3 
molecules and deposited into DNA to form a tetrasome, which includes one turn of 
DNA wrapped around the centre of the H3-H4 tetramer; 2) the two H2A-H2B dimers 
associate with the tetramer via interaction between the C-terminal docking domain of 
	 18	
H2A with H3 and H4 to form the final octamer, while the L1 loops from each H2A 
molecule interact to stabilize the association of the two H2A-H2B molecules within the 
nucleosome, and the remaining DNA wraps around the octamer. (Luger, 2001; Lewin et 
al., 2011, Billon & Cote, 2012; Dennehey & Tayler, 2014). The mechanism of 
disassembly is a reversal of the assembly process, starting with unwrapping of the DNA 
and the loss of the H2A-H2B dimer, followed by disassociation of the H3-H4 tetramer 
from the DNA (Dennehey & Tayler, 2014).  
The nucleosome, which provides the first level of organized structure of nuclear DNA, 
compacts the naked DNA by almost 6-fold, generating a 10 nm fibre that has been 
likened to “beads on a string” (Olins & Olins, 1974). The second level of chromatin 
organization consists of the interaction of the linker histone, H1, with the 10 nm fibre, 
and compacts the chromatin by approximately 40-fold to form a 30 nm fibre. Formation 
of this structure is also facilitated by the histone tails via internucleosomal interactions; 
for example, the N-terminal tail of the core histone H4 interacts with the acidic patch on 
the surface of H2A-H2B dimers in the adjacent nucleosome (Luger et al., 2012; Price & 
D’Andrea, 2013). This structure is thought to be the primary form of chromatin in both 
interphase and mitotic chromosomes. The higher-order structures beyond the 30 nm 
fibre, culminating in chromosome loops, remain poorly understood; however, 60–300 
nm fibres, termed chromonema, have been observed by light and electron microscopy 
(Luger, 2001, Maeshima et al., 2014).  
Packaged DNA can be categorized as either euchromatin or heterochromatin, depending 
on the density of staining observed during the cell cycle (Heitz, 1928; Huisinga et al., 
2006). Heterochromatin reflects highly condensed genomic areas that are poor in genes 
and rich in repetitive sequences (e.g., centromeric and pericentromeric repeats and 
	 19	
telomeric regions), as well as transcriptionally silent DNA, such as the inactive X 
chromosome in female mammals (Wilson et al., 1990) and the mating-type locus in 
yeast (Lorentz et al., 1992). By contrast, euchromatin consists of less condensed areas, 
which are gene-rich and transcriptionally active (Huisinga et al., 2006). 
 
	 20	
1.2 Chromatin organization 
When in a highly compacted state, the majority of DNA sequences are structurally 
inaccessible and functionally inactive. Hence, chromatin must exist in a dynamic state 
that can be relaxed to a greater or lesser extent, to govern the accessibility of the DNA 
to various enzymes and regulatory factors and control nuclear processes, such as 
transcription, and DNA recombination, replication, and repair. Accessibility is regulated 
by a variety of factors including the preferences of nucleosomes for some DNA 
sequences, post-translational modifications, histone variants, histone chaperones, and 
ATP-chromatin-remodelling factors (Chambers & Downs, 2012; Seeber et al., 2013; 
Chen & Shen, 2010; Price & D’Andrea, 2013; Conaway & Conaway, 2009). The 
following sections consist of a detailed discussion of these factors. 
1.2.1 DNA sequence-based nucleosome preferences 
It was previously widely believed that nucleosomes package genomic DNA in a 
nonspecific manner; however, high-resolution genome-wide analyses demonstrated that 
nucleosomes occupy the genome in favoured positions. This preferential mechanism is 
vitally important for modelling the chromatin structure in regions containing genes and 
for the regulation of their expression. In yeast, gene promoters include nucleosome-free 
regions (NFRs) upstream of the transcription start site (TSS), consisting entirely of poly 
(dA:dT) tracts, which inhibit nucleosome formation. The inhibition stems from the 
intrinsic stiffness of the tracts, which means that wrapping them around the histone 
octamer is energetically unfavourable; hence, it is possible that the depletion of 
nucleosomes at promoters depends on the length, number, and homopolymeric nature of 
these poly (dA:dT) tracts (Radman-Livaja & Rando, 2010; Struhl & Segal, 2013).  
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By contrast, nucleosomes immediately flanking NFRs, known as -1 and +1 
nucleosomes, are preferable positions for nucleosomes and are enriched in TA 
dinucleotides. Typically, nucleosome formation favours DNA sequences with flexible 
dinucleotides (AA, TT, or TA) with a periodic repeat every 10 bp, which facilitates the 
bending of DNA around the nucleosomes. Linker DNA shows a strong preference 
towards inflexible sequences, including poly (dA:dT) tracts, and therefore it favours 
exclusion of nucleosomes (Radman-Livaja & Rando, 2010; Struhl & Segal, 2013). 
In mammals, the same phenomena occur; however, the position of the +1 nucleosome 
relative to the TSS differs between organisms, suggesting variation in the mechanisms 
of transcription regulation (Radman-Livaja & Rando, 2010). 
1.2.2 Post-translational histone modifications (PTMs) 
Post-translational histone modifications (PTMs) are covalent modifications that mainly 
affect the flexible unstructured tails of histones. All histones can be post-translationally 
modified at many residues by, for example, methylation, acetylation, phosphorylation, 
ubiquitination, sumoylation, and ADP-ribosylation. PTMs can directly affect chromatin 
structure by altering histone-DNA and histone-histone chemical interactions. In 
addition, histone PTMs have vital functions in creating binding sites for non-histone 
proteins and facilitating their recruitment, due to their ability to act as scaffolds for 
numerous effector proteins, known as “readers”. Remarkably, the majority of histone 
PTMs are reversible. Cells contain enzymes to both add and remove these PTMs 
(known as “writers” and “erasers”, respectively), hence the accessibility to a specific 
genomic site and the recruitment of regulatory factors (non-histone proteins) are firmly 
controlled by PTMs. Consequently, cellular mechanisms, such as gene transcription, 
and DNA recombination, replication, and repair are mediated by histone PTMs 
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(Kouzarides, 2007; Musselman et al., 2012; Venkatesh & Workman, 2015). Notably, 
misregulation or complete loss of several histone PTMs is implicated in a number of 
human diseases, including cancer, the neurological disorder Sotos syndrome, and Wolf-
Hirschhorn syndrome (Bhaumik et al., 2007).  
The specificity of PTMs is regulated by the specificity of modifying enzymes for their 
target sites on particular histones. Many modified sites are subjected to a single PTM; 
however, others are subjected to multiple PTMs (e.g., H3K9 is either acetylated or 
methylated depending on the particular conditions). Moreover, modification of one site 
in a histone tail might lead to a subsequent effect, such as inhibition or activation, on 
another site. This led Strahl and Allis (2000) to propose the histone code hypothesis, in 
which the combined impact of multiple PTMs on one or several modified sites can 
determine a unique subsequent function. In the following sections, I consider the most 
well characterized PTMs (methylation, acetylation, and phosphorylation) and their roles 
in transcription and replication; other PTMs and their roles in DNA double-strand break 
(DSB) repair will be introduced later. 
1.2.2.1 Methylation 
Methylation usually occurs on the lysine and arginine residues of histone tails. Lysine 
can be mono-, di-, and tri-methylated, while arginine is subject to mono-methylation, or 
symmetrical or asymmetrical di-methylation. Methylation does not affect the net charge 
of nucleosomes, instead the size and hydrophobic state of the modified residue are 
altered. Lysine can be methylated on various canonical sites, including K4, K9, K26, 
K27, K36, and K79 on histone H3; K20 on histone H4; and K26 on histone H1. Reader 
domains that can specifically recognize methyl lysine have been reported, including 
chromodomain, double chromodomain (DCD), chromobarrel, tandem Tudor domain 
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(TTD), Tudor, ATRX-DNMT3-DNMT3L (ADD), ankyrin, bromo-adjacent homology 
(BAH), malignant brain tumour (MBT), plant homeodomain (PHD), Pro-Trp-Trp-Pro 
(PWWP), WD40, and zinc finger CW (zf-CW). These readers usually bind through an 
aromatic cage, which is moulded from two or four residues. The size of the aromatic 
cage and the precise composition of residues identify the specificity towards mono-, di-, 
or tri-methylated states (Musselman et al., 2012). 
Many of the functions of methylated lysine have been well described in the context of 
gene transcription regulation. Globally, methylation of histone H3 Lys4 (H3K4me) is 
considered a mark for gene activation (Schneider et al., 2004). Mono-methylation of 
this residue (H3K4me1) is a marker of active enhancer elements, and is recognized by 
the chromobarrel domain of Tip60 acetyltransferase, enabling estrogen-induced 
transcription (Jeong et al., 2011). Similarly, the binding of TAF3, a subunit of the basal 
transcription complex, TFIID, to H3K4me3 via its PHD domain is a mark of 
transcriptionally active regions (Vermeulen et al., 2007), while the binding of 
H3K4me3 to ING2, a subunit of the mSin3a histone deacetylase complex, results in 
gene repression (Shi et al., 2006). Importantly, a conserved enrichment of tri-methylated 
lysine has been reported in the 5’ regions of actively transcribed genes (Schneider et al., 
2004).  
In addition, methylation of lysine is associated with DNA replication, as the recruitment 
of ORC1, a subunit of the origin of replication complex that mediates pre-DNA 
replication licensing, is facilitated by H4K20me, through a direct interaction with its 
BAH domain (Kuo et al., 2012). Moreover, two methylation sites, H3K27 and H3K9, 
are implicated in the formation of heterochromatin and gene silencing. H3K27me1 and 
H3K9me3 are enriched in pericentromeric heterochromatin, while H3K27me3 and 
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H3K9me2 co-localize in inactive regions of euchromatin. The recruitment of polycomb 
and heterochromatin protein 1 (HP1) proteins, which are involved in the formation and 
spreading of heterochromatin, is mediated by H3K27me and H3K9me, respectively, via 
direct interaction with the chromodomains of these proteins (Fischle et al., 2003; Min et 
al., 2003; Bannister et al., 2001; Fischle et al., 2005).  
Arginine can be methylated on several canonical residues, including R2, R8, R17, and 
R26 of histone H3; R3 of histone H4; and R11 and R29 of histone H2A (Musselman et 
al., 2012). Although more studies are required to investigate the significance of the 
methylation of arginine, one good example of the functional consequences of this 
modification is the recruitment of the transcriptional activator TDRD3, which is 
mediated by the recognition of asymmetrically di-methylated histone H3 R17 and 
asymmetrically di-methylated histone H4 R3 (H3R17me2a and H4R3me2a) by the 
Tudor domain of TDRD3, promoting gene expression (Yang et al., 2010).  
1.2.2.2 Acetylation  
Acetylation also occurs on lysine residues and neutralizes the positive charge on the 
NH3 of this amino acid. Lysine can be acetylated on several canonical sites, including 
K4, K9, K14, K18, K23, K27, K36, and K56 of H3; K5, K8, K12, K16, K20, and K91 
of H4; K5 and K9 of H2A; and K5, K12, K15, K16, K20, and K120 of H2B. Acetyl 
lysine reader domains have been identified, including the bromodomain, double PHD 
finger (DPF), and double pleckstrin homology (PH) domain (Musselman et al., 2012).  
Acetylation of lysine is associated with a dynamic chromatin state and with a more open 
conformation, as a result of weakening of the interaction of the histone with negatively 
charged DNA. For a long time, this was thought to be the only purpose of acetylation; 
however, this modification has been found to be widely linked to gene transcription. 
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The recruitment of proteins of the BRD family of transcription regulators is mediated 
by acetylation via their bromodomains (Filippakopoulos et al., 2012). In addition, 
H3K14ac is essential for activating and regulating the DPF3b and MOZ genes via its 
binding to their DPF domains (Zeng et al., 2010; Qiu et al., 2012). Similarly, the 
recruitment of BRG1, a catalytic subunit of the SWI/SNF complex, at DSBs is mediated 
by the recognition of H3ac (at K9, K14, K18, and K23) by its bromodomain (Lee et al., 
2010). 
1.2.2.3 Phosphorylation 
Phosphorylation can occur on the hydroxyl groups of serine and threonine residues, and 
results in the introduction of a negatively charged group; hence, phosphorylation is 
widely thought to be involved in the compaction of chromatin. Histones can be 
phosphorylated at T3, T6, S10, T11, S28, and T45 of H3; S1 of H4; S1 and T120 of 
H2A; S139 of human histone variant H2AX; and S14 of H2B (Kouzarides, 2007; 
Musselman et al., 2012). Phosphorylation can also occur at Y57 of H2A mediated by 
casein kinase 2 (Basnet et al., 2014). 
A well-studied reader domain recruited to phosphorylated histones is the tandem BRCT 
domain that can specifically recognize and bind to the S139 of histone H2AX in 
mammals (Stucki et al., 2005; Lou et al., 2006). Phosphorylated H2AX (γH2AX) is 
widely considered to be a DSB marker and plays an important role in DSB repair; it will 
be discussed in more detail later in this chapter. In addition, phosphorylation plays a 
vital role in chromosome condensation and segregation in mitosis, as the 
phosphorylation of H3S10, mediated by Aurora B kinase, is necessary for 
disassociation of HP1 from chromosomes during mitosis, and acts in this process by 
inhibiting the interaction between the chromodomain of HP1 and H3K9me (Hirota et 
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al., 2005).  
1.2.3 Histone variants 
Histone variants are non-allelic variants that differ from the core histones (H2A, H2B, 
H3, and H4) in sequence. The variation can be as little as a single amino acid or as 
extensive as an alternative tail sequence, and can affect the interaction between DNA 
and nucleosomes or interactions within nucleosomes, resulting in changes in the level of 
chromatin compaction. The expression of histone variants is independent of replication 
and can occur throughout the cell cycle, unlike canonical histone expression, which is 
restricted to the S phase (i.e., it is DNA replication-dependent). Moreover, the 
deposition mechanism of these variants is also different, in that it generally requires 
specific factors, such as histone chaperones or chromatin remodellers. These differences 
reflect an alteration in the function of histone variants relative to their canonical 
counterparts. Variants have been identified for all core histones, except histone H4. For 
instance, H3.3 and CENP-A are variants of canonical H3, and H2AX, H2AZ, macro 
H2A, and H2ABBD are variants of canonical H2A (Sarma & Reinberg, 2005; Henikoff 
& Ahmad, 2005; Talbert & Henikoff, 2010). In the next sections, I focus on some 
universal histone variants, including CENP-A and H2AZ, while H2AX will be 
discussed later. 
1.2.3.1 CENP-A 
CENP-A (also known as Cse4 in yeast) is an H3 variant unique to centromeres; it has 
approximately 50–60% homology with canonical H3 in the histone fold domain (HFD) 
and there is no conservation in the N-terminal tail relative to the core H3 protein or 
among species (Talbert & Henikoff, 2010; Verdaasdonk & Bloom, 2011). CENP-A is 
essential for recruitment of kinetochore proteins to the centromere (Howman et al., 
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2000). Interestingly, yeast Cse4 can substitute for human CENP-A, indicating that the 
two proteins build similar nucleosome structures, regardless of the divergence of their 
sequences (Wieland et al., 2004). CATD, a CENP-A centromere-targeting domain 
within the HFD, which is critical for centromere function, facilitates the interaction of 
CENP-A with other factors (Black et al., 2007), such as suppressor of chromosome 
missegregation 3 (Scm3) in yeast (Zhou et al., 2011). In addition, tetramers of CENP-
A-H4 are more rigid than those of the canonical H3-H4 tetramer, which is important for 
the maintenance of centromere structure that is required for efficient chromosome 
segregation (Verdaasdonk & Bloom, 2011).  
The timing of CENP-A loading into centromeres during the cell cycle varies among 
species. It is loaded in anaphase and G1 in higher eukaryotes (e.g., humans and 
Drosophila melanogaster), in S–G2 in yeast, and in late G2 in plants (Verdaasdonk & 
Bloom, 2011). Various proteins have been identified from different studies in either 
human or yeast as involved in facilitating the loading of CENP-A (Fujita et al., 2007; 
Foltz et al., 2009; Verdaasdonk & Bloom, 2011), leading to a model in which licensing 
and loading are distinguished. In humans, this begins with recruitment of MIS18, 
CENP-H, CENP-I, RBAP46, and RBAP48 (Fujita et al., 2007), followed by the 
recruitment of loading proteins, such as KNL2 and HJURP (a human homolog of yeast 
Scm3) (Foltz et al., 2009). The histone chaperone, CAF1 (chromatin assembly factor 1), 
and HIR (a histone regulator) are associated with the disassembly of CENP-A from 
centromeric chromatin, and with preventing extra-centromeric incorporation of CENP-
A in Saccharomyces cerevisiae (Rosa et al., 2011).  
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1.2.3.2 H2AZ 
H2AZ is a highly conserved histone variant that shares 60% sequence identity with the 
canonical histone H2A across eukaryotes (Zlatanova & Thakar, 2008). H2AZ is 
essential in flies (Clarkson et al., 1999) and H2AZ knockout mice exhibit an embryonic 
lethal phenotype (Faast et al., 2001); however, H2AZ-deleted yeast strains exhibit slow 
growth rather than lethality. Mutant yeast strains also suffer from chromosomal 
instability (Carr et al., 1994), transcriptional defects (in both gene silencing and 
activation of transcription) (Meneghini et al., 2003), and genotoxic and environmental 
stress (i.e., formamide sensitivity at 28°C and lethality at 37°C) (Jackson & Gorovsky, 
2000). H2AZ is also involved in DNA replication and DNA repair (Downs et al., 2004; 
Xu et al., 2012). Moreover, overexpression of H2AZ has been observed in many 
patients with cancer, including breast cancer, particularly during metastasis, (Zucchi et 
al., 2004; Svotelis et al., 2010) and sporadic colorectal cancer, more specifically in 
microsatellite instability (MIN) cell lines, which exhibit a phenotype linked to a defect 
in the mismatch DNA repair pathway (Dunican et al., 2002). Taken together, this 
evidence suggests a key role for H2AZ in faithful maintenance of the genome. 
Although H2AZ shares 60% sequence similarity with canonical H2A, their crystal 
structures reveal several differences between them, which may be sufficient to alter the 
function of H2AZ (Suto et al., 2000). First, the equivalent of the docking domain of the 
core H2A histone is altered in H2AZ, which is important for interaction with H3-H4. 
Importantly, the alteration of Glu104 in H2A to Gly106 in H2AZ leads to the loss of 
three hydrogen bonds, which destabilizes the interaction with the H3-H4 tetramer. 
Second, the existence of His112, which can bind a metal ion, on the surface of H2AZ-
containing nucleosomes offers a distinctive surface for protein interactions. Third, 
H2AZ has an extended acidic patch, which provides a unique binding domain and 
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interacts with DNA, the linker histone H1, and the N-terminal tail of histone H4. Fourth 
and finally, the L1 loop is altered in H2AZ, which may reflect an alteration of the 
stability within the nucleosome, as this loop is important for H2A/H2A self-interaction. 
Taken together, these modifications in the structure of H2AZ suggest a destabilization 
of H2AZ-containing nucleosomes; however, contradicting data has emerged from 
different laboratories about the ability of H2AZ to create, or be associated with, a less 
stable chromatin environment. In 2001, Abbott and colleagues characterized the ionic-
strength dependence of reconstituted H2A- and H2AZ-containing nucleosomes from 
recombinant human histones by analytical ultracentrifugation. The sedimentation 
coefficients of these particles demonstrated a significant destabilization of H2AZ-
containing nucleosomes, compared with those containing H2A. The authors attributed 
this to the loose binding of the H2AZ-H2B dimer to the nucleosome (Abbott et al., 
2001). In agreement with this, another study in yeast showed that nucleosomal H2AZ is 
unstable and vulnerable to loss under increased salt conditions, compared with the 
canonical histones H2A and H3 (Zhang et al., 2005). By contrast, an analysis of salt-
dependent stability by fluorescence resonance energy transfer (FRET) demonstrated that 
H2AZ-containing nucleosomes are stabilized compared with core nucleosomes, due to 
the association with the H3-H4 tetramer (Park et al., 2004). However, it was recognized 
recently that the destabilizing effect of H2AZ is dependent on, first, pre-existing PTMs 
on other histones or PTMs on H2AZ itself, and, second, the presence of histone variants 
such as H3.3 (Billon & Cote, 2012; Zlatanova & Thakar, 2008). Further, nucleosomes 
containing H2AZ can have two copies of the H2AZ-H2B dimer (termed homotypic 
nucleosome, ZZ), or one copy each of H2AZ-H2B and the core dimer, H2A-H2B 
(termed heterotypic nucleosome, AZ), with a relative distribution of these forms in 
yeast chromatin of 35% and 65%, respectively (Luk et al., 2010). One can predict that 
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nucleosomes containing homotypic dimers are less stable than the heterotopic 
nucleosomes; however, more research is required to confirm such a prediction.  
In addition, H2AZ can undergo alternative post-translational modification, compared 
with the major H2A histone. Human H2AZ is acetylated on K4, K7, K11, and K13 
(Boyne at al., 2006). Prior acetylation of the core histones H4 and H2A by TIP60 is 
required to enable H2AZ to be incorporated into nucleosomes by the chromatin 
remodeller, SWR1/p400 (Altaf et al., 2009; Xu et al., 2012). Chromatin 
immunoprecipitation (ChIP) data from the Bystricky laboratory indicate that TIP48, a 
subunit of TIP60, promotes H2AZ acetylation, as depletion of TIP48 by small 
interfering (si)RNA results in a reduction in the level of acetylated H2AZ at the TSS 
and enhancer of CCND1 compared with controls (Dalvai et al., 2013).  
Interestingly, acetylation of H2AZ in mouse is dynamic throughout embryonic 
developmental stages, with preferential accumulation in euchromatin. Acetylated H2AZ 
was detected in pre-implantation blastomeres, while no acetylation was observed at the 
two-cell embryonic stage, a major genome activation stage. However, acetylation of 
H2AZ was detected at all subsequent stages investigated, including 4-, 8-, and 16-cell 
embryos, as well as the blastocyst (Bošković et al., 2012). These data suggest that 
H2AZ may be associated with diverse gene expression events at distinct embryonic 
stages.  
H2AZ lysines can also be mono-methylated at the K4 and K7 residues in the N-terminal 
tail by the methyltransferase SETD6 (Binda et al., 2013), and H2AZ can undergo mono-
ubiquitination on residues K121, K120, and K125 of its C-terminus, mediated by 
RING1B, a subunit of polycomb repressive complex 1 (PRC1) (Sarcinella et al., 2007). 
Notably, mono-ubiquitinated H2AZ localizes to the heterochromatin of the human 
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female inactive X chromosome (IMR90 cells) (Sarcinella et al., 2007), and is widely 
used as a transcriptional silencing mark (Sevilla & Binda, 2014).  
The unique features of H2AZ differentiate the function of this variant from that of the 
canonical histone, facilitating the regulation of various biological processes, including 
transcription, heterochromatin maintenance, DNA repair, and chromosome segregation 
(the latter two processes are discussed in later sections). H2AZ is involved in 
transcription; in yeast, H2AZ is found at all promoters as part of two nucleosomes 
flanking the NFR, which contains the TSS (Raisner et al., 2005). It is involved in both 
activation and repression of transcription, and evidence from an experiment, in which 
the transcriptomes in wild-type and H2AZ-deleted strains were characterized, identified 
214 genes that were activated by H2AZ and another 107 that were repressed 
(Meneghini et al., 2003). The majority of studies in yeast report an inverse correlation 
between H2AZ enrichment at promoters and transcription activity (Raisner et al., 2005; 
Li et al., 2005; Zhang et al., 2005; Millar et al., 2006). ChIP and microarray analyses 
found a correlation between the acetylation state of H2AZ and transcription activity, 
demonstrating that H2AZ associates preferentially with the promoters of repressed 
genes, whereas the acetylation of H2AZ at K14 was found to be enriched at the 
promoters of active genes (Millar et al., 2006). In humans, similar to yeast, H2AZ is 
enriched at promoters both upstream and downstream of TSSs and the level of its 
enrichment correlates with gene activity (Barski et al., 2007).  
Separate from its role in transcription, evidence published from several laboratories 
indicates the association of H2AZ with the formation of higher-order chromatin 
structure. The Tremethick group demonstrated the importance of the extended acidic 
patch in H2AZ that associates with the N-terminus of H4 on the adjacent nucleosome, 
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using a condensed array structure, and found that a larger acidic patch has a higher 
affinity for the H4 tail than core H2A, due to stronger electrostatic interactions, leading 
to a more compact nucleosome structure (Fan et al., 2004). In addition, they found that 
HP1a preferentially binds to highly folded chromatin fibres containing H2AZ, rather 
than those containing H2A (Fan et al., 2004). Moreover, the presence of H2AZ in 
satellite repeats in pericentric heterochromatin (Greaves et al., 2007) supports the 
assertion that H2AZ has a function in chromatin condensation. Overall, it is highly 
likely that H2AZ governs accessibility to chromatin by, 1) stabilizing nucleosomes and 
creating more compact chromatin, and 2) opening this condensed chromatin, when 
required, through the virtue of its ability to be modified by PTMs, and possibly more 
specifically through acetylation. 
H2AZ is expressed throughout the cell cycle and is highly dynamic; it can be 
incorporated into chromatin and then removed in a function-dependent manner 
(Papamichos-Chronakis et al., 2011). Several studies in yeast demonstrate that H2AZ 
can be deposited into chromatin via exchange of H2A-H2B with H2AZ-H2B by SWR1 
(Krogan et al., 2003; Kobor et al., 2004; Mizuguchi et al., 2004), and in mammals via 
either the SWR1 homolog SRCAP (Ruhl et al., 2006) or P400, a subunit of the 
TRRAP/TIP60 complex (Xu et al., 2012). However, the reverse mechanism (i.e., 
removal of H2AZ and re-incorporation of canonical H2A into chromatin) is still under 
study, especially in mammals. Very recently, biochemical studies identified ANP32E, 
an H2AZ chaperone that can specifically remove H2AZ from chromatin (Obri et al., 
2014; Mao et al., 2014). In yeast, INO80 controls the removal of H2AZ (Papamichos-
Chronakis et al., 2011). 
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1.2.4 Histone chaperones  
Histone chaperones were initially described as a “nucleoplasmin”, referring to the 
ability of these proteins to prevent histone-DNA aggregation at physiological salt 
concentrations, and stimulate nucleosome assembly in vitro (Laskey et al., 1978; 
Earnshaw et al., 1980). Today, the term histone chaperones refers to a large number of 
proteins that can bind to histones and are involved in accomplishing one or more of the 
following functions: transfer of newly synthesized histones from the cytoplasm to the 
nucleus, facilitation of histone PTMs by presentation of histones to histone-modifying 
enzymes, storage of free histones in the cell, deposit of histones onto DNA, and 
removal of histones from the nucleosome (Dennehey & Tyler, 2014; Gurard-Levin et 
al., 2014). Histone chaperones can be classified into H2A-H2B and H3-H4 chaperones, 
depending on their binding specificity. In addition, unique histone chaperones may exist 
for each histone variant. The activity of histone chaperones can be replication-
dependent, where they are associated with chromatin assembly during DNA synthesis, 
or replication-independent, where they function outside of periods of DNA synthesis, 
for example, during transcription. Histone chaperones vary in their structure, which 
makes it challenging to identify them; however, the majority of chaperones contain an 
acidic patch, which may facilitate their interaction with histones, since the latter are 
positively charged (Dennehey & Tyler, 2014). Here, I will only describe the ANP32E 
histone chaperone in detail, as it features strongly in the work described in this thesis.  
1.2.4.1 ANP32E, an H2AZ histone chaperone 
ANP32E belongs to the ANP32 family, consisting of 32 evolutionarily conserved 
proteins, which is part of the leucine-rich repeat (LRR) superfamily. The ANP32 family 
is characterized by an N-terminal domain containing a LRR region, which varies from 
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between two to four repeats, and a C-terminal acidic tail, rich in aspartic and glutamic 
acids. Similar aspartic/glutamic acid-rich domains are present in tubulin and many other 
histone chaperone proteins. Members of this family are associated with modulation of 
cell signal transduction and control of gene expression (Matilla & Radrizzani, 2005). 
ANP32E is a protein with a molecular weight of approximately 30.7 KDa, which was 
first identified in Xenopus laevis oocytes by stimulating its phosphorylation in nuclear 
localization signal (NLS)-dependent manner (Kurihara et al., 1996). In addition, 
ANP32E spatially co-localizes with the catalytic subunit of phosphatase 2A (PP2A) and 
inhibits its activity (Matilla & Radrizzani, 2005). High levels of ANP32E expression 
were observed in mouse thymus, peripheral blood leukocytes, colon, small intestine, 
prostate, spleen, skeletal muscle, liver, and kidney (Matilla & Radrizzani, 2005). 
ANP32E was recently identified as a histone chaperone that can specifically remove 
H2AZ from chromatin in human cells (Obri et al., 2014; Mao et al., 2014). Both studies 
carried out immune-affinity purification of H2AZ and canonical H2A and identified 
ANP32E as a major interaction partner of H2AZ. The Hamiche group reported 
ANP32E as a member of the p400/TIP60 complex, based on mass spectrometry data, in 
which the p400/TIP60 complex and some of its subunits, including RUVBL1 and 
RUVBL2, were identified in both H2AZ and ANP32E purified complexes (Obri et al., 
2014). Furthermore, pull-down and immune-precipitation (IP) experiments 
demonstrated that the specificity of the interaction of ANP32E with H2AZ is 
determined by its C-terminal acidic region, as interruption or deletion of this domain 
completely abolished the interaction with H2AZ (Obri et al., 2014; Mao et al., 2014). A 
crystal structure of the H2AZ-ANP32E complex revealed that ANP32E recognizes 
H2AZ through particular residues (T103 and I104) in the αC helix of H2AZ. 
Interestingly, these residues are conserved in H2A; the H2A glycine residue, G98, is the 
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only difference between H2AZ and H2A that has been found to be key for the specific 
interaction of ANP32E with H2AZ rather than H2A. Insertion of glycine in the H2AZ 
interaction motif completely abrogates its interaction with ANP32E (Obri et al., 2014; 
Mao et al., 2014). Remarkably, the crystal structure also revealed that the interaction 
between H2AZ and ANP32E via the H2AZ αC helix impeded the interaction between 
H2AZ and H3-H4 (Obri et al., 2014; Mao et al., 2014). Moreover, the Zhou group 
demonstrated that ANP32E prevents the aggregation of DNA with H2AZ-H2B, but not 
that between DNA and H2A-H2B (Mao et al., 2014). Finally, an in vitro experiment 
that mimicked the natural state of nucleosomes revealed that ANP32E is involved in 
removal, rather than deposition, of H2AZ. In this experiment, H2A- and H2AZ-
containing nucleosomes were assembled on a 256 bp 5S DNA, immobilized on 
magnetic beads, and incubated with recombinant ANP32E, and the purified complexes 
were analysed by SDS-PAGE and immunoblotting, and detected with either anti-H2A 
or anti-H2AZ. The results revealed that H2AZ was disassociated from nucleosomes, as 
a large amount of unbound H2AZ was detected after incubation with ANP32E (Obri et 
al., 2014; Mao et al., 2014). Together, the results of all of these various in vitro 
experiments confirm the function of ANP32E as a specific histone chaperone for the 
removal of H2AZ. 
This function of ANP32E in specific removal of H2AZ has also been addressed by cell 
culture experiments. Genome-wide comparative ChIP-seq analyses of both mouse 
embryonic fibroblasts (MEFs) (Obri et al., 2014) and human HeLa cells (Mao et al., 
2014) revealed that depletion of ANP32E results in an increase of H2AZ accumulation 
at TSS regions. In addition, the absence of ANP32E in MEFs results in incorporation of 
H2AZ into enhancer and insulator sequences, which are usually H2AZ-free regions 
(Obri et al., 2014). Also, overexpression of ANP32E in HeLa cells results in a 
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significant decrease of H2AZ accumulation at +1 nucleosomes, whereas ANP32E 
knockdown leads to an increase in the occupancy of H2AZ at +1 nucleosomes (Mao et 
al., 2014). Moreover, recent data from the Downs and Price laboratories demonstrate 
that ANP32E is required for removal of H2AZ from DSBs, and that failure to remove 
H2AZ leads to defective DSB repair pathways (Alatwi & Downs, 2015; Gursoy-
Yuzugullu et al., 2015). However, the fact that H2AZ knockout is embryonically lethal 
in mice, while ANP32E knockout does not result in such a phenotype (Obri et al., 
2014), suggests that there may be a partner molecule that also has a role in removal of 
H2AZ from chromatin. Notably, a recent work from our laboratory demonstrated that 
this is indeed the case, and that ANP32E works cooperatively with INO80, a chromatin 
remodeler, to remove H2AZ from chromatin at DSBs (Alatwi & Downs, 2015); these 
results will be presented in chapter 4. 
1.2.5 ATP-dependent chromatin remodellers 
ATP-dependent chromatin-remodelling complexes are characterized by their ability to 
use ATP hydrolysis to alter histone-DNA contacts. All of these proteins share a similar 
ATPase domain and use ATPase-derived energy to remove the nucleosomal barriers 
that can prevent various proteins from binding to DNA. This function can be exerted by 
sliding, evicting, or exchanging histones or nucleosomes (Chambers & Downs, 2012; 
Seeber et al., 2013; Chen & Shen, 2010; Price & D’Andrea, 2013; Clapier & Cairns, 
2009; Conaway & Conaway, 2009). 
Although all chromatin remodellers share a conserved ATPase domain, each also has a 
unique flanking domain, leading to the classification of these proteins into four families: 
1) SWI/SNF family proteins, which contain a bromodomain that can bind acetylated 
histone tails; 2) the ISWI family, which has SANT and SLIDE domains that can bind 
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unmodified histone tails and DNA; 3) CHD-remodelling proteins, which have a tandem 
chromodomain that associates with methylated histones; and 4) the INO80 complex, 
which has an insert in the middle of the ATPase domain (Clapier & Cairns, 2009; 
Seeber et al., 2013). However, Flaus et al. (2006) provided a new classification system 
for these remodellers, based on sequence similarities in the helicase-like region. In that 
scheme, chromatin remodellers are classified into six major families: Snf2-like, Swr1-
like, SMARCAL1, Rad54-like, Rad5/16-like, and ERCC6/SSO1653-like. These can be 
further categorized into 24 subfamilies (Figure 1.1). Here, I discuss the INO80 complex, 
which was a fundamental target of this project.  
	
Figure 1. 1 Diagram demonstrating the classification of chromatin remodellers.  
Adapted from (Flaus et al., 2006). 
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1.2.5.1 INO80: an overview 
1.2.5.1.1 Structure and subunits 
INO80 is a chromatin-remodelling complex of the Swr1-like family that was first 
identified in S. cerevisiae (Ebbert et al., 1999), but is conserved in multicellular 
eukaryotes. Some of its 15 subunits are common to both yeast and metazoan complexes. 
The yeast subunits identified to date are Ino80, Rvb1, Rvb2, Arp4, Arp5, Arp8, Act1 
(actin), Ies2, Ies6, Ies1, Ies3–5, Taf14 (Anc1), and Nhp10; the human complex shares 
the first eight subunits and also contains the mammal-specific subunits Amida, 
INO80E, NFRKB, MCRS1, INO80D, UCHL5, and YY1 (Table 1.1) (Seeber et al., 
2013).  
 
Yeast INO80 Human INO80 
Ino80 
Rvb1 
Rvb2 
Arp4 
Arp5 
Arp8 
Ies2 
Ies6 
Act1 (actin) 
Taf14/Anc1 
Ies1 
Ies3 
Ies4 
Ies5 
Nhp10 
INO80 
RUVBL1/TIP49a 
RUVBL2/TIP49b 
BAF53a (INO80K) 
ARP5 
ARP8 
IES2/PAPA-1 
IES6/C18orf37 
 
 
 
 
 
 
 
INO80D (FLJ20309) 
NFRKB 
MCRS1 
Amida (TCF3) 
YY1 
INO80E (FLJ90652/CCDC95) 
UCHL5 (UCH37) 
Table 1. 1 Subunits of the INO80 complex in yeast and humans. 
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The catalytic subunit of the INO80 complex, INO80, has an ATPase domain that 
contains a characteristic internal spacer region (Figure 1.2). This conserved region is 
essential for the recruitment of the majority of the evolutionarily conserved subunits 
IES2, IES6, and ARP5 and the AAA+ ATPase subunits RUVBL1 and RUVBL2 (Chen 
et al., 2011). INO80 also contains a helicase-SANT (HSA) domain, which is important 
for recruitment of YY1, ARP4, and ARP8, as deletion of this domain from human 
INO80 resulted in loss of these subunits (Chen et al., 2011). Finally, recruitment of the 
metazoan-specific subunits (i.e., Amida, INO80E, INO80D, NFRKB, UCHL5, and 
MCRS1) is dependent on the N-terminal region of human INO80, since deletion of this 
region led to the loss of these subunits from the complex. By contrast, deletion of the C-
terminus did not cause any loss of INO80 complex subunits (Chen et al., 2011).  
	
Figure 1. 2 Schematic diagram showing the domain organization of the catalytic subunit, INO80, of 
the human INO80 complex.  
The SNF2N ATPase domain contains an insertion in the middle. NTD, N-terminal domain; HSA, 
helicase-SANT domain; CTD, C-terminal domain. Adapted from (Chen et al., 2011). 
 
The conservation of this complex among widely divergent organisms suggests that it 
plays an important role in one or more essential processes. For example, deletion of 
INO80 in yeast results in either lethal or sick strains (Chambers & Downs, 2012), and 
causes early embryonic lethality in mouse (Min et al., 2013). The mammalian INO80 
complex contains RUVBL1 and RUVBL2, AAA+ proteins homologous to the bacterial 
helicase RuvB (Lopez-Perrote et al., 2012), a subunit of the Holliday junction branch-
migration complex (Mayanagi et al., 2008; Fujiwara et al., 2008). YY1 was first 
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identified as a subunit of human INO80 in 2007 (Wu et al., 2007). Previously, it was 
well known as a transcription factor; however, biochemical analysis by Wu et al. 
demonstrated in vitro interactions between YY1 and the INO80 subunits INO80, 
BAF53a, and RUVBL1 and 2, indicating that YY1 is also a component of the INO80 
complex. YY1 binds Holliday junctions (HJs) in vitro and interacts with RUVBL1 and 
RUVBL2, homologs of RuvB, suggesting that YY1 may be the mammalian ortholog of 
bacterial RuvA (Wu et al., 2007). In bacteria, RuvA forms an octamer (a pair of 
tetramers) that specifically binds Holliday junction DNA and target RuvB to the 
junction, where it forms two hexameric rings on either side of the RuvA octamer. 
Together, the two proteins form a complex that facilitates ATP-dependent branch 
migration of the junction (Figure 1.3) (Mayanagi et al., 2008). Two actin-related 
proteins (Arps), Arp5 and Arp8, are unique to INO80, whereas Arp4 is also found in the 
NuA4 histone acetyltransferase (HAT). Association of these unique Arps requires the 
presence of the Ruv proteins (Chambers & Downs, 2012).  
 
	
Figure 1. 3 A model for eukaryotic Holliday junction resolution based on the bacterial RuvA/RuvB 
complex. 
 RuvB is the bacterial homolog of mammalian RUVBL1 and RUVBL2, which form two hexamers 
flanking the octamer of RuvA, the putative YY1 homolog. The resultant complex binds to Holliday 
junction DNA and facilitates branch migration. 
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Since INO80 was identified as an ATPase-dependent chromatin remodeller (Ebbert et 
al., 1999), many of its subunits have been purified and structurally characterized, 
including RUVBL1/2 (Gorynia et al., 2011; Lopez-Perrote et al., 2012), actin (Vorobiev 
et al., 2003), Arp4, and Arp8 (Fenn et al., 2011; Gerhold et al., 2012). However, 
possibly due to its enormous size (1.3 MDa), the overall structure of INO80 was only 
determined very recently in S. cerevisiae (Tosi et al., 2013). A combination of a hybrid 
structural approach, three-dimensional and cryo-electron microscopy, mass 
spectrometry, and chemical crosslinking revealed the “embryonic” structure of the 
INO80 complex (Figure 1.4). This study revealed many aspects of the dependency and 
crosslinking between the subunits of INO80, and knowledge of these features could 
impact our understanding of the functions of the subunits. For example, the study found 
that association of Ies6 with the complex is dependent on the presence of Arp5, both of 
which are conserved in humans (see Table 1.2 for the other subunits). This helped to 
determine the exact part of the complex occupied by each subunit and to build up the 
“embryonic” structure, which consists of head (Rvb1/2), neck (Ies2 and Arp5), body 
(Nhp10, Ies1, Ies3, and Ies5), and foot (Act1, Arp4 Arp8, Ies4, and Taf14) regions 
(Figure 1.4) Both head and neck subunits crosslink to the INO80 ATPase, the body 
domain subunits crosslink to the N-terminus of INO80 (the metazoan subunits), and the 
foot subunits crosslink to the HSA domain region (Tosi et al., 2013). 
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Figure 1. 4 The proposed embryonic structure of the INO80 complex. Adapted from (Tosi et al., 
2013). 	
	
Table 1. 2 The dependency between INO80 subunits in yeast (Tosi et al., 2013). 
 
1.2.5.1.2 Remodelling activity 
There are multiple lines of in vitro evidence in the literature to support the idea that 
INO80 is an ATPase-dependent chromatin remodeller. Biochemical analysis 
demonstrated that INO80 can bind DNA and exert a 3’à5’ helicase activity. The 
directional helicase activity was revealed by the ability of INO80 to bind 24 mer 
oligonucleotides (3’à5’) rather than 32 mer oligonucleotides (5’à3’) in vitro (Shen et 
al., 2000). That study and others revealed that DNA binding by INO80 is ATPase-
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dependent (Shen et al., 2000; Shen et al., 2003; Udugama et al., 2011). Biochemical 
evidence for the in vitro chromatin-remodelling activity of INO80 was obtained by 
incubating the INO80 complex and ATP with a reconstructed chromatin template and 
monitoring its accessibility to the BamHI restriction enzyme. Addition of INO80 
resulted in elevated cleavage, indicating increased accessibility of the restriction site 
(Shen et al., 2000).  
Moreover, the ability of INO80 to alter nucleosome spacing was demonstrated in vitro 
by the combination of a nucleosome-sliding assay and high-resolution site-directed 
mapping. These techniques were used to demonstrate that INO80 can space 
nucleosomes almost 30 bp apart, with a preference for di- and tri-nucleosomes 
(Udugama et al., 2011). Another study revealed that this activity is dependent on the 
ATPase and HSA domains of INO80 and their recruited subunits (Chen et al., 2011). In 
this study, a sliding assay was performed on a purified FLAG-INO80 complex (WT) or 
manipulated INO80 complexes (i.e., with an N-terminal deletion (ΔN), a C-terminal 
deletion (ΔC), ΔNC, ΔN, and HAS deletion, or ATPase mutants) in the presence of 
reconstructed nucleosomes positioned near the end of the DNA strand. In all cases, 
nucleosomes slid towards the middle of the DNA, except where an INO80 mutant form 
with either an ATPase mutation or HAS deletion was used, which led to complete 
abolition of sliding activity (Chen et al., 2011). 
Further, a recent study in yeast demonstrated that INO80 has histone-exchange activity 
towards the H2AZ histone variant (i.e., removal of H2AZ and incorporation of H2A) 
(Papamichos-Chronakis et al., 2011). A mononucleosome ChIP-chip analysis 
determined an increase in H2AZ enrichment in ino80Δ, compared with wild-type, 
strains. The same study also revealed that the dynamic alteration of H2AZ content in 
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nucleosomes linked to transcription states is regulated by INO80. The KAR4 locus, a 
cell cycle-dependent gene that is highly expressed during G1 and repressed in G2 phase, 
was analysed. H2AZ is normally enriched at the repressed KAR4 promoter during G2 
and depleted during activation in G1. Depletion of INO80 resulted in maintenance of an 
equal level of H2AZ distribution during the repressed and active states, indicating that 
H2AZ cannot be removed in the absence of INO80 (Papamichos-Chronakis et al., 
2011). Importantly, the study showed that INO80 is required for removal of 
unacetylated H2AZ, as failure to remove unacetylated H2AZ (in ino80Δ strains that 
express mutant H2AZ that cannot be acetylated) resulted in sensitivity to replication 
stress and DNA damage-inducing drugs. Further, expression of an acetylated H2AZ 
mimic in ino80Δ strains rescued the phenotypes associated with INO80 depletion (i.e., 
slow growth, and defects in DNA replication and damage repair) (Papamichos-
Chronakis et al., 2011). 
Finally, the embryonic structure of yeast INO80 and the identification of all crosslinks 
between INO80 subunits and nucleosomes led to a speculative model that could explain 
how IN080 participates in the spacing of nucleosomes. Briefly, Tosi et al. hypothesized 
that INO80 can form a flexible cradle, in between its head, neck, and body regions, that 
can accommodate and embrace the nucleosome. It is envisaged that nucleosomal DNA 
binds to the head, neck, and body, while the flexible foot region attaches to histones at 
both sides of the nucleosome (Figure 1.4). The authors also suggested that the large 
conformational change in INO80 might facilitate the open nucleosome conformation, in 
which H2A-H2B dimers are moderately disassociated from the H3-H4 tetramer, and 
that this could enable the histone-exchange activity of the INO80 complex (Tosi et al., 
2013). 
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1.2.5.1.3 In vivo functions of INO80 
As a consequence of its chromatin-remodelling activity, INO80 also plays multiple 
roles in cellular metabolism. Initially, INO80 was identified as a transcriptional 
regulator that governs the expression of genes such as INO1, PHO5, and Ty1 (Ebbert et 
al., 1999). Strikingly, the ∆ino80 mutation in yeast alters the expression of 1156 genes 
by at least 1.5-fold relative to the wild-type strain (Van Attikum et al., 2004). A more 
recent study, carried out under environmental stress conditions (e.g., heat and ionic 
stress), revealed that adverse conditions increased the recruitment of INO80 to open 
reading frames (ORFs), suggesting that the complex plays a direct role in the 
transcription of stress-response genes (Klopf et al., 2009). In human HeLa cells lacking 
INO80, ARP8, IES6, and IES2 subunits of the INO80 complex, gene expression profile 
analysis revealed that 251 genes were regulated by INO80, including 149 down-
regulated, and 102 up-regulated, genes (Cao et al., 2015). 
In addition, INO80 influences DNA replication by promoting recovery of stalled 
replication forks; in the absence of yeast INO80, recovery is delayed (Shimada et al., 
2008). In mammals, INO80 is recruited to replication forks via direct interaction with 
BRCA1-associated protein-1 (BAP1), a tumour suppressor and nuclear de-
ubiquitinating enzyme, through its HAS domain; depletion of BAP1 abolishes INO80 
recruitment. Recruitment of BAP1-INO80 is mediated by interaction between BAP1 
and ubiquitinated H2A; the latter is ubiquitinated by RING1B (also called RNF2). 
Inhibition of H2A ubiquitination by RING1B depletion abolished the recruitment of 
BAP1 and INO80 to replication forks (Lee et al., 2014). INO80 is required for 
stabilization of stalled replication forks, since INO80-deficient cells exhibit a reduction 
in replication elongation (Vassileva et al., 2014; Lee et al., 2014), an increase in 
replication origin usage during S phase, hypersensitivity to hydroxyurea (HU), and 
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hyperactivity of Chk1 signalling (S phase checkpoint), and around half of replication 
forks failed to restart after release from replication stress (Vassileva et al., 2014). 
Further, human INO80 regulates ubiquitination of proliferating cell nuclear antigen 
(PCNA), a DNA polymerase sliding clamp involved in DNA synthesis and repair, 
which is essential for post-replication repair (PRR). Defects in PRR increase the amount 
of DSBs mediated by phosphorylation of the C-terminal of INO80 at either S1512 or 
S1516 during DNA replication (Kato et al., 2012). The results of these studies clearly 
demonstrate the involvement of INO80 in DNA replication.  
Although the potential role of INO80 in regulating the cell cycle in response to its 
function in DNA damage (Papamichos-Chronakis et al., 2006; Morrison et al., 2007; 
Seeber et al., 2013) or replication (Vassileva et al., 2014), by either delaying or arresting 
the cell cycle, has been referred to, the exact mechanism regulating such a process 
remains elusive. However, a very recent study reported for the first time a direct 
association of INO80 with the cell cycle via negative regulation of p21Waf1/Cip1, a 
universal inhibitor of cyclin kinases that controls the cell cycle by regulating the active 
state of cyclin-dependent kinases (CDKs) (Cao et al., 2015). Cell flow cytometry 
analysis demonstrated a delay in progression from G2/M to G1 in the absence of INO80 
compared to the control, suggesting a role for INO80 in cell cycle regulation. The 
authors then carried out gene expression profile analysis, demonstrating that among the 
genes most up- and down-regulated by INO80 were those related to the cell cycle. After 
siRNA knockdown of INO80 in HeLa cells, the mRNA levels of cyclin C (CCNC), 
BRAC2/CDKN1A interacting protein (BCCIP), and MAD2 mitotic arrest deficient like 
1 (MAD2L1) were decreased, whereas increases in the expression of cyclinG1 
(CCNG1), cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 6 (CDK6), and 
p21 were observed. Together with the observed high expression of p21 protein in 
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INO80 or ARP8 knocked-down cells, these results indicate negative regulation of p21 
by INO80 (Cao et al., 2015). Further, INO80 was found to co-localize with the activated 
p53 tumour suppressor at 2.2 and 1.0 kb upstream of the p21 TSS. The recruitment of 
INO80 at this site is mediated by p53, evidenced by the low enrichment of INO80 at the 
p21 TSS in p53-/- HCT116 cells (Cao et al., 2015). This study clearly demonstrates the 
involvement of INO80 in the cell cycle through negative regulation of p21 expression, 
which suggests direct involvement of INO80 in cancer aetiology. 
Finally, and crucially, INO80 regulates DNA repair and chromosome segregation, 
which also implicates the complex in the development of cancer. In the following 
sections, a thorough dissection of the role of INO80 in DNA repair and chromosomal 
stability will be provided. 
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1.3  DSB repair in mammals: an overview 
DSBs are among the most toxic DNA lesions; a single unrepaired lesion can lead to 
chromosomal rearrangements and genomic instability. Since tens of thousands of DNA 
breaks occur every day in each human body, it is essential to understand the 
mechanisms of their repair (Krejci et al., 2012). Here, I will briefly discuss the factors 
that influence the choice of repair mechanism, followed by an overview of repair 
pathways and a thorough discussion of the roles of the chromatin remodeller, INO80, 
and the histone variant, H2AZ, in DSB repair. 
1.3.1 DNA breaks 
Single- or double-strand breaks in DNA can be generated endogenously, e.g., by 
replication fork collapse or reactive oxygen species produced as a byproduct of cellular 
metabolism, or exogenously, e.g., by ionizing radiation (IR), UV light, or 
chemotherapy. When lesions occur in only one strand of the DNA molecule, they can 
be excised and the missing segment can be replaced by copying the sequence 
information from the intact DNA strand. By this mechanism, the vast majority of DNA 
lesions generated by internal (e.g., reactive oxygen species) or external (e.g., UV light 
and some chemical mutagens) sources are repaired by pathways including base excision 
repair (BER), nucleotide excision repair (NER), and mismatch repair (MMR). However, 
more complex damage, where two or more lesions (base and/or sugar damage) are 
induced to the double-stranded DNA molecule either opposite to each other or within a 
few nucleotides, can be induced by IR, in the form of either X-rays or gamma rays (γ-
IR). DSBs cannot be repaired by restoration of the sequence from the complementary 
strand, as information is missing from both strands; therefore, more advanced pathways 
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of repair are required to generate the missing copy and repair the damage (Iliakis et al., 
2015). 
1.3.2 DSB repair pathway choice 
DSB repair can be carried out by homologous recombination (HR), which occurs in late 
S and G2 phases of the cell cycle, non-homologous end joining (NHEJ), which is active 
throughout the cell cycle (Chapman et al., 2012; Murray et al., 2012), or by a backup 
pathway, alternative-NHEJ (Alt-NHEJ) (Windhofer et al., 2007). Although it remains 
unclear how the cell decides which repair pathway to use in each case, in-depth work 
from the Jeggo laboratory suggests that several factors significantly influence the choice 
of pathway. These include the following: 1) the position of the cell in the cell cycle; 2) 
the status of resection initiation; 3) the complexity of the DNA lesion; and 4) chromatin 
structure at the site of damage (Shibata et al., 2011). The same group previously 
demonstrated that DSBs within regions of heterochromatin are repaired preferentially 
by HR in the G2 phase (Beucher et al., 2009).  
A fascinating model for the competition between NHEJ and HR to repair DSBs was 
proposed by the Jeggo group (Shibata et al., 2011). In that model, a first attempt to 
repair the damage is made by NHEJ by rapid binding of DNA-PK and KU to DSB ends, 
followed by prompt and efficient DSB repair. However, if the two ends cannot rapidly 
rejoin, either due to the presence of a complex DSB or compact chromatin that first 
needs to be relaxed, the repair will be performed by HR. If, for any reason (e.g., loss of 
CtIP), resection cannot be initiated, then a second attempt will be made by NHEJ. 
However, if the resection was initiated successfully, or perhaps an extensive resection 
was achieved, repair will commit to HR. This model was based on the observation that, 
in CtIP-depleted cells, resection was abolished, while cells repaired DSBs rapidly and 
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efficiently by NHEJ, whereas, blocking HR after the initiation of resection, by depleting 
BRCA2, prevented repair by either HR or NHEJ, probably due to the excess of resected 
ssDNA (Shipata et al., 2011). This model explains the crucial role of lesion resection 
state in pathway choice. 
Other factors that have a basic influence on either the initiation or progress of resection 
should be taken into account, including cell cycle phase and the balance between 53BP1 
and BRCA1. Resection occurs in a cell cycle-dependent manner with CDK 
phosphorylation of several substrates, including CtIP and EXO1, during S and G2 
phases (Mimitou & Symington, 2011); more details will be provided later in this 
chapter. The resection process can be blocked by the prevention of CtIP binding to 
DNA ends by 53BP1, promoting repair by NHEJ. Hence, 53BP1 function is a barrier to 
resection when it is phosphorylated by ATM, promoting the recruitment of Rif1 and 
PTIP, which stimulates further recruitment of the downstream nuclease, Artemis. 
Depletion of either 53BP1 or Rif1 results in extensive resection and inhibition of repair 
by NHEJ (Ceccaldi et al., 2016); however, BRCA1 promotes HR repair through direct 
interaction with phosphorylated CtIP to initiate resection, which is required for efficient 
resection (Yun & Hiom, 2009). 
1.3.3 DSB repair pathways 
1.3.3.1 NHEJ 
Around 80% of DSBs induced by IR are repaired by NHEJ, which does not require a 
homologous template (Beucher et al., 2009; Riballo et al., 2004). In this pathway, the 
Ku heterodimer (Ku70/Ku80) binds to broken DNA ends, thereby preventing resection 
(Mimori & Hardin, 1986). Ku forms a ring that encircles double-stranded DNA, 
translocates along the DNA, and recruits the catalytic subunit of DNA-dependent 
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protein kinase (DNA-PKcs) (Gottlieb & Jackson, 1993). PKcs facilitates Ku binding to 
the DNA end ligation complex, consisting of ligase IV, XRCC4, and XLF. Ligation is 
performed through a series of interactions, starting with that of Ku with the BRCT 
domain of ligase IV, which interacts with XRCC4 via two BRCT domains in the C-
terminus of ligase IV (Costantini et al., 2007). The resulting complex then interacts with 
XLF, facilitating tethering of the DSB ends (Ahnesorg et al., 2006). Consequently, the 
DNA ligase complex is able to ligate the broken ends and repair the lesion; however, 
when incompatible ends are present, an extra step is required before ligation can occur. 
In such cases, the Artemis endonuclease is activated by autophosphorylation, mediated 
by DNA-PKcs. Activated Artemis cleaves the hairpin structures formed at DNA ends to 
remove the damaged or mismatched nucleotides (Ma et al., 2002; Schlissel, 2002). 
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Figure 1. 5 The NHEJ repair pathway. 
 In response to DSBs, the Ku70/80 heterodimer (blue rings) binds to the broken DNA ends. This 
promotes the recruitment of DNA-PKcs, which bind to the broken DNA ends and activate Artemis. 
Activated Artemis processes the broken DNA ends and can cause loss of genetic information. Ultimately, 
Ligase IV, XRCC4, and XLF ligate the broken DNA ends together.  
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1.3.3.2 HR 
HR is a complex pathway of DSB repair in which a homologous sequence on a sister 
chromatid is used as a repair template. The Jeggo laboratory showed that around 20% of 
DSBs induced by IR (γ-rays or X-rays) in G2 phase are repaired by HR (Beucher et al., 
2009). HR is critical for repair of several kinds of damage, including collapsed 
replication forks and chromosome breaks, and deficiencies in HR are thought to be 
responsible for a subset of breast, ovarian, and other cancers (Roy et al., 2012). 
The HR pathway involves a cascade of signals that recruit repair factors, eventually 
resulting in repair of the lesion. Repair is initiated by the recruitment of the MRN 
complex, which contains the MRE11, RAD50, and NBS1 proteins, to the damage site. 
At the site of the lesion, MRN activates the protein kinase, ATM (Lavin, 2008). 
Activation of ATM is associated with stimulation of the repair checkpoints controlled 
by p53 and Chk2, as well as recruitment of repair proteins, such as BRCA1 and 53BP1 
(Jackson & Baetek, 2009; Kennedy & D’Andrea, 2006). Activation of ATM also results 
in phosphorylation of histone H2AX at serine 139 near the C-terminus. This creates a 
docking site for the BRCT domain of the MDC1 protein. Phosphorylated H2AX 
(γH2AX) forms foci in response to irradiation within minutes; these foci are widely 
used as DSB markers (Lou et al., 2006). Recruitment of MDC1 to DSBs forms a 
binding site for subsequent recruitment of the MRN and ATM complex, resulting in the 
creation of a γH2AX domain that spreads along the chromatin for hundreds of kilobases 
around the DSB (Figure 1.5) (Rogakou et al., 1998; Xu et al., 2012; Price & D’Andrea, 
2013). MDC1 also facilitates the later recruitment of two E3 ubiquitin ligases, RNF8 
and RNF168, which ubiquitinate the chromatin and promote recruitment of BRCA1 and 
53BP1. It remains unclear how cells decide to undergo repair via HR; as noted above, 
this decision could be affected by several factors (Shibata et al., 2011). 
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HR is initiated by a resection step in which the 5’ overhangs are degraded to yield 
single-stranded DNA (ssDNA) with a 3’ overhang “tail”. This is a complicated process 
involving several helicases, endonucleases, and other proteins. Once this step is 
initiated, the cell is committed to repair the damage by HR, and may block KU binding 
(Shibata et al., 2011). Initiation of resection is thought to be regulated by the MRN-CtIP 
complex. When DSBs occur during S or G2 phases, CtIP is activated through an 
interaction with either CDK (via phosphorylation on T847) (Huertas & Jackson, 2009) 
or ATM (via phosphorylation on S664/745) (Shibata et al., 2011). Phosphorylated CtIP 
is then recruited to the damage site via direct interaction with the FHA domain in the N-
terminus of NBS1, a component of the MRN complex (Mimitou & Symington, 2009; 
Mimitou & Symington, 2011). Subsequently, resection proceeds through two steps, in 
which the active MRN-CtIP complex binds to the 5’ DNA ends and resects or removes 
approximately 50–100 nucleotides, resulting in the formation of short 3’ ssDNA tails. 
The second step then occurs rapidly, to recruit EXO1 and BLM-DNA2, which bind to 
the 5’ DNA ends and perform an extensive resection, yielding long 3’ ssDNA tracts. 
The long ssDNA tracts activate DNA damage checkpoints and ensure fidelity of repair 
by preventing repair with short repeats. These tracts vary in length from a few hundred 
nucleotides to tens of kilobases, depending on the availability and location of the 
homologous templates and the speed of the repair (Figure 1.6) (Chung et al., 2010; 
Mimitou & Symington, 2011). 
Once the long ssDNA overhangs are generated, they are quickly coated by replication 
protein A (RPA), which stabilizes them, protects them from degradation, and prevents 
them from forming secondary structures (Fanning et al., 2006). This step is followed by 
the replacement of RPA with RAD51, resulting in the formation of a RAD51 filament. 
The incorporation of RAD51 is thought to be regulated by BRCA2, a repair protein 
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implicated in breast cancer, because defects in this protein completely abolish RAD51 
filament formation (Liu et al., 2010). RAD51 monomers bind to the eight BRC repeats 
on BRCA2, which promotes their binding to ssDNA in a one-to-one binding fashion 
(Filippo et al., 2008; Ceccaldi et al., 2016). The RAD51 filament is involved in the 
search for the homologous sister chromatid, by a mechanism that remains poorly 
understood. Once the homologous template is found, the RAD51 filament invades the 
homologous strand, and the missing sequence is copied. Finally, Holliday junction 
resolution takes places, resulting in the separation of the newly generated strands in 
which the damage has been repaired (Figure 1.6) (Krejci et al., 2012).  
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Figure 1. 6 The homologous recombination repair pathway. 
Once DSBs are induced, MRN is recruited to the site of damage and activates ATM. Activation of ATM 
leads to H2AX phosphorylation and further recruitment of MDC1, 53PB1, and BRCA1. Next, MRN-CtIP 
binds to the 5’ end of the DNA, resulting in the production of a short 3’ ssDNA that is directly coated by 
RPA. Extensive resection is then achieved by EXO1 and BLM-DNA2, resulting in a long 3’ ssDNA 
coated with RPA. Next, BRCA2 is recruited and facilitates the replacement of RPA with RAD51, 
resulting in the formation of the RAD51 filament, which is involved in the search for the homologous 
sister chromatid from which the missing sequence is copied, allowing repair of the damage. 
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1.3.3.3 Alt-NHEJ 
Alt-NHEJ was originally described as a backup mechanism for the NHEJ pathway for 
end joining of chromosomal DSBs during V(D)J recombination, due to its error-prone 
outcomes and its novel detection in the absence of NHEJ. However, the current 
dominant hypothesis is that this pathway functions primarily in the presence of both HR 
and NHEJ (Caccaldi et al., 2016). Alt-NHEJ is an error-prone mechanism that generates 
chromosomal translocations and mutagenic rearrangements. Although this pathway is 
recognized, its detailed mechanism remains ambiguous. Alt-NHEJ can proceed when 
Poly (ADP-ribose) polymerase 1 (PARP1) is recruited to DSBs. A short end resection is 
formed that facilitates recruitment of other proteins, including DNA ligase I and III, 
XRCC1, and polymerase θ (Pol θ), resulting in annealing at microhomologies (Iliakis et 
al., 2015; Caccaldi et al., 2016). 
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Figure 1. 7 The Alt-NHEJ repair pathway.  
Alt-NHEJ is mediated by the recruitment of PARP1 to DSBs. Resection of short DNA sequences can 
occur to expose microhomology regions (the example illustrated here is TAG). These are eventually 
annealed by Lig I/III, XRCC1, and Pol θ. Thus, this pathway is error prone as a result of excessive DNA 
deletion.  
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1.3.4 Chromatin response to DSBs 
The occurrence of DSBs within the highly compact organization of chromatin structure 
presents a challenge for the DSB repair machinery to detect and access the damaged 
area and to repair it. The “access-repair-restore” model was proposed in 1991, and 
highlights the need for initial reorganization of the chromatin, followed by repair of the 
damage, and finally restoration of the local chromatin after the repair is completed 
(Smerdon, 1991). This involves highly complex chromatin modifications, achieved by a 
collection of histone variants, PTMs, histone chaperones, and remodelling factors, some 
of which are responsible for chromatin relaxation, while others play roles in recruiting 
repair factors and promoting the repair. Herein, I will focus on some of the very early 
events that lead to relaxation and opening of the chromatin for repair.  
Although phosphorylation of H2AX by ATM is one of the most frequent PTMs that 
lead to activation of the DNA damage response, this step is dependent on upstream 
chromatin decondensation. Bakkenist et al. (2003) demonstrated that altering chromatin 
and chromosome structure in the absence of DSBs, by exposing cells to hypotonic 
conditions, chloroquine or a histone deacetylase inhibitor, led to a rapid induction of 
phosphorylated ATM, as determined by western blot and immunofluorescence analyses. 
However, using the same treatment after exposure of cells to IR (2 Gy) enhances the 
amount of phosphorylated ATM, suggesting that activation of ATM requires an 
upstream change in chromatin structure (Bakkenist et al., 2003). In addition, another 
group monitored the local expansion of chromatin upon induction of DSBs by laser-
microirradiation in WT, H2AX-/-, and ATM-/- MEFs expressing GFP-tagged H2B. The 
similarity in expansion (approximately 30%) observed upon DNA damage in WT MEFs 
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and those depleted of H2AX or ATM suggested that chromatin is decompacted after 
induction of DSBs, independently of ATM and H2AX (Kruhlak et al., 2006).  
Acetylation is a key factor in the opening of chromatin at DSBs. As mentioned 
previously, lysine acetylation promotes the formation of relaxed chromatin structures by 
neutralizing the negative charge on lysines, and therefore decreasing both histone-DNA 
and histone-histone interactions within nucleosomes (Musselman et al., 2012). At 
DSBs, histones H2AX and H4 are acetylated by the TIP60 HAT and acetylation spreads 
for hundreds of kilobases away from the DSB (Downs et al., 2004; Murr et al., 2006). 
CBP and p300 HATs can also acetylate H2AX at K36 (Jiang at al., 2010); H3 at K18; 
and H4 at K5, K8, K12, and K16, at DSBs (Ogiwara et al., 2011). Moreover, another 
HAT, MOF (also called KAT8), facilitates H4 acetylation at K16 (Li et al., 2010). 
Depletion of MOF by siRNA results in a 20 minute delay of γH2AX formation after 
treatment with IR (Sharma et al., 2010). This suggests that H4 acetylation may be an 
upstream event that facilitates the formation of γH2AX. As mentioned previously, the 
N-terminal tail of the core histone H4 interacts with the acidic patch on the surface of 
H2A-H2B dimers of adjacent nucleosomes (Luger et al., 2012). Disruption of this 
interaction by acetylation of H4 at K16 inhibits the formation of 30 nm fibres and 
results in chromatin relaxation (Shogren-Knaak et al., 2006); therefore, it has been 
suggested that an additional increase in H4 and H2A acetylation may promote further 
relaxation at DSBs (Kruhlak et al., 2006; Price & D’Andrea, 2013). However, it was 
shown recently that H4 acetylation by TIP60 requires incorporation of H2AZ at DSBs 
(Xu et al., 2012); this will be discussed further later in this section. 
Other PTMs are also associated with an early response to DSBs, including poly(ADP-
ribosyl)ation and ubiquitylation. Poly(ADP-ribosyl)ation is facilitated by poly(ADP-
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ribose) polymerases (PARPs), which add multiple ADP-ribose moieties to form a 
poly(ADP-ribose) (PAR) chain. This is one of the earliest PTMs detected at DNA 
damage sites. Poly(ADP-ribosyl)ation functions together with NHEJ to facilitate the 
recruitment of repair factors such as XRCC1. Poly(ADP-ribosyl)ation is also likely to 
be associated with chromatin relaxation to enable repair because it is involved in the 
recruitment of chromatin-remodelling factors including CHD1L (also called ALC1) 
(Smeenk & Attikum, 2013). Ubiquitylation involves the attachment of ubiquitin (a 
highly conserved 76-amino acid protein) to lysine residues at the C-terminus of the 
target protein. Ubiquitin is adenylated by an E1 ubiquitin ligase in an ATP-dependent 
manner. The adenylated ubiquitin is transferred to an E2 ubiquitin ligase, which in turn 
binds to an E3 ubiquitin ligase to facilitate the ligation of ubiquitin to the target protein 
(Smeenk & Attikum, 2013). In response to DSBs, the E3 ubiquitin ligase RNF8 is 
recruited to DSBs through an interaction with phosphorylated MDC1 via its FHA 
domain, which facilitates Ubc13 (an E2 ligase)-mediated polyubiquitination of the H1 
linker histone at K63.  This in turn signals the recruitment of RNF168 (an E3 ligase), 
which promotes ubiquitination of histone H2A at K13 and K15. These ubiquitylation 
events serve as a platform to recruit various repair proteins including 53PB1 and 
BRCA1 (Smeenk & Attikum, 2013; Smeenk & Mailand, 2016). 
1.3.5 DSB repair in regions of heterochromatin 
In mammals, heterochromatin (HC) is characterized by enrichment of histone 
methylation marks (most typically H3K9me3 at constitutive HC, while H3K27me3 
marks facultative), low levels of histone acetylation, in addition to the presence of HP1, 
KAP1, histone deacetylases (HDACs), and histone methyltransferases, which are 
required for its maintenance (Saksouk et al., 2015). HC is a barrier to DSB repair, and 
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slow repair at regions of HC has been reported (Boucher et al., 2009; Shibata et al., 
2011). Also, as mentioned above, in the G2 phase of the cell cycle, DSBs at HC induced 
by IR are predominantly repaired by HR. This was determined based on the co-
localization of RPA foci, which are specific markers of HR, and H3K9me3/H4K20me3, 
which are markers of HC (Kakarougkas et al., 2013). Notably, HR can also function at 
euchromatin when NHEJ is inhibited by depletion of the key factor, DNA-PK (Shibata 
et al., 2011). Ideally, NHEJ will repair DSBs in G2 rapidly and efficiently; however, if 
prompt repair cannot occur, resection will be initiated to allow for slow repair by HR 
(Shibata et al., 2011; Kakarougkas et al., 2013). At HC DSBs, KAP1 and HP1 are 
phosphorylated by ATM. This leads to the release of CHD3 (an ATP-remodeller with 
affinity for methylated histones) from HC, resulting in the relaxation of the compact 
chromatin (Price & D’Andrea, 2013). 53BP1 also plays important and opposing role at 
HC DSBs induced by IR in G2. In general, 53BP1 acts as a barrier to resection and 
directs repair towards NHEJ; however, under these specific circumstances (i.e., HC 
DSBs induced by IR at G2), this protein acts to promote HR. This is evidenced by the 
outcomes of knockdown of 53BP1, which results in an increase in chromosome breaks 
and a decrease in RPA foci, RAD51 foci, and sister chromatid exchanges, similar to the 
phenotype observed as a result of ATM inhibition, which is rescued by depleting KAP1. 
This, together with the fact that co-depletion of KAP1 and 53BP1 restores the defect in 
HR caused by depletion of BRCA1, led the authors to propose a model postulating an 
essential role for 53BP1 in HC DSB repair. In the model, the barrier of 53BP1 at HC 
DSB ends is overcome by BRCA1, perhaps by repositioning its binding away from the 
DNA molecule ends to allow resection, while retention of 53BP1 at the chromatin 
tethers activated ATM and subsequent robust KAP1 phosphorylation leads to the 
promotion of HC relaxation (Kakarougkas et al., 2013). 
	 63	
1.3.6 Role of INO80 in DNA repair 
Yeast cells lacking Ino80 are hypersensitive to factors that induce DNA damage, for 
example, hydroxyurea (HU), methyl methanesulfonate (MMS), ultraviolet (UV) light, 
and IR, suggesting the involvement of INO80 in DNA repair (Shen et al., 2000). A 
ChIP study in yeast provided physical evidence for the recruitment of several INO80 
subunits to DSBs; Ino80, Arp5, and Arp8 can be detected at DSBs within 30 minutes of 
damage induction (Van Attikum et al., 2004). In yeast, INO80 is recruited to DSBs via 
a direct interaction with γH2AX, mediated by the Nhp10, Ies3, and Arp4 subunits 
(Downs et al., 2004; Van Attikum et al., 2004; Morrison et al., 2004). In mammals, 
however, the recruitment of INO80 to DSBs is independent of γH2AX, but sensitive to 
loss of ARP8, suggesting that ARP8 mediates the initial recruitment of INO80. In 
support of this idea, recruitment of INO80 to sites of laser-induced DNA damage is not 
defective in H2AX−/− MEFs, but recruitment is abolished in ARP8-deficient human cells 
(Kashiwaba et al., 2010). Additionally, immunofluorescence and chromatin 
fractionation data from cells defective in ARP5 reveal a severe reduction in the 
accumulation of γH2AX following DSB induction, suggesting a direct interaction 
between ARP5 and γH2AX that could facilitate the spread of H2AX phosphorylation 
into the chromatin around DSBs (Kitayama et al., 2009). By contrast, the other subunits 
of INO80 do not appear to be involved in similar interactions with γH2AX, or in the 
process of INO80 recruitment (Kashiwaba et al., 2010). 
Recently, Gospodinov et al. (2011) showed that INO80 mediates 5’à3’ resection of 
DSB ends, as revealed by labelling of ssDNA with bromodeoxyuridine (BrdU) and 
simultaneous immunofluorescence detection of BrdU and foci of RPA, a protein that 
coats ssDNA. Depletion of ARP8 and the absence of INO80 have similar effects on 
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RPA foci (Gospodinov et al., 2011). Consistent with this finding, a recent study in mice 
revealed that INO80 depletion leads to a decrease in formation of both RPA32 and 
BrdU foci (Min et al., 2013). Biochemical studies reveal that RUVBL2 (TIP49b) and its 
yeast homolog, Rvb2, act as 3’à5’ DNA helicases at 3’ ssDNA overhangs of at least 
30 nucleotides in length, suggesting the potential involvement of RUVBL (TIP49) in 
the resection step of HR (Papin et al., 2010). A recent study from the Jackson laboratory 
found that depletion of the INO80 complex or its subunits, YY1 or RUVBL1, results in 
a mild defect in resection upon treatment with Campothecin, reflected by a reduction in 
the intensity of BrdU staining (ssDNA) rather than a reduced number of foci (Nishi et 
al., 2014). Further, the study showed a novel role for NFRKB, a subunit of human 
INO80, in regulating resection in a mechanism regulated by ubiquitin carboxyl-terminal 
hydrolase L5 (UCHL5), another subunit of human INO80, also known as UCH37. 
Briefly, depletion of UCHL5 resulted in a significant reduction (by almost half) of 
NFRKB expression, suggesting that UCHL5 stabilizes and protects NFRKB from 
degradation, perhaps via its ubiquitylation activity. A similar phenotype resulted from 
either individual or combined depletion of UCHL5 and YY1, observed as a reduction in 
HR efficiency, RPA intensity, RAD51 foci formation, and IR resistance, together with a 
reduction in the recruitment of EXO1, but not CtIP. This suggests that ubiquitination 
and degradation of NFRKB, which is regulated by UCHL5, is a key factor that controls 
the extensive resection during HR (Nishi et al., 2014). Another group also reported a 
mild defect in resection, manifested as a slight reduction in the percentage of cells with 
RPA foci, in a stable INO80 knockout cell line (Dong et al., 2014). These multiple lines 
of evidences suggest that the INO80 complex is involved in resection; however, the 
exact roles played by INO80 in this process remain unknown. 
The literature does not provide clear evidence that INO80 is involved in regulating the 
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formation or accumulation of RAD51 foci. Gospodinov et al. (2009) showed that, in 
mammalian cells lacking RUVBL (TIP49), accumulation of RAD51 foci in response to 
irradiation decreased 2-fold relative to the control; however, because this subunit 
belongs to multiple chromatin-remodelling complexes (INO80, TRRAP-TIP60, and 
SRCAP), it was necessary to determine which RUVBL-containing complex mediates 
this effect on RAD51 foci. The authors treated the cells with sodium butyrate, a histone 
deacetylase inhibitor, resulting in hyperacetylation and relaxation of chromatin. As a 
result, RAD51 foci were completely restored, and the authors therefore attributed the 
activity of RUVBL to its association with TRRAP-TIP60, a HAT, rather than INO80. 
Subsequently, however, the same authors (Gospodinov et al., 2011) reported that 
absence of the INO80 subunit causes a severe reduction in the recruitment of 53BP1, a 
DNA repair protein, but has no concomitant effect on formation of RAD51 foci. This	discrepancy	 raises	 questions	 and	 suggests	 that	 further	 studies	 are	 required	 to	understand	the	role	of	INO80	in	DNA	repair	(see discussion in chapter 3). However, 
in haploid yeast, in which the homologous donor chromosome is absent, lack of Arp8 
results in defective RAD51 recruitment, whereas in the presence of the homologous 
donor (i.e., when DSBs are repairable) no defect in RAD51 accumulation is observed 
(Tsukuda at al., 2009). These conflicting observations suggest that RAD51 might be 
regulated indirectly by INO80; however, additional studies will be required to test this 
idea. 
Defects in INO80, RUVBL, or YY1 cause UV hypersensitivity in both mouse (Wu et 
al., 2007) and human (Park et al., 2010) cells, and the recruitment of INO80 to DSBs 
induced by laser-microirradiation in human cells (Kashiwaba et al., 2010) clearly 
reflects its association with DNA repair in mammals. Consistent with these 
observations, a GFP reporter system revealed a severe defect in HR repair efficiency 
	 66	
(approximately 8-fold decreased relative to control cells) caused by the absence of 
either INO80 or YY1 (Wu et al., 2007). Therefore, it is clear that loss of INO80 results 
in a failure of DSB repair, at least to some extent.  
How, then, does INO80 promote DNA repair in mammalian cells? One possible answer 
is that INO80 regulates the expression of genes that are involved in repair. An analysis 
of published microarray data and an immunoprecipitation study revealed that expression 
of RAD54B and XRCC3, both of which are implicated in DSB repair, is repressed by 
depletion of INO80 in human cells (Park et al., 2010). However, the fact that INO80 is 
recruited to DSBs weakens this model. An alternative possibility is that INO80 acts as a 
chromatin remodeller to regulate the removal, exchange, and spacing of histones near 
DSBs, thereby opening the damage site and providing access to factors involved in 
repair. A conclusive demonstration of such an effect remains elusive; future efforts 
should address this issue in mammalian cells, with support from data obtained in yeast. 
A ChIP study shows that enrichment of histones H2B and H3 at DSBs is reduced in 
INO80-depleted cells; this observation was interpreted as a reflection of eviction 
activity at break sites (Tsukuda et al., 2005). The ability of the INO80 subunits, YY1 
and RUVBL1/2, to bind Holliday junctions in vitro, together with the involvement of 
the complex in resection, supports a possible role for the INO80 complex as a chromatin 
remodeller acting to reorganize the chromatin, particularly in these two steps of DSB 
repair, which require further modifications (Jeggo & Downs, 2014).  
INO80 was previously linked to H2AZ, a variant of H2A, in the context of its role as a 
transcriptional regulator. Moreover, H2AZ was recently shown to be critical for HR 
repair in mammals (Xu et al., 2012), providing potential insight into the possible 
function of INO80 at DSBs; this issue will be addressed in detail later in this chapter. 
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Importantly, these models are not mutually exclusive, and it is very likely that both 
functions of INO80 are involved in DSB repair. Investigation of INO80 function during 
HR in response to DSBs is one of the major targets for this thesis, and further published 
data relating to this role will be provided in chapters 3 and 4 (Lopez-Perrote et al., 2014; 
Alatwi & Downs, 2015). 
1.3.7 H2AZ: A critical histone variant involved in DNA repair 
Evidence from ChIP experiments in yeast (Kalocsay et al., 2009) and mammals (Xu et 
al., 2012) demonstrates the physical enrichment of H2AZ at DSBs. A report from the 
Price laboratory describes the extensive characterization of the role of H2AZ in DNA 
repair in human cells (Xu et al., 2012). In that study, the authors confirmed the 
exchange of H2AZ at DSBs by ChIP, taking advantage of the zinc finger nucleases 
(p84-ZFN and p230-ZFN). Remarkably, H2AZ accumulated at DSBs within 4 h, 
similar to γH2AX, but with a lower level of enrichment. H2AZ exhibited the ability to 
spread around DSBs for approximately 10–50 kb along the chromatin, also similar to 
the behaviour of γH2AX. In addition, the study revealed a new role for P400 in the 
exchange of H2AZ with the canonical H2A histone at DSBs; either inactivation or 
deletion of P400 caused a significant reduction (approximately 2-fold) in H2AZ 
enrichment at DSBs. Moreover, Xu et al. (2012) showed that the incorporation of H2AZ 
at DSBs is important for acetylation, based on similar defects in enrichment of 
acetylated histone H4, in the absence of H2AZ, P400, or TIP60. Immunofluorescence 
analysis of H2AZ-depleted cells revealed a severe reduction, if not complete abolition, 
of ubiquitination (FK2 foci) and BRCA1 foci formation. However, ATM activation, 
H2AX phosphorylation, and recruitment of MDC1, 53BP1, and CtIP were not impacted 
by the absence of H2AZ. Together, these data suggest that H2AZ depletion may 
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negatively impact HR. To test this idea, the authors used a GFP HR reporter system that 
revealed a moderate reduction in the level of HR compared with that of the control in 
H2AZ-depleted cells.  
Surprisingly, the NHEJ pathway was also defective in H2AZ-depleted cells. Therefore, 
additional experiments were performed to assess resection and KU70/80, critical factors 
in HR and NHEJ, respectively (Xu et al., 2012). In yeast, it was reported that H2AZ 
deletion caused a delay in resection, observed as a lag in RPA recruitment to DSBs, 
which was monitored by a ChIP assay for Rfa1, a RPA subunit (Kalocasy et al., 2009). 
Unexpectedly, in human cells resection was defective, as an increase in RPA and BrdU 
foci was observed, whereas KU70/80 was lost. However, inhibition of ssDNA 
formation in H2AZ-depleted cells by silencing of CtIP rescued the reduction of 
KU70/80 as well as the defect in NHEJ. These results led the authors to argue that, 
when both HR and NHEJ are defective, cells must activate a backup repair pathway. As 
cells lacking KU70 could repair DSBs via the Alt-NHEJ pathway, a process requiring 
CtIP rather than KU70/80, the authors speculated that, in the absence of H2AZ, cells 
repair DSB via Alt-NHEJ. This model was confirmed by observation of Alt-NHEJ in 
cells lacking H2AZ, using a GFP-Alt-NHEJ reporter system (Xu et al., 2012). Together, 
these lines of evidence emphasize the importance of the role of H2AZ at DSBs; 
however, little is known about the mechanism of H2AZ exchange at DSBs in mammals, 
and this thesis reveals for the first time a role for INO80 in regulating the removal of 
H2AZ at DSBs in human cells (Alatwi & Downs, 2015); more details will be provided 
in chapter 4. 
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1.4 Chromosome instability  
Chromosomal insatiability (CIN) is a type of genomic instability that has been observed 
in many solid tumours and various haematological malignancies, and is strongly 
associated with several types of cancer, including breast, lung, and colon cancer. CIN 
refers to a dynamic state, where cells continuously gain or lose whole chromosomes or 
parts of chromosomes. Tumours may exhibit one of two types of CIN: numerical CIN 
(nCIN), caused by loss or gain of whole chromosomes at a higher rate than normal cells, 
and structural CIN (sCIN), caused by an increased rate of structurally abnormal 
chromosomes (McGranahan et al., 2012). The main cause for nCIN is chromosome 
missegregation, while sCIN can result from aberrant DNA repair pathways, telomere 
dysfunction, and chromosomal fragile sites, with a phenotype of gain or loss of 
chromosome fragments, deletion, amplification, and translocation of DNA 
(McGranahan et al., 2012). In this section, I will provide an overview of mitotic 
chromosome segregation and centromere structure, as a key factor in the maintenance of 
proper segregation, and a summary of the known roles of INO80 in chromosomal 
stability. 
1.4.1 Chromosome segregation in mitosis in human cells: an overview 
During interphase, cells undergo growth phase (G1 phase), DNA replication (S phase), 
and another growth phase (G2 phase), before preparing to enter mitosis. Mitosis 
consists of five sub-phases: prophase, prometaphase, metaphase, anaphase, and 
telophase. Upon entry to mitosis (prophase), chromosomes condense and centromeres 
form to facilitate the recruitment of kinetochore proteins and centrosomes to form the 
two poles of the mitotic spindle (Verdaasdonk & Bloom, 2011; Cheeseman & Desai, 
2008; Sullivan & Morgan, 2007). Moreover, and importantly, cohesin is released from 
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chromatin except in the centromeric region, which is protected by shogoshin 1, to allow 
proper segregation (Losada, 2014). Cohesin is a ring complex consisting of SMC1, 
SMC3, RAD21, and either SA1 or SA2, required for sister chromatid cohesion. During 
prometaphase, the nuclear envelope breaks down and kinetochores attach to spindle 
microtubules. In metaphase, all chromosomes undergo bi-oriented attachment to the 
spindle; inappropriate attachment or mono-oriented attachment causes an arrest in 
metaphase. Once all chromosomes are properly attached, tension is generated, resulting 
in activation of Cdc20, which binds to APC to form the APC-Cdc20 complex. APC-
Cdc20 degrades securin, leading to activation of separase. Active separase will cleave 
centromeric cohesin and facilitate sister chromatid separation during anaphase. Finally, 
during telophase, chromatids decondense and the nuclear envelope re-forms, resulting 
in two daughter cells, each of which has an exact copy of the duplicated genome 
(Verdaasdonk & Bloom, 2011; Cheeseman & Desai, 2008; Sullivan & Morgan, 2007). 
1.4.2 Centromere structure 
The centromere is a unique region of mitotic chromosomes that is essential in linking 
sister chromatids and serves as a loading platform to assemble the kinetochore, a special 
structure that forms on both sides of the centromere to facilitate attachment to spindle 
microtubules. In addition, cohesin and condensin (a multi-subunit complex essential for 
the structure and function of chromosomes) are enriched at centromeres, serving to 
generate tension and facilitate chromosome segregation (Verdaasdonl & Bloom, 2011; 
Bloom, 2014). 
The centromere itself is constructed of a defined sequence that varies in length among 
species. For example, simple eukaryotes, such as budding yeast, have a centromere 
consisting of 125 bp, while human centromeres can be up to 5 Mb in length and contain 
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between 1 and 4 Mb of 171 bp alpha satellite repeats, known as a regional centromere. 
Despite this, it is widely believed that the unique chromatin structure of centromeres is 
the main determinant of their function, rather than their specific sequence (Verdaasdonl 
& Bloom, 2011; Bloom, 2014). 
What is special about chromatin at centromeres? Chromatin can be categorized into two 
regions at centromeres: centromeric and pericentric. Centromeric chromatin is identified 
by the deposition of the histone variant CENP-A (see 1.2.3.1) and enrichment of 
H3K4me2, which is associated with euchromatin (Verdaasdonl & Bloom, 2011; Bloom, 
2014). Depletion of H3K4me2 results in a lack of HJURP, a complex that deposits 
CENP-A into chromatin, and abolishes CENP-A deposition at centromeres (Bergmann 
et al., 2011). By contrast, pericentric chromatin, which flanks the centromeric region, is 
enriched in H3K9me2, H3K9me3, and H4K20me3, and is associated with 
heterochromatin (Verdaasdonl & Bloom, 2011; Bloom, 2014). These PTMs are 
important for recruiting cohesin, maintaining pericentric structure, and accurate 
segregation (Verdaasdonl & Bloom, 2011). By contrast, loss of H4K20me3 is a 
hallmark of human cancer and can result in aberrant centromere function and a 
consequent increase in the level of aneuploidy (Fraga et al., 2005; Verdaasdonl & 
Bloom, 2011).  
Histone variant H2AZ is enriched in centromeric and pericentric chromatin in both 
humans and mouse. Interestingly, CENP-A-containing nucleosomes contain H2A, 
while H2AZ is associated with H3K4me2-containing nucleosomes and to a lesser extent 
with H3K9me3 (Greaves et al., 2007). H2AZ-containing nucleosomes function as a 
boundary between euchromatin and heterochromatin (Meneghini et al., 2003). A study 
in fission yeast showed that loss of H2AZ results in loss of silencing at centromeres and 
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defects in chromosome segregation. They found that H2AZ functions in silencing 
centromeres via regulation of the expression of CENP-C, a centromere protein required 
for centromere silencing. Overexpression of CENP-C rescues the defect caused by 
H2AZ depletion (Hou et al., 2010). Recently, it was revealed that incorporation of 
H2AZ in pericentric chromatin is regulated by the heterochromatin state at this region, 
since alteration of the state of pericentric heterochromatin, using either SUV39h double-
null MEFs that lack H3K9me3, or inhibition of methylation by treatment of NIH3T3 
fibroblasts with 5’-aza 2’-deoxycytidine, leads to enrichment of H2AZ at pericentric 
heterochromatin. Further, the state of pericentric heterochromatin influences the centric 
chromatin state by altering the level of CENP-A (Boyarchuk et al., 2014). 
1.4.3 The role of INO80 in chromosomal stability 
The first indication that the INO80 complex plays a role in chromosome segregation 
came from the Downs laboratory (Chambers et al., 2012). Their study showed that the 
absence of either Ies6 or Ino80 leads to a defect in chromosome segregation; the authors 
attributed this phenotype to an alteration in pericentric chromatin (i.e., chromatin 
flanking the centromeres) rather than changes to centromeric nucleosomes themselves. 
Furthermore, the study revealed that H2AZ enrichment in pericentric chromatin is 
altered in strains lacking Ies6 and Ino80, and that overexpression of H2AZ accelerates 
development of polyploidy, whereas down-regulation of H2AZ prevents it. The authors 
ultimately attributed these alterations to misincorporation of H2AZ, and concluded that 
the INO80 complex is involved in the maintenance of genome stability.  
In support of this idea, a mammalian study from the Shi laboratory also showed that 
loss of YY1 (an INO80 subunit) causes polyploidy and chromosomal abnormalities, 
including chromosome and chromatid breaks, and triradial or quadriradial chromosomes 
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(Wu et al., 2007). These authors investigated the potential causes of this phenotype by 
performing FACS analysis on cells exposed to UV-C radiation to monitor defects in cell 
cycle progression. Since no defect was observed during the G1/S and G2/M 
checkpoints, the phenotype was attributed to a direct function of YY1 in DNA repair. 
Further, a recent study reported an up-regulation of premature separation of sister 
chromatids, with an increase in chromosome breaks in metaphase, caused by down-
regulation of INO80 in the CH12-F3 cells, a lymphoma cell line (Kracker et al., 2015).  
Finally, as mentioned previously, INO80 is a negative regulator of p21, which is a 
potent CDK inhibitor that regulates the G2/M cell cycle phase (Cao et al., 2015). The 
same study showed that INO80 also regulates other M phase checkpoint proteins, 
including MAD2L1 (See 1.2.5.1 for more details). Further, silencing of INO80, using 
siRNA in a p53+/+ HCT116 cell line, resulted in an increase of cells with large nuclei, 
most of which showed high expression of p21. Remarkably, depletion of INO80 using 
siRNA also resulted in a significant increase in the number of cells with more than two 
centrosomes per nucleus, aberrant cytokinesis, and multipolar spindle formation (Cao et 
al., 2015). These multiple lines of evidence indicate that INO80 plays fundamental roles 
in chromosome stability. How this type of chromatin remodeller is associated with this 
pathway remains elusive; it may be through negative regulation of p21 expression, or 
alternatively as a result of a more direct role in mediating kinetochore attachments, for 
example. Determination of the answer to this question was established as one of the 
aims of this thesis. 
 
 
 
 
	 74	
1.5 Thesis objectives  
This thesis aimed to investigate and identify the roles of the mammalian INO80 
complex across three major areas.  
 
First, work from the Shi laboratory has identified that YY1 functions as a subunit of the 
human ATPase chromatin remodelling complex INO80. Furthermore, they showed that 
YY1 is able to bind HJs in vitro and interact with the RuvB homologs RUVBL1 and 
RUVBL2, suggesting that YY1 might represent the mammalian ortholog of bacterial 
RuvA (Wu et al., 2007). Therefore, the major aims for Chapter 3 were to investigate 
whether human YY1 exhibits a similar structure to bacterial RuvA, forms multimers in 
vivo, and/or has the ability to function together with RUVBL1/2 in vivo to promote HR. 
 
Second, evidence from yeast (Downs et al., 2004; Morrison et al., 2004; Van Attikum et 
al., 2004) and mammals (Gospodinov et al., 2008, 2011; Kashiwaba et al., 2010) has 
confirmed the involvement of INO80 in HR repair, although the exact mechanism 
impacted by INO80 in this repair pathway has remained unclear. Yeast INO80 regulates 
the removal of H2AZ from chromatin (Papamichos-Chronakis et al., 2011) and 
evidence from human cells has indicated the critical role of H2AZ incorporation in DSB 
repair (Xu et al., 2012). Hence, the experiments in Chapter 4 aimed to test whether 
INO80 promotes HR via a pathway that involves the removal of H2AZ from damaged 
chromatin. 
 
Finally, a study on yeast from our laboratory revealed a new role for INO80 in 
chromosome segregation via a pathway that regulates H2AZ enrichment within 
centromeric structures (Chambers et al., 2012). Chromosomal instability represents a 
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hallmark for most advanced cancer such as colon, lung, and cervical tumours (Tanaka 
& Hirota, 2016; McGranahan et al., 2012). Thus, the aims of Chapter 5 were to 
highlight the role of mammalian INO80 in maintaining chromosomal stability and to 
test the suitability of INO80 as a therapeutic target for CIN+ tumour cells. 
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2.1 Cell lines and culturing conditions 
The cell lines used in this study were as follows: 
§ 1BR-hTERT: Immortalised human fibroblasts  
§ A549: Human lung adenocarcinoma epithelial cell line 
§ HeLa: Human cervical cancer cell line 
§ U2OS: Human osteosarcoma cell line (CIN+) 
§ RKO:  Human colorectal carcinoma cell line (CIN−) 
§ DLD1: Human colorectal adenocarcinoma cell line (CIN−) 
§ HT-29: Human colorectal adenocarcinoma cell line (CIN+) 
§ NCIH747: Human colorectal adenocarcinoma cell line (CIN+) 
 
A549, HeLa, and RKO cell lines were complemented with MEM Complete medium 
comprised of minimum essential medium (MEM) (Gibco) supplemented with 10% 
foetal bovine serum (Gibco) and 1% penicillin and streptomycin (Gibco). 1BR-hTERT, 
U20S, and HT-29 cells were cultured in Dulbecco’s MEM (Gibco) and DLD1 and 
NCIH747 cell lines were cultured in PRMI (Gibco) containing 15% foetal bovine serum 
and 1% penicillin/streptomycin. All cells were incubated at 37°C in a humidified 95% 
air and 5% CO2 atmosphere. 
2.2 Irradiation (IR) 
Cells were irradiated by exposure to a 137Cs source at a dose rate of 1 Gy/9 s. For G2 
phase experiments, 4 μM aphidicolin (Sigma-Aldrich; A4487) was added to prevent S-
phase cells from progressing into G2. 
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2.3 Small interfering RNA (siRNA) knockdown conditions 
siRNA-mediated knockdown was performed using: 
1) HiPerFect Transfection Reagent (Qiagen) for the experiments described in Chapters 
3 and 4, using the following transfection conditions: 
Per 4 × 105 cells in 4 ml media, the following reaction mixture was assembled and then 
added to suspended cells following a 10 min incubation at room temperature (RT): 
• 20 µM siRNA from 50 mM stock siRNA solutions 
• 12 μl Hiperfect transfection reagent 
• 200 μl OptiMEM (Gibco). 
The cells were then grown for 24 h and another round of transfection was carried out. 
The cells were then grown for an additional 48 h prior to IR.  
 
2) Lipofectamine RNAiMAX Transfection Reagent (Invitrogen) for the experiments 
described in Chapter 5, using the following transfection conditions: 
Per 4 × 105 cells in 4 ml media, the following reaction mixture was assembled and 
added to suspended cells following a 10 min incubation at room temperature (RT): 
•  20 µM siRNA from 50 mM stock siRNA solutions 
• 2.5 μl  Lipofectamine RNAiMAX Transfection Reagent 
• 500 μl OptiMEM. 
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Table 2. 1 siRNA oligos used in this project. 
siRNA Supplier  Sequence  
INO80 Dharmacon SMARTpool siRNA 
INO80 Origene SMARTpool siRNA 
YY1 Dharmacon SMARTpool siRNA 
RUVBL2 (TIP49b) Dharmacon SMARTpool siRNA 
BRCA2 Dharmacon SMARTpool siRNA 
H2AZ Dharmacon SMARTpool siRNA 
ANP32E Dharmacon 5ʹ-CGGCUUCCCAGCUUAAAUA-3ʹ 
SRCAP Dharmacon SMARTpool siRNA 
 
2.4 Immunofluorescence for HR analysis 
Cells plated on cover slips were fixed for 10 min with 4% paraformaldehyde (PFA) in phosphate	 buffered	 saline (PBS) (v/v) (Electron Microscopy Sciences; 15710), and 
permeabilised for 1 min with 0.2 % Triton X-100 in PBS. For RPA or Rad51 foci, pre-
extraction was achieved by incubating the cells with 0.2 % Triton X-100 in PBS for 
0.5–1 min prior to PFA fixation, during which process the non-chromatin bound protein 
would be removed allowing for clear visualization of the remaining protein. Then, cells 
were washed with PBS and incubated with primary antibody diluted in 2% (w/v) bovine	 serum	 albumin (BSA) in PBS for 1 h at RT. Cells were then washed three 
times and incubated with secondary antibody (diluted in 2% (w/v) BSA in PBS) for 30 
min at RT in the dark. Slides were mounted using VECTASHIELD+DAPI (Vector 
Laboratories Ltd.) and visualized using a Nikon e400 microscope for counting; for 
imaging, an Applied Precision® DeltaVision® RT Olympus IX70 deconvolution 
microscope and softWoRx® Suite software were used. In each sample a minimum of 25 
cells was scored blindly; error bars represent the SD error between three independent 
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experiments. 
2.5 Western blotting (WB)  
Cells were lysed by resuspension in Laemmli buffer and sonicated using a Diagenode 
Bioruptor sonicating waterbath for 2 cycles using pulses of 30 s on and 30 s off. 
Samples were then electrophoresed and immobilized on nitrocellulose membranes. The 
membranes were blocked with 5% milk (Marvel milk powder in Tris-buffered saline 
with 0.1% Tween 20 (TBST) buffer) for 1 h at RT. Primary antibodies were then added 
to the membrane at the appropriate dilution in 5% milk and incubated overnight at 4°C. 
The membranes were then washed 3 times with TBST buffer and incubated with the 
secondary antibody for 1 h at RT. Pierce® ECL Western Blotting Substrate was used 
for the chemiluminescent detection of secondary antibodies; blots were exposed to 
chemiluminescence-sensitive film in the dark room and the films were developed. 
Table 2. 2 Primary antibodies used in this project. 
Antibody Supplier Catalogue No. Concentration 
γH2AX Millipore 05-636 1:800 
RPA Millipore NA18 1:100 
RAD51 Santa Cruz 
Biotechnology 
SC_8349 1:200 
CENP-F Abcam ab5 1:1000 
CENP-A Abcam ab13939 1:100 
INO80 Abcam ab118787 1:2000 
INO80 Bethyl A303-371A 1:2000 
YY1 Santa Cruz 
Biotechnology 
H-414 1:1000 
RUVBL2 Abcam ab36569 1:5000 
H2AZ Cell Signaling 
Technology 
2718S 1:1000 
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ANP32E Sigma-Aldrich SAB2100124 1:1000 
Ku80 Abcam ab33242 1:1000 
KAP-1 Abcam ab22553 1:1000 
Tubulin  Abcam ab7750 1:10000 
 
Table 2. 3 Secondary antibodies used in this project. 
Antibody Supplier Catalogue No. Concentration 
FITC Sigma Aldrich F0257 1:100 
CY3 Sigma Aldrich C2306 1:200 
AlexFluor 488 Invitrogen A21206 1:400 
AlexFluor 555 Invitrogen A21422 1:400 
Goat Anti-Rabbit 
HRP 
Dako P0449 1:2000 
Rabbit Anti-Mouse 
HRP 
Dako P044801-2 1:2000 
Rabbit Anti-goat 
HRP 
Dako P0449 1:2000 
 
2.6   Sister chromatid exchange (SCE) assay 
HeLa cells (2 × 105 cells) were double transfected with siRNA oligos. At 24 h following 
transfection, the cultures were grown for two cell cycles (approximately 48 h) in the 
presence of 15 μM BrdU (Sigma-Aldrich). Cells were treated with 100 μg mitomycin C 
(Sigma-Aldrich) for the last 16 h of the 48 h culture period. Colcemid (Sigma-Aldrich) 
was added at a final concentration of 0.1 μg/ml 2 h before harvesting cells. The 
harvested cells were swelled in 60 mM KCl for 15 min at RT and then fixed with 
methanol/glacial acetic acid (3:1). Next, the fixed cell suspension was dropped onto 
glass slides and air-dried overnight. Slides were then stained with 10 μg/ml Hoescht 
33258 (Sigma-Aldrich) for 20 min, UV-irradiated (355 nm) for 1 h, heated at 60°C for 1 
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h, and stained with Giemsa (1:20 diluted in dH2O; Sigma-Aldrich: 32884) for a 
maximum of 5 min. Slides were then rinsed, air-dried overnight, and mounted with 
Eukitt quick-hardening mounting medium (Sigma-Aldrich). Slides were visualized 
using a Zeiss light microscope and Simple-PCI software. SCEs were scored in a 
minimum of 1000 chromosomes; error bars represent the SD error between three 
independent experiments. 
2.7   Bimolecular fluorescence complementation assay (BiFC)  
2.7.1 Cloning  
2.7.1.1 Plasmids and constructs  
The pBiFC plasmid was provided by Dr. Chang-Deng Hu (Addgene). The coding 
region of the human YY1 gene was amplified from YY1 cDNA and cloned into the BiFC 
plasmids to generate YY1_VN and YY1_VC. Similarly, the coding region of the human 
RUVBL2 gene was amplified from RUVBL2 cDNA and cloned into pBiFC_VC to 
generate RUVBL2_VC.  
Table 2. 4 Plasmids and components used for cloning.  
Plasmid Source  Description  
pBiFC_VN Addgene; 22010 
(pBiFC_VN173) 
Mammalian expression vector encoding 
the N-terminal region of fluorescent 
protein Venus, CMV promoter, AMPR 
pBiFC_VC Addgene; 22011 
(pBiFC_VC155) 
Mammalian expression vector encoding 
the C-terminal region of fluorescent 
protein Venus, CMV promoter, AMPR 
YY1 cDNA Source BioScience Human full length cDNA 
RUVBL2 cDNA Origene; 
NM_006666 
Human cDNA open reading frame (ORF) 
clone 
YY1_VN Generated for this Mammalian expression vector encoding 
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study the YY1 gene and the N-terminal region of 
fluorescent protein Venus, CMV 
promoter, AMPR 
YY1_VC Generated for this 
study 
Mammalian expression vector encoding 
the YY1 gene and the C-terminal region of 
fluorescent protein Venus, CMV 
promoter, AMPR 
RUVBL2_VC Generated for this 
study 
Mammalian expression vector encoding 
the RUVBL2 gene and the C-terminal 
region of fluorescent protein Venus, CMV 
promoter, AMPR 
 
Table 2. 5 Oligonucleotides used for cloning. 
Oligo 
no. 
Name Sequence (5' to 3') Application 
1688 YY1-VN_F 
 
CGATGAATTCAATGG
CCTCGGGCGACACCCT 
 
Forward primer for cloning YY1 
into pBiFC_VN using the EcoR1 
site 
1689 YY1-VN_R CTTCAGATCTATCTGG
TTGTTTTTGGCCTTAG 
Reverse primer for cloning YY1 
into pBiFC_VN using the BglII 
site 
1690 YY1-
VC155_F 
CGATGAATTCGGATG
GCCTCGGGCGACACC
CT 
Forward primer for cloning YY1 
into pBiFC_VC using the EcoR1 
site 
1691 YY1-VC_R TCTAAGATCTCCTGGT
TGTTTTTGGCCTTAG 
Reverse primer for cloning YY1 
into pBiFC_VC using the BglII 
site 
1692 RUVBL2-
VC_F 
CGATGAATTCGGATG
GCAACCGTTACAGCC
ACA 
Forward primer for cloning 
RUVBL2 into pBiFC_VC using 
the EcoR1 site 
1693 RUVBL2-
VC_R 
TCTACTCGAGATGGA
GGTGTCCATGGTCTCG 
Reverse primer for cloning 
RUVBL2 into pBiFC_VC using 
the XhoI site 
	 84	
1694 RUVBL2_F
_CH  
AAGATCTCCAAGCTG
GGCCGCTCCTTCACAC 
Forward primer to check the 
sequence of the RUVBL2 cDNA 
that was inserted in pBiFC_VC, 
located after the first 600 bp of 
the ORF 
 
2.7.1.2 PCR  
PCR-based DNA amplification was used for the amplification of the coding region of 
the YY1 and RUVBL2 genes and for verification of their integration. PCR was 
performed by using the KOD Hot Start DNA polymerase kit (Novagen) following 
manufacturer protocol. Amplified DNA products were purified using the QIAquick 
PCR Purification Kit (Qiagen) following manufacturer protocol. 
2.7.1.3 Restriction Digestion  
To generate YY1_VN and YY1_VC, sequential restriction digests of DNA were carried 
out in 10 µl reaction volumes using 8 µl DNA, 0.5 µl BglII restriction enzyme (New 
England Biolabs), and 1 µl of the appropriate NE Buffer. The reaction tubes were incubated 
overnight at 37°C. Next, 0.5 µl EcoR1 restriction enzyme (New England Biolabs) was 
added to the reaction followed by incubation for 3 h at 37°C. However, to generate 
RUVBL2_VC, double restriction digestion of the DNA was performed utilizing both of 
the relevant restriction enzymes simultaneously; the reaction tubes were incubated 
overnight at 37°C. 
2.7.1.4 DNA ligation 
Ligation of DNA fragments into the appropriately digested plasmids was performed 
using T4 DNA Ligase (New England Biolabs) by mixing the following in 1.5 ml 
Eppendorf tubes: 25 ng vector DNA, 75 ng insert DNA, 1 μl ligase buffer, 1 μl T4 DNA 
ligase, and H2O to a total volume of 10 μl; the reaction tubes were then incubated 
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overnight at RT. Insert DNA and linearized plasmid DNA were mixed in a ratio of 3 insert: 
1 vector, according to the following equation:  
 !!"#$% !"#$ × 3 × 25 !" (!"#$%& !"#$%&!' !"#$)!"#$%& !"#$  
 
2.7.1.5 Transformation of bacteria with the ligated plasmids 
For each ligation reaction, 50 μl competent cells (XL1 blue) were added. The mixtures 
were incubated on ice for 40 min, subjected to heat-shock at 42°C for 1 min, then 
immediately placed back on ice for 2 min. Next, 500 μl Luria-Bertani (LB) broth media 
free of antibiotic was added to each reaction tube followed by incubation for 30 min in a 
30°C shaker incubator. The tubes were then spun at 13,000 rpm for 1 min, the 
supernatant was discarded, and the pelleted bacteria were plated on LB agar plates 
containing the appropriate antibiotic (Ampicillin, 100 μg/ml; Sigma). The plates were 
incubated overnight at 37°C. Individual colonies were picked and grown in 2 ml LB 
medium containing the appropriate antibiotic overnight in a 30°C shaker incubator.	
DNA was extracted using QIAprep Spin Miniprep or Maxiprep kits (Qiagen) as 
described in the manufacturer protocol. 
2.7.1.6 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments by size. DNA samples 
containing 1× loading buffer (1 part loading dye, 5 parts 30% glycerol) in a volume of 
12 μl were loaded onto a 1% agarose gel (1× TAE (40 mM Tris·acetate, 2 mM 
Na2EDTA·2H2O, pH 8.5) and 3 μl ethidium bromide). In addition, 12 μl of an 
appropriate ladder (New England Biolabs) was loaded in a separate lane. Following 
separation based on charge (80 V, room temperature), the DNA fragments were 
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visualised using a UV light imager and cut out of the gel using a clean scalpel. DNA 
was extracted from the agarose gel using a QIAquick Gel Extraction Kit (Qiagen) 
following manufacturer protocol. 
2.7.2 BiFC assay  
For the BiFC assay, 1.5 × 105 U2OS cells were plated on a coverslip and co-transfected 
with 0.25 μg VN- and VC-driven plasmids using the NanoJuice Transfection Reagent 
Kit (Novagen). At 24 h post transfection, cells were irradiated with 5 Gy γ-IR, fixed 
with 3% (w/v) PFA, permeabilised with 0.5% Triton X-100 in PBS for approximately 
30 min, and mounted using VECTASHIELD+DAPI. Slides were analysed and imaged 
using an Applied Precision® Delta Vision® RT Olympus IX70 deconvolution 
microscope. 
2.7.3 Laser microirradiation used for tracking BiFC foci  
To track BiFC foci, 2 × 105 U2OS cells were plated onto 35-mm glass-bottom dishes 
(MatTek) and co-transfected with YY1_VN and YY1_VC constructs using a NanoJuice 
Transfection Reagent Kit. The cells were allowed to express the constructs for 24 h and 
were then incubated with 10 μg/ml Hoechst 33285 for 1 h at 37°C prior to IR. BiFC 
positive cells were irradiated with a v405 laser line (20% power/2000 repetition) 
through a 60× objective using a Spinning Disc confocal microscope and Slidebook 5.5 
software. Images were captured at 10 s intervals following laser damage for a total time 
of 2 min. 
 
	 87	
2.8  Laser microirradiation used for tracking protein dynamics at 
sites of damaged chromatin 
Exponentially growing human U2OS cells were plated onto 35-mm glass-bottom dishes 
and transfected with pTGFP-H2AZ, pEGFP-RUVBL2 (Origene), or pEGFP-H2B using 
NanoJuice according to the manufacturer’s protocol. The cells were allowed to express 
the construct for 24 h and were then incubated with 10 μg/ml Hoechst 3458 for 30 min 
at 37°C prior to irradiation. The microscope system used was an Intelligent Imaging 
Innovations spinning disk confocal microscope with a Yokogawa CSU-X1 spinning 
disk device on an Olympus IX-71 confocal microscope. GFP positive cells were 
irradiated with a 405 nm ultraviolet laser set at power of 7:1000 for either H2AZ or 
H2B and at 30:1000 for RUVBL2 and channelled through a 60× objective. Images were 
captured at 10 s intervals following laser damage for a total time of 5 min for H2AZ and 
H2B and 30 min for RUVBL2. The generated images were acquired using a 
Photometrics Evolve 512×512 EMCCD camera using Slidebook 6 software. In protein 
recruitment experiments, signal intensity was quantified along the laser path using 
Slidebook 6 software in a minimum of 10 cells; error bars represent the SD between 
three independent experiments. 
Table 2. 6 Plasmids used in laser microirradiation experiments for tracking protein dynamics at 
sites of damaged chromatin. 
Plasmid Source  Description  
pTGFP-H2AZ Origene Mammalian expression vector, 
TGFP under the control of the 
CMV promoter, AMPR 
pEGFP-RUVBL2 Origene Mammalian expression vector, 
EGFP under the control of the 
CMV promoter, AMPR 
pEGFP-H2B Hocheggerlab’s laboratory  Mammalian expression vector, 
EGFP under the control of the 
CMV promoter, AMPR 
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2.9 Resection assay 
Cells were treated for 1 h with 1 mM camptothecin (Sigma-Aldrich) and left to recover 
for 1 h. Recovered cells were then stained, and γH2AX positive cells were scored as 
described previously (section 2.4) for a minimum of 100 cells per experiment. 
2.10   Analysis of micronuclei and abnormal mitosis 
Prior to observation, 2 × 105 cells were double-transfected with siRNA oligos, plated on 
cover slips, and left to grow for 24 h. Transfection cultures were then fixed for 10 min 
with 4% PFA in PBS (v/v). Slides were mounted with VECTASHIELD+DAPI and 
visualized using an EVOS® FL microscope (AMG) for counting. A minimum of 1000 
cells was scored blindly; error bars represent the SD error between two independent 
experiments. Images were obtained using an Applied Precision® Delta Vision® RT 
Olympus IX70 deconvolution microscope with softWoRx® Suite software.  
2.11 Analysis of aneuploidy  
For aneuploidy assessment, 2 × 105 cells were double transfected with siRNA oligos, 
plated on cover slips, and left to grow for 24 h. Transfection cultures were then fixed for 
10 min with 4% PFA in PBS (v/v). Cells were washed with PBS and incubated with 
primary antibody diluted in 2% (w/v) BSA in PBS for 1 h at RT. Cells were then 
washed three times and incubated with secondary antibody (diluted in 2% (w/v) BSA in 
PBS) for 30 min at RT in the dark. Slides were mounted with VECTASHIELD+DAPI. 
A minimum of 30 anaphase cells were imaged using an Applied Precision® Delta 
Vision® RT Olympus IX70 deconvolution microscope with softWoRx® Suite software. 
Deconvoluted images were then analysed using ImageJ Software and the numbers of 
	 89	
CENP-A foci were scored in all images; error bars represent the SD error between two 
independent experiments. 
2.12 Cell viability assay  
Viability assays were carried out in 96-well plates. Cells were counted and triplicate-
seeded in a total volume of 100 μl medium. Cell densities were optimized as follows: 
U2OS: 3000 cells/well, HT29: 2000 cells/well, NCIH747: 5000 cells/well, DLD1: 2000 
cells/well, and RKO: 4000 cells/well. Cells were incubated with 20 μl CellTiter-Blue 
reagent (Promega) for 1–3 hours before being read depending on the required time 
point. Fluorescence was measured using a microplate reader (Promega). Data represent 
a relative mean to the readout of the first time point (24 h) from three independent 
experiments.  
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recombination	
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3.1 Introduction 
YY1 (Ying Yang 1) represents a ubiquitous zinc-finger transcription factor belonging to 
the Polycomb Group protein family, which comprise a collection of homeobox gene 
regulators that are associated with haematopoiesis and cell cycle regulation. Human 
YY1 is a 414-amino acid protein with an estimated molecular weight of 44 KDa. The 
C-terminus of YY1 contains four C2H2-type zinc-finger motifs that characterize its 
transcriptional function as an activator or repressor. These motifs are vital for 
interaction with DNA as well as for protein-protein interaction (Houbaviy et al., 1996). 
However, the N-terminus is thought to be involved in transcriptional activation only; 
furthermore, it is followed by a glycine-rich domain and 11 consecutive histidine 
residues, the functions of which remain elusive. YY1 controls a range of cellular and 
viral genes through its ability to either activate or repress their expression; this 
transcriptional role has been extensively studied and reviewed elsewhere (Gordon et al., 
2005). Moreover, YY1 has been shown to be implicated in replication, embryogenesis, 
and cell growth, differentiation, and proliferation. Overexpression of YY1 in a range of 
cancer cells including; prostate, cervical, colorectal, ovarian, and breast cancers has 
further suggested its utility as a prognostic marker (Gordon et al., 2006). 
 
Previously, work from the Shi laboratory has identified that YY1 also functions as a 
subunit of the human ATPase chromatin remodelling complex INO80 (Wu et al., 2007). 
Therein, a double-tag experiment was performed to purify the Flag-HA-YY1 complex 
from HeLa cells, after which the proteins co-purified with the YY1 complex were 
identified by tandem mass spectrometry. This process identified seven subunits of the 
INO80 complex including INO80, RUVBL1, RUVBL2, ARP4, ARP5, ARP8, and β-
actin, as well as DNA-PKcs and KU86, components required for non-homologous end 
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joining repair, within the YY1 complex. The association of these factors with the 
complexes was then confirmed by western blotting and glycerol-gradient sedimentation, 
which failed to identify the KU86 component. In addition, YY1 was found to physically 
interact with the N-terminal and the middle segment of INO80, and interactions were 
identified with RUVBL1, RUVBL2, and ARP4 as well. Notably, glycerol-gradient 
sedimentation for the YY1 protein showed multiple bands with different molecular 
weights, suggesting the ability of YY1 to form multimers in vitro. Moreover, Wu et al. 
(2007) also demonstrated an association of the YY1-INO80 complex in homologous 
recombination (HR) repair as indicated by a decrease of approximately 13-fold in HR 
efficiency of I-SceI-induced double strand breaks (DSBs) in short hairpin (sh)YY1 
and/or shINO80 treated HR-293T and HT1080-1885 cell lines. Further in vitro evidence 
was provided by using a gel-shift assay to show the ability of YY1 to bind Holliday 
junctions (HJ), whereas CtIP (used as a control owing to its ability to bind ssDNA) and 
RUVBL1/2 failed to bind HJ in vitro (Wu et al., 2007). 
 
RUVBL1 and RUVBL2 are ATPases associated with diverse cellular activities (AAA+) 
proteins that exhibit 45% identity and 65% similarity in their sequence and are 
homologous to the bacterial helicase RuvB (Lopez-Perrote et al., 2012). RuvB is a 
subunit of the HJ branch-migration complex, which together with RuvA and RuvC 
provides the energy for the resolution of HJs (Mayanagi et al., 2008; Fujiwara et al., 
2008, Lopez-Perrote et al., 2012). All AAA+ proteins contain highly conserved motifs 
termed Walker A and Walker B that are responsible for ATPase activity and usually 
form a hexameric ring structure (Nano & Houry, 2013). The structures of human 
RUVBL1 and RUVBL2 have been determined and were found to form a dodecamer 
consisting of two heterohexameric rings, with alternating subunits in each ring, that 
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bound back-to-back via their internal DII domain (Figure 1.3) (Lopez-Perrote et al., 
2012). In addition, RUVBL1 and RUVBL2 have the ability to bind dsDNA and ssDNA 
as well (Matias et al., 2006). Notably, the binding domain for ssDNA, which comprises 
the N-terminal αβα subdomain of the AAA+ domain, is similar to the ssDNA binding 
domain of replication protein A (RPA) (Matias et al., 2006). RUVBL1 and RUVBL2 
are essential subunits of several complexes including INO80, SWR1, TIP60, PI3K 
(which regulates the activity of phosphatidylinositol 3-kinase), and R2TP (associated 
with the biogenesis of small nucleolar ribonucleoproteins (snoRNPs)) (Nano & Houry, 
2013) and are thus associated with a variety of cellular functions including transcription, 
DNA repair, telomere assembly, mitotic spindle assembly, and cancer (Nano & Houry, 
2013). 
 
The ability of YY1 to bind HJs in vitro and interact with the RuvB homologs RUVBL1 
and RUVBL2 suggests that YY1 might represent the mammalian ortholog of bacterial 
RuvA (Wu et al., 2007). In bacteria, RuvA forms an octamer (a pair of tetramers) that 
specifically binds HJ DNA and targets RuvB to the junction, where it forms two 
hexameric rings on either side of the RuvA octamer. Together, the two proteins form a 
complex that facilitates ATP-dependent branch migration of the junction (Figure 1.3) 
(Mayanagi et al., 2008). However, several related questions remain unanswered; i.e., 
whether human YY1 exhibits a similar structure to bacterial RuvA, forms multimers in 
vivo, and/or has the ability to function together with RUVBL1/2 in vivo to promote HR. 
To address these issues, we established a collaboration with the Llorca laboratory 
(López-Perrote et al., 2014), wherein they characterised the structure of YY1 for the 
first time and examined the ability of YY1 to bind multi-types of DNA. In turn, I tested 
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the ability of YY1 to form multimers in vivo and examined the role of YY1 during HR 
(López-Perrote et al., 2014). 
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3.2 Results 
3.2.1 YY1 forms multimers in vitro and in vivo 
As was mentioned above, it has been reported that YY1 can form multimers in vitro 
(Wu et al., 2007). To confirm this ability of the protein, our collaborator expressed a 
His-tagged YY1 in bacteria and then purified the full-length His-YY1. The purified 
complex was then subjected to oligomerisation analysis, in which the His-YY1 was first 
cross-linked for 30 minutes using a glutaraldehyde (GA) reagent and then analysed by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and western 
blotting with an anti-YY1 antibody. As can be seen in Figure 3.1, only monomeric His-
YY1 was detected in the control (i.e., His-YY1 without GA cross-linking); however, 
four cross-linked bands with different molecular weights were detected together with 
the monomer YY1 in the sample incubated with GA, confirming the ability of YY1 to 
form multimers in vitro (López-Perrote et al., 2014). Notably, this study also 
demonstrated that His-YY1 behaved as oligomers in size exclusion chromatography 
(SEC, a technique used widely to purify proteins depending on their sizes). 
Furthermore, it was found that His-YY1 migrated as two distinct molecules, termed 
complex A (approximately 100–150 kDa) and complex B (approximately 200–300 
kDa) (López-Perrote et al., 2014).  
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Figure 3. 1 YY1 multimerises in vitro.  
Western blot with an anti-YY1 antibody of His-YY1 after crosslinking with glutaraldehyde (GA); lane 1, 
molecular weight standards (Bio-Rad); lane 2, control without GA; lane 3, 30 minutes of incubation with 
GA. The His-YY1 monomer migrates as a 70 kDa protein in SDS-PAGE (labelled as *). Crosslinked 
bands, with relative molecular weights of multiples of the YY1 monomer, are labelled with arrows (from 
López-Perrote et al., 2014). 
 
 
Next, I attempted to determine whether the oligomerisation of YY1 also occurs in vivo. 
To this end, I used the bimolecular fluorescence complementation (BiFC) assay, which 
allows the ready observation of in vivo interactions between adjacent proteins. When the 
assay is successful, interaction is detected as a fluorescent signal (Figure 3.2A); 
however, in some cases even bona fide interactions cannot be detected using this 
method, either because the proteins are separated by a large distance or because their 
conformations or orientations prevent fluorescence complementation (Shyu et al., 2008; 
Kerppola, 2008). For this procedure, I cloned the coding region of YY1 into each of the 
BiFC constructs, i.e., vectors containing N- and C-terminal non-fluorescent fragments 
of the Venus protein (VN and VC, respectively) to detect YY1 self-interaction in vivo. 
These constructs were transiently co-transfected into U2OS cells, which were incubated 
for 24 h to allow expression. Prior to observation, the cells were permeabilised and 
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fixed (see method 2.7.2). As controls, cells were co-transfected with 1) YY1-VN and 
empty vector VC, 2) YY1-VC and empty VN, or 3) the two empty vectors, VN and VC.   
 
Notably, we were able to detect large fluorescent foci in cells transfected with the two 
plasmids containing the YY1 coding region, whereas a pan-nuclear fluorescence with 
no foci was present in the controls (Figure 3.2B). This observation demonstrated that 
YY1 forms a multimer in vivo. 
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Figure 3. 2 YY1 in vivo mutimerisation.  
(A) Scheme of the expression constructs used in BiFC experiments. The coding sequence of YY1 was 
fused to either the N-terminal (YY1-VN) or C-terminal (YY1-VC) domain of Venus. (B) U2OS cells 
transiently co-transfected with plasmids expressing the fusions in A were analysed by fluorescence 
microscopy. Co-transfection of YY1-VN with VC or YY1-VC with VN displayed no difference in pan-
nuclear fluorescence compared with cells co-transfected with the empty vectors (VC and VN). Only cells 
co-transfected with both YY1 fusion constructs (YY1-VN and YY1-VC) exhibited distinct foci present in 
the nuclei. 
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3.2.2 Characterization of YY1 structure  
As little is known regarding the structure of the human YY1, our collaborator utilised 
high-resolution electron microscopy (EM) to further characterise the purified His-YY1 
complex A. This revealed a square-shaped molecule with a low-density region at its 
centre (Figure 3.3A) (López-Perrote et al., 2014). Additionally, the two-dimensional 
averages of the His-YY1 complex showed the existence of 2 or 4 identical YY1 
subunits (Figure 3.3A). Furthermore, they were able to demonstrate the three-
dimensional structure of the human YY1 by analysing 16,362 images obtained by EM 
through image processing methods and the ab initio random conical tilt (RCT) method. 
This revealed that the human YY1 protein was composed of two regions: the top region 
“head” comprised a compact square-shaped region and the bottom region “arms” was 
slightly elongated (Figure 3.3B) (López-Perrote et al., 2014). 
	
Figure 3. 3 Structure of human YY1 (complex A). 
(A) Single molecule images and 2D reference-free averages of complex A of His-YY1 show a typical 
square shape. Scale bar represents 5 nm. (B) 3D structure of the YY1 dimer. Scale bar represents 25 Å 
(from López-Perrote et al., 2014).  
A 
B 
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Next, our collaborator attempted to characterise complex B of the YY1. To this end, 
they purified a more stable YY1 tagged to Strep-II on the N-terminus, which prevents 
YY1 aggregation. Then, the purified oligomeric form of Strep-II-YY1 was stabilized by 
a GraFix method in a glycerol/GA gradient. Oligomerisation of this complex was 
confirmed by high-resolution EM as for His-YY1 (complex A) (Figure 3.4A & B) 
(López-Perrote et al., 2014). This revealed an elongated structure of approximately 100 
Å in length, approximately double in size compared to complex A, which was also re-
purified from Strep-II-YY1 and processed using the same method to confirm its 
previously observed structure (Figure 3.4A & B). This led to the conjecture that YY1 
dimers might associate in two different ways to form large oligomeric complexes 
(Figure 3.4C). 
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Figure 3. 4 YY1 multimerises in larger complexes through the association of YY1 dimers. 
Raw molecule images and 2D reference-free averages of (A) Strep-II-YY1 and (B) His-YY1 (complex A 
& B). (C) Left panel: representative RCT structures obtained from images and averages of Strep-II-YY1 
(complex A & B). Scale bar represents 25 Å. Right panel: hypothetical models for YY1 association. Two 
potential ways of association of YY1 dimers into larger oligomers, based on the 2D averages and the 
RCT structures of complexes A and B, are proposed (from López-Perrote et al., 2014). 
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3.2.3 YY1 binds ssDNA, dsDNA, and HJs in vitro, which is enhanced 
by the RUVBL1-RUVBL2 complex 
The C-terminal region of YY1 contains C2H2 type zinc finger motifs that characterize its 
function as a transcription factor and are capable of binding a consensus DNA sequence 
[5ʹ-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3ʹ] found at the promoter of genes (Houbaviy 
et al., 1996), as shown by Wu et al. using DNA substrates containing the consensus 
sequence (Wu et al., 2007). Our collaborator further disclosed the capability of the 
oligomeric form of human YY1 to bind different types of DNA substrates that include 
or exclude the consensus sequence (López-Perrote et al., 2014). To this end, they used 
the purified oligomeric form of YY1; i.e., complex B of Strep-II-YY1, to test its 
capability to bind DNA in vitro in an electrophoretic mobility shift assay (EMSA) by 
incubating the Strep-II-YY1 complex with different types of DNA substrate: HJ, 
dsDNA without the consensus sequence, dsDNA with the consensus sequence, and 
ssDNA (Figure 3.5A). The shifted bands observed in this assay indicated that 
oligomeric YY1 could bind HJ, ssDNA and dsDNA regardless of its specificity for 
consensus sequence binding (Figure 3.5A). 
 
Our collaborator further confirmed that human YY1 was able to bind RUVBL1 and 
RUVBL2 in vitro, as previously demonstrated (Wu et al., 2007). More specifically, 
pulldown data confirmed that oligomeric YY1 could bind RUVBL1 whereas it failed to 
bind RUVBL2. In addition, it was shown that YY1 could bind the whole complex, i.e., 
RUVBL1-RUVBL2, that had been expressed and purified using the same method as for 
purifying His-YY1 (Figure 3.5B) (López-Perrote et al., 2014). This result suggests that 
YY1 binds the RUVBL1-RUVBL2 complex through a direct interaction with 
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RUVBL1. 
 
Notably, Our collaborator was also able to demonstrate that the presence of the 
RUVBL1-RUVBL2 complex enhanced the ability of oligomeric YY1 to bind HJ and 
dsDNA (Figure 3.5C & D) as well as ssDNA (López-Perrote et al., 2014). This was 
performed using the EMSA technique by incubating Strep-II-YY1 and His-RUVBL1-
RUVBL2 with HJ and dsDNA substrates, which resulted in shifted bands of greater 
intensity (Figure 3.5C & D) compared to those observed when YY1 alone was 
incubated with the DNA substrates (Figure 3.5A) (López-Perrote et al., 2014). 
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Figure 3. 5 YY1 binding to DNA and RUVBL1-RUVBL2 in vitro. 
(A) EMSA assay showing binding of Strep-II-YY1 to several DNA substrates: HJ (lanes 1–5), dsDNA 
non-consensus sequence (lanes 6–10), 80-nt ssDNA (lanes 11–14), and dsDNA consensus sequence 
(lanes 15–19). The binding reaction consisted of 0.3 nM DNA mixed with different concentrations of 
YY1 (nM) as shown above the lanes. (B) Pulldown experiment showing the interaction between Strep-II-
YY1 and His-RUVBL1, His-RUVBL2, His-RUVBL1-RUVBL2, or RUVBL1-RUVBL2. (C) EMSA 
assay showing that RuvBL1-RuvBL2 enhances the binding of YY1 to the dsDNA consensus sequence; 
the reactions contain decreasing concentrations of His-RUVBL1-RUVBL2 (as shown in nM) and 15 nM 
Strep-II-YY1. (D) EMSA assay showing that RuvBL1-RuvBL2 enhances the binding of YY1 to HJ; 
protein concentrations used are shown at the top of each lane (nM) (from López-Perrote et al., 2014).  
 
 
 
 
 
 
A B 
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3.2.4 YY1 functions together with RUVBL2 to promote RAD51 
filament formation, likely as subunits of the INO80 complex; this 
function is enhanced by the ATPase activity of RUVBL2 
YY1 was previously identified as a subunit of the human INO80 complex and its 
absence and/or that of INO80 led to a decrease in the HR efficiency of I-SceI-induced 
DSBs (approximately 13-fold) (Wu et al., 2007). However, the precise mechanism by 
which it functions in HR remained unclear, although it has been suggested that it might 
bind HJ and promote branch migration. The finding by our collaborator that the 
RUVBL1-RUVBL2 complex enhanced the ability of YY1 to bind dsDNA, ssDNA, and 
HJ in vitro (López-Perrote et al., 2014) urged us to further investigate its role during 
HR. To this end, we monitored HR in A549 cells and used siRNA to silence a group of 
genes (Figure 3.6A). These cells were exposed to 3 Gy γ-irradiation (IR) to induce 
DSBs and then fixed at 0 (i.e., before damage), 2, or 8 h. Next, I stained for γH2AX, 
RPA, and RAD51 to determine whether the absence of the aforementioned subunits 
resulted in damage sensitivity (by monitoring γH2AX foci) and to determine whether 
the cells exhibited defects in resection (by monitoring RPA foci) or RAD51 filament 
formation (by monitoring RAD51 foci) (Figure 3.6B–D). HR is restricted to S and G2 
phases; however, because 20% of DSBs are repaired via HR in G2 phase and, more 
specifically, most of the breaks that occur in heterochromatin areas are repaired by HR 
in G2 (Shibata et al., 2011), I stained for CENP-F to mark G2 cells and only counted 
cells that were CENP-F–positive (Figure 3.6B–D). In addition, to ensure that only cells 
in G2 at the time of IR were analysed, I added aphidicolin to cells prior to IR to arrest 
S-phase cells and prevent them from progressing to G2 (Shibata et al., 2011; Beucher et 
al., 2009). 
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These experiments demonstrated that depletion of any of the tested proteins per se did 
not cause damage to dsDNA, as reflected by the absence of γH2AX foci prior to IR. 
Furthermore, at 2 h, all siRNA-treated cells exhibited similar phenotypes as the control, 
indicating that the damage induced by IR was not affected by YY1, RUVBL2, or 
INO80 depletion. Furthermore, the reduction in γH2AX foci at 8 h post IR suggested 
that G2 cells had undergone repair and that no additive defect was caused by the 
absence of YY1, RUVBL2, or INO80. In contrast, BRCA2-depleted cells were unable 
to repair the damage as efficiently as the other cells (Figure 3.6B). Similarly, no defect 
was observed in resection, as reflected by the comparable numbers of RPA foci in cells 
depleted for YY1, RUVBL2, INO80, or BRCA2 and control cells (Figure 3.6C). 
 
Notably, the number of RAD51 foci was reduced by approximately 2-fold in YY1 and 
RUVBL2 depleted-cells compared to controls, although the defect in BRCA2-depleted 
cells was much more severe (Figure 3.6D). This suggested that these two factors might 
function in promoting or stabilizing RAD51 foci during HR. Next, to test whether YY1 
and RUVBL2 worked together during HR, we co-depleted these proteins, as further 
defects might be expected if the two proteins function in different pathways to promote 
HR. However, the co-depletion of YY1 and RUVBL2 resulted in no additive defect on 
the number of RAD51 foci as compared to that observed following their individual 
depletion. This suggested that YY1 functions co-operatively with RUVBL2 to promote 
HR, likely by stimulating or stabilizing the formation of RAD51 filaments. It has been 
shown that co-depletion of YY1 and INO80 resulted in a similar defect on the HR 
efficiency to that observed following the absence of either individually (decrease of 
approximately 13-fold) (Wu et al., 2007). Here, I co-depleted RUVBL2 and individual 
subunits of the human INO80 complex to determine whether this function is specific to 
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the YY1-RUVBL1-RUVBL2 complex as a distinct mechanism or if it represents a 
subsequent function resulting from the roles of these proteins as subunits of the INO80 
complex. As previously, an additional defect in the number of RAD51 foci would be 
predicted if the two complexes were working in separate pathways to promote HR. 
However, cells co-depleted for RUVBL2 and INO80 showed similar defects in RAD51 
foci to that observed in the absence of YY1 and/or RUVBL2, suggesting that YY1 and 
RUVBL2 function during HR as part of the INO80 complex. 
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Figure 3. 6 INO80 is required for RAD51 foci formation.  
(A) Western blot showing the efficiency of RUVBL2, YY1, and INO80, knockdown; KAP-1 is used as a 
loading control. Immunofluorescence images of G2 nuclei (A549 cells), showing the number of γH2AX 
(B), RPA (C), or RAD51 (D) foci in control (siCTR) and knocked down cells at 2h post exposure to 3 Gy 
of γ-IR; right panel: number of foci per G2 cell either before exposure to 3 Gy of γ-IR (0 h) or at 2 (B-D) 
and 8 h (B) after damage. Average number of foci per G2 cell were quantified and presented as the means 
of 3 independent experiments; error bars represent ± SD. 
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Next, to determine whether the ATPase activity of the RUVBL1/2 is required for 
RAD51 foci formation after IR exposure, a point mutation within the Walker A motif of 
RUVBL2 was utilized by (Amani Ismail, 2014) that impairs ATP binding but does not 
disrupt protein folding. An siRNA-resistant GFP-tagged RUVBL2 expression construct 
was generated within which the K83A point mutation was introduced. Then, U2OS 
cells were transfected with siRUVBL2, both siRUVBL2 and wild-type GFP-RUVBL2, 
or both siRUVBL2 and mutant GFP-RUVBL2-K83A. The transfected cells were then 
irradiated, fixed, and the RAD51 foci were counted as described. We found that 
inhibition of RUVBL2 ATPase activity yielded a decrease in the number of RAD51 foci 
in siRUVBL2-cells transfected with the mutant GFP-RUVBL2-K83A similar to that 
caused by depletion of RUVBL2 (siRUVBL2 alone); however, transfection of 
RUVBL2 depleted-cells with the wild-type construct rescued the defect in RAD51 foci 
formation to the level of the control (Figure 3.7). This clearly showed that the ATPase 
activity of RUVBL2 is required to promote RAD51 foci formation during HR.  
 
	
Figure 3. 7 RUVBL2 ATPase activity is required for promoting RAD51 foci formation. 
U2OS cells transfected with siRNA directed against RuvBL2 and either GFP, GFP-RuvBL2, or GFP-
RuvBL2-K83A. Average RAD51 foci per GFP positive G2 cell was quantified and presented as the 
means of 3 experiments; error bars represent ± SD (Amani Ismail, (from López-Perrote et al., 2014)).  
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3.2.5 YY1 and RUVBL2 might have a late function during HR 
To investigate the possibility that the observed HR defect phenotypes (Figure 3.6) 
reflect the roles of the YY1 and RUVBL2 proteins as subunits of the INO80 complex 
rather than as branch-migration enzymes, we carried out sister chromatid exchange 
assays (SCE) on HeLa cells depleted of YY1, RUVBL2, or both YY1 and RUVBL2, 
with the supposition that if the proteins act as a branch-migration enzyme, simultaneous 
depletion should result in an additive phenotype. Specifically, the SCE assay allowed us 
to monitor defects in the final outcome of HR by counting the number of exchanges 
between sister chromatids. Here, I induced DSBs in HeLa cells by using mitomycin C 
(MMC) rather than IR to confirm that the observed defects in RAD51 foci were not 
specific to DSBs induced by IR in G2 cells. In this experiment, BrdU-labelled HeLa 
cells were incubated with MMC for 16 h, colcemid was added to arrest cells in mitosis, 
and then the mitotic cells were harvested. To observe SCE, chromosomes were spread 
and stained. 
 
Notably, if the YY1 and RUVBL2 have a distinct function during this late step in HR, a 
more severe defect in the number of SCEs would be expected than that observed in 
RAD51 foci. However, although depletion of YY1 and RUVBL2 resulted in a decrease 
of the number of SCEs compared to the control, this defect was similar to that 
previously observed in the formation of RAD51 foci. This result suggested that the 
defect in RAD51 might be passed on to the next stage of HR and therefore could not be 
recovered. Similarly, the co-depletion of YY1 and RUVBL2 caused no additive defect 
in the number of SCEs to that observed in RUVBL2 or YY1 depletion, suggesting that 
these two proteins function in the same pathway to promote repair by HR (Figure 3.8). 
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Figure 3. 8 Loss of YY1 and/or RUVBL2 causes a defect in SCE number.  
(A) Western blot data showing the efficiency of RUVBL2 and YY1 knockdown; KAP-1 is used as a 
control. (B) Representative images of mitotic spreads in either MMC treated or untreated HeLa cells; 
chromosomes were labelled with BrdU and stained with Giemsa allowing visualisation of the exchange 
between sister chromatids. (C) Number of SCEs per 100 chromosomes were quantified and presented as 
the mean of 3 independent experiments; error bars represent ± SD  
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3.2.6 YY1 and RUVBL2 might not represent the homologous complex 
of the bacterial branch-migration enzyme RuvA 
The in vitro data by our collaborator showed that YY1 is able to bind dsDNA and HJ 
and interacts with the RUVBL1-RUVBL2 complex (López-Perrote et al., 2014), 
suggesting that YY1 might represent the human homolog of bacterial RuvA. However, 
our current in vivo results suggest that YY1 functions together with RUVBL2 to 
promote RAD51 foci formation during HR as part of their function within the INO80 
complex. To resolve this dilemma, I investigated whether YY1 behaves as an oligomer 
in response to its role in HR. For this, I performed a BiFC experiment as previously 
described (see 3.2.1); U2OS cells transfected with the given plasmid (Figure 3.9) were 
then irradiated with 5 Gy γ-IR to induce DSBs (Figure 3.9). However, similar foci were 
observed in the damaged cells (Figure 3.9) as had been observed in non-irradiated cells 
(i.e., undamaged cells; Figure 3.2B). This result suggested that YY1 although exists as a 
multimer in vivo, this multimerisation is not related to its function in HR. 
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Figure 3. 9 YY1 mutimerisation in vivo after exposure to 5Gy γ−IR. 
U2OS cells transiently co-transfected with plasmids expressing the fusion proteins as in Figure 3.2A were 
exposed to 5Gy of γ-IR and analysed by fluorescence microscopy. Co-transfection of YY1-VN with VC 
or YY1-VC with VN displayed no difference in pan-nuclear fluorescence compared with cells co-
transfected with the empty vectors (VC and VN). Only cells co-transfected with both YY1 fusion 
constructs (YY1-VN and YY1-VC) exhibited distinct foci present in the nuclei. 
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I next conducted additional experiments to determine whether this multimerisation was 
specific for damage. To this end, I first stained for γH2AX in cells expressing YY1-
BiFC foci to determine whether these foci were co-localized with sites of damage. No 
such co-localization was observed (Figure 3.10), although cells were allowed to recover 
for approximately 2 h prior to fixation, providing sufficient time for proteins to localize 
to the damage sites. Therefore, I subsequently utilised laser micro-irradiation to induce 
damage, because this method allows greater precision in monitoring recruitment (Figure 
3.11). These experiments revealed that YY1 foci were not localized to the damage sites. 
In combination with the previous results, these observations led to the conclusion that 
YY1 represents a constitutively multimeric protein but that this multimerisation is not 
specific to its role in DSB repair. 
 
	
Figure 3. 10 Lack of YY1-BiFC foci co-localization with γH2AX foci.  
U2OS cells were co-transfected with YY1-VN and YY1-VC, irradiated with 5Gy of γ−IR, left to recover 
for 2 h, fixed with 4% PFA, and stained with anti-γH2AX antibody. Stained cells were analysed by a 
fluorescence microscope. 
 
	
Figure 3. 11 Laser micro-irradiation treatment of U2OS cells co-transfected with YY1-VN and 
YY1-VC. The red line indicates the laser path. 
 
		
117	
To address the possible function of YY1 as a component of a branch-migration enzyme, 
it was necessary to determine whether the oligomeric YY1 associates with RUVBL2 in 
vivo. To address this issue, I again utilised the BiFC assay. Specifically, I cloned 
RUVBL2 into a BiFC vector that encoded the C-terminal domain of Venus (Figure 
3.12A), as confirmed by sequencing of the resultant plasmid by GATC Biotech. U2OS 
cells were transfected with both YY1_VN and RUVBL2_VC, and the transfectants 
were subjected to the same conditions described previously (see section 3.2.1). 
Although large BiFC foci were observed in the positive control (YY1_VN+YY1_VC) 
as previously described as well as a pan-nuclear fluorescence in the negative control 
(transfected with empty victors VN+VC) (Figure 3.12B), no foci nor fluorescence 
signal of any kind were detected in cells transfected with YY1_VN and RUVBL2_VC 
(Figure 3.12B), suggesting that these proteins might not associate physically. However, 
as previously described, a negative finding from this assay does not conclusively rule 
out the possibility of YY1 and RUVBL2 interaction. Additionally, the in vitro 
interaction of YY1 and RUVBL1-RUVBL2 (Figure 3.5) and the in vivo co-operative 
function of YY1 and RUVBL2 (Figures 3.6 and 3.8) support the possibility the 
observed result (Figure 3.12B) is due to a technical limitation of this assay. 
 
To summarize, the results presented above demonstrate that YY1 forms a multimer in 
vivo regardless of its function in HR. Although a physical association of YY1 and 
RUVBL2 in vivo could not be confirmed, the HR foci data indicate that the functions of 
these proteins are similar. Notably, this similarity might be due to their activities as 
components of the INO80 complex rather than as a homolog of the bacterial branch-
migration enzyme RuvA. 	
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Figure 3. 12 In vivo association between YY1 and RUVBL2 was not detected.  
(A) Schematic illustrating the cloning strategy used, wherein the coding sequences of YY1 and RUVBL2 
were cloned into the N-terminal (YY1_VN) and the C-terminal (RUVBL2_VC) domains of Venus, 
respectively. (B) U2OS cells transiently co-transfected with plasmids expressing the fusions in A were 
analysed by fluorescence microscopy. Co-transfection of YY1-VN with YY1-VC was used as a positive 
control, whereas co-transfection with the two empty victors VC+VN was used as a negative control. Cells 
co-transfected with YY1-VN and RUVBL2-VC failed to express any fluorescence compared to either the 
positive control exhibiting BiFC foci, or the negative control displaying pan-nuclear fluorescence. Images 
were taken using the EVOS® FL microscope, scale bars = 250 μm. 
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3.3 Discussion  
This chapter aimed to characterize the biochemical features and the function of the 
human YY1 protein in vitro and in vivo. We showed that human YY1 exists as 
multimers in vitro and in vivo and we provide a deeper characterization of its 
architecture. In addition, we demonstrated that YY1 associates with the RUVBL1-
RUVBL2 in vitro and in vivo and that this association is essential to promote its binding 
to different DNAs and to perform its function in HR to potentially promote RAD51 
filament formation. However, we have insufficient evidence to determine whether YY1 
is a human homolog to the bacterial RuvA protein.  
3.3.1 Human YY1 is a multimeric protein  
Our findings confirmed the previously reported multimerisation feature of human YY1 
(Wu et al., 2007). More precisely, the biochemical and structural characterisation of 
purified His-YY1 and Strep-II-YY1 revealed that human YY1 assembles as dimers that 
can associate into larger oligomeric complexes. Furthermore, we also provided in vivo 
evidence for the multimerisation of human YY1 (see sections 3.2.1 & 3.2.2). Although 
the crystal structure of YY1 revealed in 1997 provided essential information about its 
C2H2-type zinc-finger motifs that regulate its transcriptional activity, little was known 
regarding the structure of the YY1 oligomeric form. Here, we characterized the 
structural organization of the YY1 oligomers for the first time using EM (see section 
3.2.2). Previously, two type of RuvA-DNA complexes have been reported: 1) complex 
I, wherein a single tetramer binds to one side of the open junction structure, and 2) 
complex II, consisting of two tetramers that together form octomeric RuvA, wherein the 
two tetramers sandwich the HJ DNA in the centre and form the octomer (Yamada et al., 
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2004). This corresponds with our results, which suggest that the human YY1 consists of 
two dimers, each built up of oligomers that might contain 2 or 4 identical subunits 
according to the SEC data (López-Perrote et al., 2014). Despite the fact that we could 
not confirm the exact number of these oligomers, the overall structure of complex A 
(Figure 3.3) obtained by EM showed a very similar architecture to the tetrameric 
bacterial RuvA protein structure that was established by Mayanagi et al. (2008) as part 
of the RuvA-RuvB/HJ-DNA complex (Figure 3.13). The analysed structure of complex 
A revealed a square-shaped molecule with a low-density region at its centre (Figure 
3.3A); this region might indicate the location where the single tetramer binds to one side 
of the open junction. In comparison, complex B was revealed as an elongated structure 
that is approximately double the size of complex A, and might represent the octomeric 
form of YY1 similar to RuvA complex II. Although it is highly likely that this similarity 
in the structure reflects homogeneity between the human YY1 and the bacterial RuvA, 
more evidence is required to confirm this conjecture. For example, it might be necessary 
to characterise the structure of the whole complex, i.e., the YY1-RUVBL1-
RUVBL2/HJ-DNA complex, by EM to confirm that this complex represents the human 
homolog of the bacterial HJ branch-migration enzyme, similar to the one established by 
Mayanagi et al. (2008), i.e., the RuvA-RuvB/HJ-DNA complex.  
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Figure 3. 13 Comparison between the structure of YY1 complex A and tetrameric RuvA. 
(A) 2D reference-free averages of complex A of His-YY1 show a typical square shape (from López-
Perrote et al., 2014). (B) Electron microscopic images of the RuvA/RuvB/Holliday junction DNA 
complex. The tetrameric RuvA in the centre is tethered to RuvB hexameric rings on either side (from 
Mayanagi et al., 2008). 
 
3.3.2 YY1 association with RUVBL1-RUVBL2 enhances its ability to 
bind several types of DNA 
The C-terminal region of the YY1 protein contains C2H2 type zinc finger motifs that 
characterize its function as a transcription factor, as these motifs are capable of binding 
to a consensus DNA sequence [5ʹ-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3ʹ] found at the 
promoters of genes (Houbaviy et al., 1996). Previous work using DNA substrates 
containing the consensus sequence (Wu et al., 2007), however, only showed the ability 
of YY1 to bind DNA in the context of its transcriptional function. Our findings, in 
contrast, demonstrated that the oligomeric form of YY1 is able to bind in vitro to 
dsDNA containing the consensus sequence as well as to dsDNA without the consensus 
sequence, HJ, and ssDNA (see section 3.2.3). This suggested that YY1 functions in a 
distinct pathway from its transcriptional activity by binding to DNAs in the absence of 
the consensus sequence. In addition, the varied binding ability was identified using the 
oligomeric rather than the monomeric form of YY1, potentially suggesting that the 
A 
B 
RuvA RuvB RuvB 
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oligomeric status of YY1 is responsible for promoting its ability to support disparate 
DNA binding. This assumption, however, requires further testing for confirmation. 
 
Additionally, our collaborator showed that YY1 preferentially binds the RUVBL1-
RUVBL2 complex through interacting with RUVBL1 rather than RUVBL2 (see section 
3.2.3). This is partially in agreement with a previous study that reported a direct 
interaction between YY1 and each of RUVBL1 and RUVBL2 (Wu et al., 2007). Our 
collaborator, however, were unable to identify such an interaction with RUVBL2 even 
in reaction with higher protein concentrations (López-Perrote et al., 2014). One possible 
explanation is that YY1 might interact with the RUVBL1-RUVBL2 complex through 
direct interaction with only the RUVBL1 protein. However, the finding of Wu et al. 
(2007) that YY1 interacts in vitro with RUVBL2 does not support this prediction. 
Therefore, RUVBL2 might also interact with YY1 albeit with lower affinity than 
observed for YY1-RUVBL1, being below the level of detection in the conditions used 
by our collaborator. Alternately, the oligomeric form utilized by our collaborator might 
not allow the detection of such an interaction in vitro. Therefore, parallel experiments 
using both forms of YY1; i.e, monomeric and oligomeric forms, might help to resolve 
this discrepancy. 
Notably, regardless of the precise state of the interaction between YY1 and RUVBL1 
and RUVBL2, the presence of RUVBL1-RUVBL2 as a whole complex positively 
shifted the affinity of YY1 towards binding all types of DNA. Previously, it has been 
reported that YY1 in its role as a transcription factor is able to direct the transcription 
initiation of the P5 promoter by first assembling the YY1-DNA complex, which then 
facilitates the recruitment of transcription factor IIB (TFIIB) to form a more stable 
complex; the YY1-TFIIB-DNA complex in turn recruits pol II to the promoter (Usheva 
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& Shenk, 1996). In similar manner, the YY1-DNA complexes formed by YY1 
oligomers binding to various types of DNA might then target the RUVBL1-RUVBL2 
complex to form a functional YY1-RUVBL1-RUVBL2-DNA complex, which in turn 
might either function as an independent complex or facilitate further recruitment of 
other proteins/complexes such as the INO80 complex or DNA repair proteins. In 
comparison, in fission yeast the recruitment of the Ino80 complex to a target gene is 
mediated by interaction with Iec1, which contains zinc finger motifs similar to those of 
YY1 (Hogan et al., 2010). Thus, validation of this predicted model appears to be a 
worthy topic of future studies. 
3.3.3 YY1 co-operates with RUVBL2 to promote HR 
It has been reported that YY1 functions during HR as part of the INO80 complex, 
potentially through binding HJs and promoting their branch migration (Wu et al., 2007). 
The finding by our collaborator that RUVBL1-RUVBL2 enhanced the ability of YY1 to 
bind HJ in vitro (López-Perrote et al., 2014) supports the potential role for the YY1-
RUVBL1-RUVBL2 complex in HR. However, we found that depleting the respective 
subunits yielded no impact on DSB repair as measured by the number of γH2AX foci as 
a marker for DSBs even after 8 h of recovery (Figure 3.6B). These findings, on the 
other hand, do not necessarily rule out a potential role for YY1 and RUVBL2 in HR, as 
it highly likely that cells may have chosen another pathway to repair the damage, thus 
leading to an unaltered DSB readout. 
 
Previously, only two studies have focused on the involvement of INO80 in HR 
(Gospodinov et al., 2008, 2011); however, these yielded conflicting results, 
demonstrating in the first instance that RUVBL1 and RUVBL2, which are subunits of 
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INO80 and other chromatin-remodelling complexes such as TIP60, are required for 
formation of RAD51 foci. However, the authors attributed this role to TIP60 rather than 
INO80, based on the restoration of the defect in RAD51 foci by treatment with a histone 
deacetylase inhibitor (sodium butyrate), which mimics the role of TIP60 in acetylation 
and relaxation of chromatin. In contrast, the same authors reported in 2011 that INO80 
depletion reduced HR efficiency (approximately 2-fold) and caused defects in both the 
recruitment of an essential repair protein, 53BP1, and in resection; however, no defect 
was observed in the formation of RAD51 foci. Here, it could be argued that because HR 
is achieved by a series of dependent steps, an upstream defect should have affected the 
downstream steps, especially given the observed 2-fold defect in HR level.  In contrast, 
in our study we observed a defect in RAD51 with no obvious defect in RPA foci in the 
absence of RUVBL2, YY1, RUVBL2, and YY1, or of both RUVBL2 and INO80 
(Figure 3.6C&D). However, this discrepancy might be attributable to differences in 
study design such as the choice of cell lines or the method of counting, as Gospodinov 
et al. (2011) counted the number of cells with foci, whereas we counted the number of 
foci per cell (see Figure 1.3B–D). In addition, the studies used different methods to 
induce DSBs (IR vs. MMC), which might also have caused the differences in the 
observed outcomes. Notably, we counted only G2 cells, owing to the specific 
involvement of HR in the repair of DSBs in heterochromatin areas (Shibata et al., 
2011), wherein a role for a chromatin remodeller such as INO80 would be obvious. 
Finally, we also confirmed that the defect in RAD51, particularly in RUVBL2-depleted 
cells, is related to its activity as a member of the INO80 complex. Specifically, we 
showed that a double knockdown of RUVBL2 and either of two INO80 subunits, 
INO80 or YY1, exhibits a phenotype identical to those of the respective single 
knockdowns. This observation seriously challenges the claim in Gospodinov et al. 
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(2008) that the defects might be attributed to TIP60 rather than INO80. Furthermore, 
our SCE data (Figure 3.8) might suggest that the conflict between our results and those 
of previous reports as related to the RAD51 foci phenotype arises solely from the 
depletion of YY1 and RUVBL2 rather than being due to specificity to G2 cells or DSBs 
induced by IR, as in these experiments we induced DSBs by treating cells with MMC 
and counted the final outcomes of HR.  
 
Notably, the results from a recent study by the Jackson laboratory, published 
subsequently to our findings (López-Perrote et al., 2014; Nishi et al., 2014), fit to some 
extent with our data. Therein, it was demonstrated that depletion of the INO80 complex 
or its YY1 or RUVBL1 subunits resulted in a mild defect in resection upon treatment 
with campothecin, as reflected by a reduction in the intensity of BrdU incorporation 
(ssDNA) rather than the number of foci (Nishi et al., 2014). This suggests that our 
experimental method may have prevented us from observing such a mild defect. 
Additionally, the same group observed a reduction in RAD51 foci caused by the 
absence of YY1 and UCHL5 (a subunit of human INO80). Thus, a mild defect in 
resection may have caused the observed defect in the subsequent formation of RAD51 
foci. If so, the question arises as to how YY1 and RUVBL1/2 may function during 
resection. I suggest that the following features of these proteins might be useful in 
developing a relevant model: 1) YY1 in its role as a transcription factor facilitates DNA 
strand separation during initiation (Usheva & Shenk, 1996), and 2) the ssDNA binding 
domain of RUVBL1 and RUVBL2 is similar to that of RPA (Matias et al., 2006). Thus, 
one hypothesis might be that YY1-RUVBL1-RUVBL2 may function during resection 
by forming the functional complex YY1-RUVBL1-RUVBL2-DNA as previously 
predicted (see section 3.3.2), in which YY1 binds to dsDNA (i.e., to the broken ends) 
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and functions to facilitate DNA strands separation. Simultaneously, the YY1-DNA 
might promote recruitment of RUVBL1-RUVBL2, which in turn may bind to the 
resultant ssDNA to stabilize the 3ʹ overhang generated by MRN-CtIP either before or 
during RPA loading. In addition, the YY1-RUVBL1-RUVBL2-DNA complex might 
facilitate further recruitment of essential DSB repair proteins such as BRCA2. 
Alternately, this complex might utilize the ATPase activity of RUVBL1/2 to allow for 
further relaxation of the chromatin either during this step or upon HJ binding. 
Conversely, another possibility may be that YY1 is only involved in extensive resection 
by facilitating EXO1 recruitment, as it has been reported that co-depletion of YY1 and 
UCHL5 caused a reduction in EXO1 but not CtIP recruitment (Nishi et al., 2014). 
However, it is possible that the observed defect in RAD51 foci is a consequence of the 
mild defect in the intensity of RPA foci, or because these proteins function to promote 
or stabilize the RAD51 filament. To differentiate and substantiate these models, 
additional studies will be required. 
3.3.4 Lack of in vivo evidence for homology between YY1, a human 
subunit of the INO80 complex, and RuvA, a bacterial subunit of 
the branch-migration enzyme 
HR is an essential process that plays fundamental roles in DSB repair, resumption of 
stalled replication forks, or gene rearrangement in meiosis (Krejci et al., 2012). HJ is an 
essential final step in HR to effect efficient repair. In prokaryotes, the complex RuvAB 
promotes branch migration whereas the endonuclease RuvC resolves the junction 
(Yamada et al., 2004). X-ray structure and EM analyses of the RuvA-DNA complex 
demonstrated that the N-terminal domains I and II of RuvA are required for recognition 
of the HJ, whereas the C-terminal domain III is required to target RuvB hexameric rings 
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(mammalian homologs: RUVBL1-RUVBL2) on either side of RuvA (Yamada et al., 
2004). As discussed above, on the one hand, our results suggest the YY1 protein as a 
strong candidate to represent a human homolog of bacterial RuvA based on the structure 
and the ability of YY1 to bind HJ and RUVBL1-RUVBL2 in vitro. On the other hand, 
our in vivo results, which not only showed that YY1 associates with RUVBL2 in HR as 
part of the INO80 complex but also that these proteins demonstrated no additive 
function in SCE, diminishes the possibility of such homology. This is because if YY1 is 
the human homolog to RuvA, its main function should be to facilitate HJ branch 
migration, and, consequently, a noticeable impact should be observed in the number of 
SCE in the absence of such a function, i.e., in the absence of YY1 and RUVBL2.  In a 
final attempt to obtain in vivo evidence for homogeneity between YY1 and RuvA, we 
examined the response of the multimeric YY1 form to DSBs induced by IR. However, 
our results (see section 3.2.6), suggested that although YY1 is a multimeric protein, co-
localization to sites of damage did not occur. Furthermore, we were unable to show an 
in vivo association between YY1 and RUVBL2 (Figure 3.12). Whereas we suggest that 
this negative finding is highly likely to represent a limitation of the BiFC method, as in 
some cases even bona fide interactions cannot be detected therewith (Shyu et al., 2008; 
Kerppola, 2008). The RUVBL1-RUVBL2 complex comprises two hexameric rings, 
each formed from alternating subunits (López-Perrote et al., 2012). Therefore, YY1 
might only interact directly with RUVBL1 rather than RUVBL2. However, further data 
are needed to determine whether YY1 is the functional ortholog of RuvA. 
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Removal	of	H2AZ	by	INO80	promotes	
homologous	recombination	
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4.1 Introduction 
INO80 is an ATPase chromatin-remodelling complex comprised of multiple subunits 
and belongs to the INO80 family, which defined by a characteristic insertion in the 
ATPase domain. The yeast Swr1 and human p400 and SRCAP proteins are also 
members of the INO80 family. Notably, members of this family are capable of histone 
exchange (Seeber et al., 2013). In particular, the exchange of histone H2AZ, a histone 
variant of the core histone H2A, is controlled by INO80 family proteins. In yeast, Swr1 
functions as part of the SWR complex to regulate the removal of H2A and incorporation 
of histone H2AZ into chromatin (Krogan et al., 2003; Kobor et al., 2004; Mizuguchi et 
al., 2004), whereas in mammals SRCAP (Ruhl et al., 2006) and p400 (as part of TIP60) 
(Xu et al., 2012) are responsible for the equivalent reaction. However, the reverse 
reaction, i.e., removal of H2AZ and incorporation of H2A, is catalysed by INO80 in 
yeast (Papamichos-Chronakis et al., 2011). Conversely, no evidence has been provided 
to indicate that the mammalian INO80 contributes in H2AZ removal from chromatin; 
instead, a histone chaperone, ANP32E, has been recently found to remove H2AZ from 
chromatin in mammals (Mao et al., 2014; Obri et al., 2014).  
 
Incorporation of H2AZ into damaged chromatin has been found to be critical for DSB 
repair in mammals (Xu et al., 2012). Upon the induction of DSBs, H2AZ accumulates 
at the damaged site in a similar pattern to that of γH2AX but with less enrichment, 
spreading on either side of the DSBs for approximately 10–50 kb along the chromatin. 
Notably, the incorporation of H2AZ at DSBs by p400 (as part of TIP60) has been found 
to restrict resection, wherein the absence of H2AZ causes an increase in the number of 
RPA foci and ssDNA. Furthermore, H2AZ incorporation was shown to be critical for 
NHEJ repair, as its absence resulted in the loss of KU70/80 and a decrease in NHEJ 
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efficiency. Conversely, the inhibition of resection by silencing CtIP in H2AZ-depleted 
cells rescued the defects of KU70/80 recruitment and NHEJ (Xu et al., 2012). Thus, this 
study clearly demonstrated that H2AZ incorporation into damaged chromatin is critical 
for DSBs repair, specifically the NHEJ pathway. However, whether the H2AZ removal 
reaction is also vital for DSB repair has not yet been established. 
 
Substantial evidence from yeast (Downs et al., 2004; Morrison et al., 2004; Van 
Attikum et al., 2004) and mammals (Gospodinov et al., 2008, 2011; Kashiwaba et al., 
2010) has confirmed the involvement of INO80 in HR repair, although the exact 
mechanism affected by INO80 in this repair pathway has remained unclear. This 
capacity, together with the well-known function of yeast INO80 in regulating the 
removal of H2AZ from chromatin (Papamichos-Chronakis et al., 2011) and the 
established evidence for the critical role of H2AZ incorporation in DSB repair (Xu et 
al., 2012) led us to formulate the hypothesis that INO80 might promote HR by 
removing H2AZ to allow resection. To test this hypothesis, we aimed to address two 
main questions in this chapter; first, whether human INO80 is involved in the removal 
of histone H2AZ from damaged chromatin as is observed in yeast; and second, whether 
the removal reaction of histone H2AZ is also critical for HR (Alatwi & Downs, 2015).  
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4.2 Results 
4.2.1 H2AZ dynamics at sites of damaged chromatin 
ChIP data from human cells has revealed that H2AZ accumulates to the sites of DSBs 
(Xu et al., 2012). To illustrate the dynamics of the histone variant H2AZ at sites of 
damaged chromatin, U2OS cells were transfected with the GFP-H2AZ expression 
construct and laser micro-irradiation was utilised to induce damage after 24 h, followed 
by live cell imaging to monitor the accumulation of H2AZ at damaged DNA. H2AZ 
was found to accumulate at damaged sites within seconds (Figure 4.1A); however, the 
incorporated H2AZ was then rapidly removed from the sites of DNA damage, as 
indicated by the return of the fluorescence signal intensity to pre-damaged levels within 
approximately 3 minutes (Figure 4.1A&C). 
 
To determine whether the mammalian INO80 is able to facilitate the removal of H2AZ 
from chromatin as shown for yeast INO80 (Papamichos-Chronakis et al., 2011), we 
attempted to monitor the accumulation of H2AZ at sites of damaged chromatin in the 
absence of INO80. Towards this end, INO80 was depleted in U2OS cells using siRNA; 
then, after 24 h, the cells were transfected with GFP-H2AZ and laser micro-irradiated 
the following day. Live cell imaging demonstrated that in INO80-depleted cells, H2AZ 
was able to accumulate normally, with no obvious differences compared to the control. 
However, the removal of H2AZ was significantly slower in INO80-depleted cells 
compared to the control (Figure 4.1B&C). This result clearly showed that the removal 
of H2AZ from damaged chromatin is at least partially dependent on INO80, whereas 
H2AZ incorporation is INO80-independent. 
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Next, in order to support our finding and to confirm that the observed fluorescent signal 
reflected an actual accumulation of H2AZ after the induction of damage by laser micro-
irradiation, the behaviour of histone H2B in U2OS cells transfected with a GFP-H2B 
expression construct was determined using live cell imaging after applying the same 
conditions previously utilised for monitoring H2AZ accumulation. As can be seen in 
Figure 4.2, no detectable signal was observed at the sites of DNA damage, indicating 
that the behaviour of H2B differed from that of H2AZ.  
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Figure 4. 1 H2AZ dynamics at sites of damaged chromatin. 
(A) H2AZ is rapidly incorporated and removed from damaged DNA. (B) H2AZ dynamics at sites of 
damaged chromatin in siINO80 cells. In (A) & (B), U2OS cells were transfected with GFP-H2AZ, laser 
micro-irradiated, and captured by live cell imaging; the laser path and time points are shown. (C) 
Quantification of relative mean fluorescence intensity in control and siINO80 cells from three 
independent experiments. A minimum of 10 cells were monitored per experiment; error bars represent ± 
SD. Scale bars = 10 μm. 	
 
A B 
C 
A
CD
Alatwi and Downs, Figure 1
B
G
FP
-H
2A
.Z
 R
el
at
iv
e 
m
ea
n 
in
te
ns
ity
E
Timepoint (s)
0 
0.5 
1 
1.5 
2 
2.5 
0
29
010 5030 70 90 11
0
13
0
15
0
17
0
19
0
21
0
23
0
25
0
27
0
Control
siINO80
G
FP
-R
uv
B
L2
 m
ea
n 
in
te
ns
ity
 (A
U
)
Timepoint (m)
00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser
path of laser 00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser 00:00 01:00
05:00 10:00 15:00
20:00 25:00 29:50
3000 
4000 
5000 
6000 
7000 
0 2 4 6 8 10
 
12
 
14
 
16
 
18
 
20
 
22
 
24
 
26
 
28
 
30
 
A
CD
Alatwi and Downs, Figure 1
B
G
FP
-H
2A
.Z
 R
el
at
iv
e 
m
ea
n 
in
te
ns
ity
E
Timepoint (s)
0 
0.5 
1 
1.5 
2 
2.5 
0
29
010 5030 70 90 11
0
13
0
15
0
17
0
19
0
21
0
23
0
25
0
27
0
Control
siINO80
G
FP
-R
uv
B
L2
 m
ea
n 
in
te
ns
ity
 (A
U
)
Timepoint (m)
00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser
path of laser 00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser 00:00 01:00
05:00 10:00 15:00
20:00 25:00 29:50
3000 
4000 
5000 
6000 
7000 
0 2 4 6 8 10
 
12
 
14
 
16
 
18
 
20
 
22
 
24
 
26
 
28
 
30
 
A
CD
Alatwi and Downs, Figure 1
B
G
FP
-H
2A
.Z
 R
el
at
iv
e 
m
ea
n 
in
te
ns
ity
E
Timepoint (s)
0 
0.5 
1 
1.5 
2 
2.5 
0
29
010 5030 70 90 11
0
13
0
15
0
17
0
19
0
21
0
23
0
25
0
27
0
Control
siINO80
G
FP
-R
uv
B
L2
 m
ea
n 
in
te
ns
ity
 (A
U
)
Timepoint (m)
00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser
path of laser 00:00 00:10
00:30 01:00 02:00
03:00 04:00 04:50
path of laser 00:00 01:00
05:00 10:00 15:00
20:00 25:00 29:50
3000 
4000 
5000 
6000 
7000 
0 2 4 6 8 10
 
12
 
14
 
16
 
18
 
20
 
22
 
24
 
26
 
28
 
30
 
		
134	
	
 
Figure 4. 2 H2B dynamics at sites of damaged chromatin.  
U2OS cells transfected with GFP-H2B were laser micro-irradiated and captured by live cell imaging; 
time points and arrowheads indicating laser paths are shown. 
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4.2.2 RUVBL2, a subunit of INO80, accumulates at the sites of 
damaged chromatin 
INO80 has been shown to accumulate at DNA DSBs by ChIP (Gospodinov et al., 
2011). Here, the dynamics of the INO80 subunit RUVBL2 at damaged DNA were 
examined using live cell imaging, for which U2OS cells were transfected with a GFP-
RUVBL2 expression construct and then laser micro-irradiated after 24 h to allow for 
gene expression. The accumulation of RUVBL2 at sites of damage was monitored by 
live cell imaging for approximately 30 minutes. As can be seen in Figure 4.3, RUVBL2 
accumulated at the damaged chromatin and remained for at least 20 minutes after 
damage, in agreement with the previous finding by Gospodinov et al. (2011). 
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A 
 
B 
	
Figure 4. 3 RUVBL2 accumulation at sites of damaged chromatin.  
(A) U2OS cells transfected with GFP-RUVBL2 were subjected to laser micro-irradiation and captured by 
live cell imagining; the laser path and time points are shown. (B) Quantification of mean fluorescence 
intensity at sites of damaged DNA from three independent experiments; error bars show ± SD. 
Scale bars = 10 μm. 
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4.2.3 H2AZ is a barrier for resection 
As mentioned in Chapter 3, we have found that the contribution of INO80 to HR in 
mammalian cells may occur through the promotion of RAD51 filament formation 
(López-Perrote et al., 2014). To investigate whether the role of mammalian INO80 in 
the removal of H2AZ from damaged chromatin (Figure 4.1) contributed to the HR 
pathway, A549 cells were transfected with siINO80, siH2AZ, or both knockdown 
constructs (Figure 4.4A). As previously described, these cells were then exposed to 3 
Gy γ−IR to induce DSBs and fixed at 0 h (i.e., before damage) and after 2 h. Next, the 
cells were stained for γH2AX, a marker for DSBs, and RPA as a readout for ssDNA 
formation. To restrict our analysis to G2 cells, CENP-F staining was used to mark G2 
cells and only CENP-F-positive cells were counted (Figure 4.4C). In addition, to ensure 
that the only cells analysed were those in G2 at the time of IR, aphidicolin was added to 
the cells prior to IR to arrest S-phase cells and prevent them from progressing to G2 
(Beucher et al., 2009; Shibata et al., 2011). 
 
Depletion of INO80 and H2AZ did not cause any further DSBs, as no added defect in 
the number of γH2AX signals was observed at 0 h, prior to the induction of DSBs by 
IR, compared to the control. Furthermore, cells lacking INO80 and H2AZ were not 
sensitive to IR, as the level of DSBs at 2 h after exposure to 3Gy γ−IR also did not 
differ from that of the control. At 8 h post IR, the number of γH2AX signals decreased 
2-fold, suggesting that the cells managed to repair some of the induced damage. 
However, the similar response between control and knocked-down cells at 8 h post IR 
suggested that in the absence of INO80 and H2AZ the cells were able to repair the 
damage by another repair pathway (Figure 4.4B). 
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In addition, the lack of either INO80 or H2AZ did not cause any obvious defect in the 
number of RPA foci prior to the induction of DSBs by IR (Figure 4.4C), indicating that 
the absence of these proteins per se did not affect resection or induce further damage to 
the dsDNA. Furthermore, after 2 h of inducing DSBs by IR, no obvious defect was 
observed on resection, i.e., the number of RPA foci, in INO80-depleted cells compared 
to the control (Figure 4.4C), although the depletion of H2AZ caused a significant 
increase in the number of RPA foci (Figure 4.4C). This result is consistent with the 
previous findings of Xu et al. (2012), which showed that H2AZ incorporation is 
required for accurate resection and that the absence of H2AZ leads to the occurrence of 
uncontrolled resection. Notably, the co-depletion of INO80 in cells lacking H2AZ 
resulted in a decrease of the number of RPA foci to a level approximating that of the 
control (Figure 4.4C), potentially suggesting that INO80 has a role in resection although 
this could not be observed directly using the current method.  
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A                                                B 
 
  
 
 
 
 
 
 
 
 
C 
	
Figure 4. 4 H2AZ acts as a barrier for resection.  
(A) Western blotting demonstration of the efficiency of siRNA knockdown. KAP1 was used as a loading 
control. (B) IR induction of γH2AX foci in A459 cells treated with siRNAs. (C) IR induction of RPA foci 
in A459 cells treated with siRNAs. Left panel: representative images at 2h post exposure to 3 Gy of γ-IR, 
right panel: quantification of the means of foci from three independent experiments; error bars show ± 
SD. P values were determined by Student’s t-test, and samples were compared with control cells. **P ≤ 
0.01, N.S., not significant. Scale bars = 5 μm.  
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4.2.4 Cells lacking SRCAP exhibit a resection defect 
To validate the role of INO80 in resection observed by ourselves and others 
(Gospodinov et al., 2008, 2011), as we observed no obvious defect in its absence while 
others reported a defected resection phenotype, a control experiment was designed to 
test whether the observed resection phenotype by us represented an artefact related to 
the utilised methodology or was specific to the absence of INO80 and its subunits. 
Towards this end, SRCAP was used as a control for resection. SRCAP represents an 
ATPase chromatin remodeller that has been recently found to promote resection by 
promoting the accumulation of CtIP at DSBs (Dong et al., 2014). Accordingly, SRCAP 
was depleted singly and in conjunction with INO80 via siRNA in A549 cells using the 
method described in section 4.2.3, and followed by staining for RPA to monitor 
resection (Figure 4.5). 
 
As expected, depletion of SRCAP caused a decrease in the number of RPA foci similar 
to that reported by Dong et al. (2014), validating this method as a means to detect 
resection deficits. However, the co-depletion of SRCAP and INO80 did not result in an 
additive defect (Figure 4.5). As depletion of INO80 alone (Figure 4.4B) also did not 
alter the number of observed RPA foci, this result further suggests that INO80 might 
not function in resection.   
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Figure 4. 5 Cells lacking SRCAP exhibit a resection defect.  
IR induced RPA focus formation in A549 cells treated with siControl, siSRCAP, or siSRCAP/siINO80. 
Upper panel: representative images at 2h post exposure to 3 Gy of γ-IR. Lower panel: quantification of 
foci. Data represent the means of 3 independent assays ± SD. P values were determined by Student’s t-
test, and samples were compared with control cells. ***P = 0.0009, **P = 0.002, N.S., not significant. 
Scale bars = 5 μm. 
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4.2.5 INO80 has a mild effect on resection 
As a discrepancy existed regarding whether INO80 functions in resection that we had 
previously attributed to the different methodologies used to monitor resection 
(Discussion, Chapter 3), the results from different methods for monitoring resection 
were compared. To replicate the method previously used by the Jackson laboratory, 
which had resulted in the observation of a mild defect in resection in the absence of 
YY1, a subunit of human INO80 (Nishi et al., 2014), A549 cells lacking of several 
subunits (i.e., siINO80, siYY1, siH2AZ and siINO80/H2AZ cells) were treated with 
camptothecin (CPT) for 1 h and the number of cells with RPA foci was monitored. This 
approach allowed us to observe a modest but statistically significant defect in cells 
lacking either INO80 or YY1 (Figure 4.6), suggesting that INO80 may function to 
promote resection after the induction of DSBs, in contrast to the conclusions indicated 
in section 4.2.4. 
	
Figure 4. 6 Cells depleted for INO80 exhibit a mild defect in resection.  
Quantification of RPA foci following 1 h of treatment with 1 mM camptothecin (CPT). Error bars 
represent ± SD from three independent experiments. P values were determined by Student’s t-test, and 
samples were compared with control cells. **P ≤ 0.01, ***P ≤ 0.001, N.S., not significant. 
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4.2.6 Depletion of H2AZ rescues the RAD51 foci formation defect 
Previously, we showed that the INO80 subunits YY1 and RUVBL2 promote the 
formation or stabilisation of RAD51 foci (López-Perrote et al., 2014). This was 
attributed to a component of the function of the whole complex, as co-depletion of these 
subunits along with the INO80 subunit resulted in no additive phenotype (Chapter 3; 
3.2.4). In confirmation of these results, Figure 4.7 shows that the depletion of the 
INO80 subunit alone also resulted in a defect in RAD51 foci, which was similar to that 
observed in Chapter 3 (Figure 3.6). 
 
However, as the aim of this chapter was to investigate the mechanism by which INO80 
promotes RAD51 foci formation, it was hypothesised that the removal of H2AZ by 
INO80 might be a key step in this process. To test this conjecture, INO80 and H2AZ 
were co-depleted in A549 cells and the accumulation of RAD51 foci in G2 cells was 
analysed using method described previously to monitor RPA (section 4.2.3). Notably, 
the depletion of H2AZ in cells lacking INO80 rescued the defect in RAD51 foci 
formation in siINO80 cells (Figure 4.7). In addition, the loss of H2AZ alone caused a 
slight albeit statistically insignificant increase in the number of RAD51 foci (Figure 
4.7), which might further influence the upstream increase in RPA foci observed in 
H2AZ-depleted cells (Figure 4.4B).  
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Figure 4. 7 INO80-depleted cells exhibit significant defects in RAD51 foci number that can be 
rescued by H2AZ depletion.  
Left panel: representative images at 2h post exposure to 3 Gy of γ-IR; right panel: quantification of the 
means of foci from three independent experiments. Error bars show ± SD. P values were determined by 
Student’s t-test, and samples were compared with control cells.  *P ≤ 0.05, N.S., not significant. Scale 
bars = 5 μm. 
 
 
It was also noted from the SRCAP control experiment that the depletion of SRCAP 
resulted in a reduction in number of RAD51 foci (Figure 4.8), as had been observed 
previously and attributed to an upstream consequence of the defect in resection caused 
by the absence of SRCAP (Dong et al., 2014). However, co-depletion of INO80 and 
SRCAP did not result in any additive defect in the number of RAD51 foci beyond that 
observed upon single depletion of either subunit (Figure 4.8), suggesting that both 
INO80 and SRCAP might be required to promote RAD51 foci formation. 
 
A
B
-/-
si
C
on
tro
l
si
H
2A
.Z
si
IN
O
80
/
H
2A
.Z
si
IN
O
80
DAPI RPA CENPF overlay
si
C
on
tro
l
si
H
2A
.Z
si
IN
O
80
/
H
2A
.Z
si
IN
O
80
DAPI RAD51 CENPF overlay
si
C
on
tro
l
si
H
2A
.Z
si
IN
O
80
/s
iH
2A
.Z
H2A.Z
INO80
KAP1
0 
10 
20 
30 
40 
50 
60 
70 
0h 2h 
R
PA
 fo
ci
 / 
G
2 
ce
ll 
Time post 3Gy 
siControl 
siINO80 
siH2AZ 
siH2AZ/INO80 
0 
5 
10 
15 
20 
25 
30 
0h 2h 
R
AD
51
 fo
ci
/ G
2 
ce
ll 
Time post 3Gy 
siControl 
siINO80 
siH2AZ 
siH2AZ/ INO80 
C
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
si
C
on
t  
si
IN
O
80
 
si
YY
1 
si
H
2A
Z 
si
IN
O
80
/
H
2A
Z 
%
 c
el
ls
 w
ith
 >
10
 R
PA
 fo
ci
 
af
te
r C
PT
 tr
ea
tm
en
t 
D
Alatwi and Downs, Figure 2
**
***
NS NS
**
*
NS
NS
NS
*
NS NS NS
NS
NS NS
	
		
145	
	
Figure 4. 8 SRCAP depletion causes a reduction in the number of RAD51 foci.  
IR induced RAD51 focus formation in in A549 cells treated with siControl, siSRCAP, or 
siSRCAP/siINO80. Upper panel: representative images at 2h post exposure to 3 Gy of γ-IR. Lower panel: 
quantification of foci. represent the means of 3 independent assays ± SD. P values were determined by 
Student’s t-test, and samples were compared with control cells.  ***P = 0.00098, **P = 0.00248, N.S., 
not significant. Scale bars = 5 μm. 
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4.2.7 ANP32E works together with INO80 to remove H2AZ from 
chromatin 
ANP32E has been identified recently as an H2AZ histone chaperone that can bind 
specifically to H2AZ and remove it from chromatin globally (Mao et al., 2014; Obri et 
al., 2014). To test whether the ANP32E is able to remove H2AZ from chromatin at 
DSBs in particular in similar manner to INO80, its effects on both resection and RAD51 
filament formation were monitored. Specifically, siRNA was utilised to deplete 
ANP32E, H2AZ, or both proteins (Figure 4.9A) and RPA and RAD51 foci formation in 
G2 cells was monitored as previously described.  
 
Notably, we found that the loss of ANP32E resulted in a slight albeit statistically 
insignificant reduction in the number of RPA foci as well as a significant reduction in 
the number of RAD51 foci (Figure 4.9B&C) that was similar to that observed 
previously following INO80 knockdown. Furthermore, H2AZ depletion in cells lacking 
ANP32E also rescued the defect in RAD51 (Figure 4.9C), suggesting that ANP32E 
functions to remove H2AZ from damaged chromatin as well as globally.  
 
The similar phenotypes caused by INO80 and ANP32E depletion with respect to 
resection and RAD51 foci raised the question of the nature of the relationship between 
these two complexes in removing H2AZ from chromatin at DSBs. To address this issue, 
INO80 and ANP32E were co-depleted in A549 cells and the impact on RPA and 
RAD51 foci was examined (Figure 4.9A). It could be expected that if the two 
complexes functioned in distinct pathways to promote RAD51 foci formation, the 
phenotype caused by co-depletion would differ from that caused by single depletion of 
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either component. However, a similar phenotype was observed in each instance (Figure 
4.9B&C), which suggested that INO80 works together with ANP32E to promote 
RAD51 foci formation by removing H2AZ from damaged chromatin. 
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Figure 4. 9 INO80 and ANP32E work together to promote RAD51 foci formation following 
irradiation and their deficit can be rescued by H2AZ depletion.  
(A) Western blotting showing the efficiency of siRNA knockdown. KU80 was used as a loading control. 
(B) IR induction of RPA foci in A459 cells treated with siRNA. Left panel: representative images at 2h 
post exposure to 3 Gy of γ-IR, right panel: quantification of the means of foci from three independent 
experiments; error bars show ± SD. P values were determined by Student’s t-test, and samples were 
compared with control cells. *P ≤ 0.05; N.S., not significant. (C) IR induction of RAD51 foci in A459 
cells treated with siRNA. Left panel: representative images at 2h post exposure to 3 Gy of γ-IR, right 
panel: quantification of the means of foci from three independent experiments; error bars show ± SD. P 
values were determined by Student’s t-test, and samples were compared with control cells. ***P ≤ 0.001, 
N.S., not significant. Scale bars = 5 μm. (See figures 4.4 & 4.7 for siINO80 or siH2AZ data). 
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4.2.8 INO80 and ANP32E are required for efficient repair by HR 
The observed defect in the number of RAD51 foci in cells depleted of INO80 and/or 
ANP32E suggested that HR was impaired in these cells. This defect, however, was 
minimal compared to that in cells lacking a core HR protein such as BRCA2. Therefore, 
the number of sister chromatid exchanges (SCEs) were monitored as a readout for the 
final outcome of HR, which could also provide an overview regarding the efficiency the 
repair pathway. Towards this end, INO80, ANP32E, H2AZ, and were co-depleted 
pairwise by siRNA knockdown in HeLa cells as shown in Figure 4.10. Next, these cells 
were labelled with BrdU and incubated with MMC for 16 h, colcemid was added to 
arrest the cells in mitosis followed by harvesting of the mitotic cells. To observe SCEs, 
chromosomes were spread and stained according to standard procedure. 
 
Cells depleted of INO80 or ANP32E showed a reduction in the number of SCEs 
compared to the control cells (Figure 4.10A&B) and co-depletion of INO80 and 
ANP32E resulted in a similar defect as either single depletion (Figure 4.10B). Notably, 
the SCE defects were rescued upon H2AZ depletion in cells lacking either factor 
(Figure 4.10A&B), which confirms the previous finding that INO80 and ANP32E work 
co-operatively to remove H2AZ from damaged chromatin. However, the absence of 
H2AZ alone did not affect the efficiency of HR, as the number of SCEs in following 
H2AZ knockdown was similar to the control level (Figure 4.10A). This finding might 
suggest that the incorporation of H2AZ into chromatin is not important for HR although 
its removal is critical for repair by HR; this possibility will be discussed further in the 
Discussion (section 4.3) of this chapter.  
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Figure 4. 10 Depletion of H2AZ rescues the SCE defect in cells depleted of INO80 or ANP32E. 
Top panel in (A) & (B) Representative images of mitotic spreads in either MMC-treated or untreated 
HeLa cells; chromosomes were labelled with BrdU and stained with Giemsa allowing visualisation of the 
exchange between sister chromatids. Lower panel in (A) & (B) Quantification of the number of SCEs per 
100 chromosomes in several siRNA cells. Error bars represent the means of 3 independent experiments ± 
SD. P values were determined by Student’s t-test, and samples were compared with control cells. *P ≤ 
0.05, **P ≤ 0.01, N.S., not significant. 
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4.3 Discussion 
The aim of this chapter was to investigate the mechanism by which INO80 promotes 
HR. A key study from the Price laboratory showed that H2AZ plays a critical role in 
HR (Xu et al., 2012), suggesting that the role of INO80 in the removal of H2AZ from 
chromatin might be involved in regulation HR; however, this INO80 function has not 
previously been demonstrated in mammals. In particular, Xu et al. (2012) observed an 
increase in RPA and BrdU foci (denoting ssDNA) caused by the depletion of H2AZ, 
indicating that H2AZ restricts resection. In comparison, our results demonstrated that in 
the absence of INO80, the formation of RAD51 foci was defective. It was therefore 
hypothesised that if mammalian INO80 also functions in H2AZ removal, as has been 
reported in yeast (Papamichos-Chronakis et al., 2011), INO80-depleted cells should be 
unable to remove H2AZ, resulting in the blockage of resection and subsequent defects 
in the formation of RAD51 foci. Thus, if this model were correct, depletion of H2AZ in 
cells lacking INO80 should rescue the RAD51 foci defect (Figure 4.11). Overall, the 
findings of this chapter supported this hypothesis, as it was shown that H2AZ was 
transiently incorporated into damaged chromatin followed by its rapid removal and the 
removal reaction was dependent on INO80. In addition, it was found that H2AZ acted 
as a barrier for resection and that INO80 functioned together with ANP32E during HR 
to remove H2AZ to allow resection and the subsequent efficient repair by HR.  		
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Figure 4. 11 Diagram illustrating the status of HR in four models.  
(A) Normal HR: H2AZ is incorporated into chromatin by P400 and then needs to be removed by either 
INO80, according to yeast data (Papamichos-Chronakis et al., 2011), or ANP32E as has been shown in 
mammals (Mao et al., 2014; Obri et al., 2014) in order to achieve proper repair. (B) Model proposed by 
Xu et al. (2012), in which the absence of H2AZ causes an increase in resection. (C) Model based on the 
data from the current study, in which the absence of INO80 results in a decrease in RAD51 foci numbers. 
(D) The hypothesised model, in which H2AZ removal in INO80-depleted cells would rescue the defect in 
RAD51 foci formation. 
		
4.3.1 H2AZ removal from damaged chromatin in human cells is 
dependent on INO80  
The finding of this chapter revealed that H2AZ transiently accumulates to the sites of 
DNA damage. By using laser micro-irradiation and live cell imaging we provided 
evidence that H2AZ is incorporated into damaged chromatin within seconds and then 
rapidly removed within approximately 3 minutes (Figure 4.1) (Alatwi & Downs, 2015). 
This result is in agreement with a study that was published simultaneously with our 
published data, in which laser micro-irradiation in fixed cells was used to observe the 
accumulation of H2AZ in human cells in conjunction with an anti-H2AZ antibody 
(Gursoy-Yuzugullu et al., 2015). Similar to our results, they found that H2AZ 
accumulates to the damaged sites immediately after damage induction and that no 
H2AZ signals were detected in fixed samples after 10 minutes. The difference in the 
time required for H2AZ removal between the studies might be attributed to the distinct 
methodologies used; notably, sample fixation may result in a poorer representation of 
the actual process in cells compared to live cell imaging procedures.  
 
Furthermore, this chapter provided the first evidence that mammalian INO80 regulates 
the removal of the histone variant H2AZ (Figure 4.1) (Alatwi & Downs, 2015), similar 
to its function in yeast (Papamichos-Chronakis et al., 2011). Specifically, laser micro-
irradiation and live cell imaging data showed that in INO80-depleted cells, H2AZ was 
accumulated at levels similar to those of the control, whereas the removal of H2AZ was 
significantly slower in INO80-depleted cells (Figure 4.1). Notably, it has been shown in 
yeast that INO80 is required for the global removal of unacetylated H2AZ from 
chromatin and that the failure of H2AZ removal leads to a sensitivity towards 
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replication stress and DNA damage-inducing drugs (Papamichos-Chronakis et al., 
2011). Furthermore, and most importantly, a histone exchange essay by Papamichos-
Chronakis et al. (2011) showed that INO80 activity in yeast involves the replacement of 
the histone H2AZ with a core histone H2A, i.e., H2AZ is removed from the chromatin 
and replaced with H2A. H2A- or H2AZ-mononucleosomes were incubated with SWR1 
and INO80 chromatin remodellers and H2AZ or H2A dimers, respectively, and the 
reactions were analysed by native PAGE and western blot. This revealed INO80’s 
ability to replace histones, more precisely replacing H2AZ with H2A (Papamichos-
Chronakis et al., 2011). However, our micro-irradiation data showed that INO80 only 
removed H2AZ from the damaged chromatin and we have no evidence to claim that 
INO80 replaces H2AZ with H2A. A likely experiment to consider in future would be to 
co-transfect cells with both GFP-H2AZ and mCherry-H2A. This would allow us to 
easily monitor the dynamics of both histones as well as INO80 activity towards them. 
Currently, our data only reflect the ability of INO80 in removing H2AZ from the 
damaged chromatin, as opposed to it being replaced with H2A. 
 
Additionally, the dynamics of RUVBL2, a subunit of INO80, were followed using live 
cell imaging after damage induction by laser micro-irradiation, which demonstrated that 
RUVBL2 begins to accumulate at sites of damaged DNA within one minute and 
remains for approximately 20 minutes (Figure 4.3). Owing to a technical issue it was 
not possible to show the accumulation of the INO80 subunits at the damaged DNA 
sites; however, based on the previous data from Chapter 3 it was considered likely that 
INO80 functions in HR as a whole complex rather than as independent subunits, such as 
RUVBL2 and YY1. Furthermore, this result agreed with a previous published ChIP 
study, which showed that INO80 is recruited to sites of DNA damage (Kashiwaba et al., 
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2010; Gospodinov et al., 2011). Therefore, our data indicated that the INO80 complex is 
likely recruited to damaged DNA during a period that overlaps with the removal of 
H2AZ from damaged chromatin.  
 
Finally, it is worth noting that the recent report by Gursoy-Yuzugullu et al. (2015) also 
showed that the removal of H2AZ from damaged DNA required ANP32E. This is in 
agreement with another recent finding of the role for ANP32E as a histone chaperone 
that can bind specifically to H2AZ and effect its global removal from chromatin in 
mammals (Mao et al., 2014; Obri et al., 2014). 
4.3.2 INO80 has a moderate role in resection 
The results of this chapter showed that the depletion of INO80 did not lead to an 
obvious defect in resection (Figure 4.4C), which is consistent with our previous results 
(López-Perrote et al., 2014) but conflicts with the findings of two reports by others that 
investigated the role of INO80 in HR (Gospodinov et al., 2008, 2011). This discrepancy 
has been discussed thoroughly in Chapter 3 and was attributed to the different 
methodologies used (see Chapter3, section 3.3.3). In comparison, the experiments in the 
present chapter utilised SRCAP, which has a critical role in resection, as a positive 
control (Dong et al., 2014) such that the known resection phenotype following SRCAP 
depletion could be detected via our method to observe resection in G2 cells following 
the induction of DSBs by 3 Gy of γ-IR. This both validated the used method and 
clarified that the observed resection phenotype related to INO80 depletion, if present, 
reflects only a modest function of INO80 in resection in G2 cells.  
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Notably, however, other groups have recently reported a moderate role for the INO80 in 
resection as well. For example, the Jackson group reported a mild defect in resection, 
observed as a reduction in the intensity of BrdU foci (ssDNA) rather in than their 
number upon treatment with CPT, caused by depletion of INO80, YY1, or RUVBL1 
(subunits of the INO80 complex) (Nishi et al., 2014). Similarly, Dong et al. (2014) 
reported a modest defect in resection in a stable INO80 knockout cell line, observed as a 
slight reduction in the percentage of cells with RPA foci upon treatment with 10 Gy IR. 
Accordingly, an additional method was thus also utilised in the current chapter to mimic 
the subtle INO80 resection phenotype, wherein resection was monitored as the 
percentage of cells with RPA foci upon treatment with CPT. This method allowed the 
observation of a modest but statistically significant defect in resection in cells depleted 
for either INO80 or YY1 (Figure 4.6). It should be noted, however, that the mechanism 
of DSB formation by CPT arises from replication stress during S phase as this chemical 
inhibits the nuclear enzyme DNA topoisomerase type I (topo I) (Liu et al., 2000). 
Therefore, the inability to observe a significant albeit mild phenotype in the G2-
exclusive method might reflect a restriction of the role of INO80 in resection to S phase. 
 
Furthermore, the results presented in this chapter confirm the critical role for H2AZ in 
resection, which has been reported previously by Xu et al. (2012). Specifically, the 
absence of H2AZ resulted in an increase in RPA foci number suggesting that H2AZ 
acts as a barrier for resection. Notably, Xu et al. (2012) found that the absence of H2AZ 
caused a loss of KU70/80 in addition to an increase in resection, whereas the inhibition 
of resection following CtIP depletion in H2AZ-depleted cells resulted in restoration of 
KU70/80 levels and NHEJ pathway function. These results indicate that the 
incorporation of H2AZ at DSBs is an important factor for efficient NHEJ and the loss 
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of the KU complex in cells lacking H2AZ might suggest that H2AZ serves as a key 
factor for its recruitment. In addition, the current results also showed that in cells 
depleted for both INO80 and H2AZ, the number of RPA foci was restored to the control 
level (Figure 4.4C), supporting that INO80 might play a role in resection even in G2 
cells.  
4.3.3 INO80 promotes RAD51 foci formation by removing H2AZ at 
DSB sites 
It was demonstrated in Chapter 3 that INO80, including its subunits YY1 and RUVBL2, 
functions in HR by promoting or stabilising RAD51 foci formation. The aim of the 
current chapter was to investigate the mechanism underlying this function of INO80. In 
particular, it was found that the absence of the INO80 protein, a catalytic subunit of the 
INO80 complex, caused a reduction in the number of RAD51 foci similar to that 
observed previously in cells lacking YY1, RUVBL2, or both INO80 and RUVBL2. 
This confirmed the previous assertion that INO80 acts as a whole complex to promote 
repair by HR. Conversely, the significant defect in RAD51 foci is unlikely to represent 
a direct consequence of the modest defect in resection, suggesting that INO80 has an 
additional function in promoting RAD51 foci formation. One possibility is that the 
INO80 complex is involved in either the recruitment or expression of the key repair 
protein BRCA2. In particular, a very recent study has shown that INO80 and YY1 
regulate the expression of the BRCA2- and CDKN1A-interacting protein (BCCIP) (Su 
et al., 2016). BCCIPα and β interact directly through their N-terminal regions with 
BRCA2 (amino acids 2883 to 3053) and have been shown to interact with RAD51 as 
well (Lu et al., 2005). Notably, these interactions were found to be critical for HR as 
silencing BCCIPα and/or β by shRNA resulted in a significant reduction of IR-induced 
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RAD51 foci (Lu et al., 2005). Thus, INO80 might regulate repair via HR through the 
regulation of BCCIP expression.  
  
Alternatively, the complete rescue of the defect in RAD51 foci formation upon H2AZ 
depletion in cells lacking INO80 (Figure 4.7) suggests an additional possibility for 
INO80 function, confirming the assumption that INO80 functions in HR by removing 
H2AZ from damaged chromatin to allow efficient repair. In other words, the RAD51 
foci defect in cells lacking INO80 is consequent to resection blockage caused by the 
failure to remove H2AZ from damaged chromatin in the absence of INO80. Notably, 
the rescue phenotype in cells co-depleted of both INO80 and H2AZ, which indicates 
that H2AZ needs to be removed to permit the accurate loading of RAD51 at focal sites, 
further supports this model. 
4.3.4 INO80 work co-operatively with ANP32E to promote HR by 
removing H2AZ from damaged chromatin 
ANP32E has been recently identified as a mammalian H2AZ histone chaperone that can 
bind and remove H2AZ from chromatin. ANP32E recognises and binds to H2AZ 
through an interaction between its C-terminal acidic region and the αC helix of H2AZ 
(T103 and I104) (Mao et al., 2014; Obri et al., 2014) and disruption of this H2AZ 
region inhibits their interaction (Gursoy-Yuzugullu et al., 2015). These H2AZ residues 
are conserved in H2A although with the inclusion of an extra glycine residue; notably, 
the insertion of a similar glycine residue in H2AZ also abolishes the interaction with 
ANP32E (Mao et al., 2014; Obri et al., 2014). An aim of the current chapter was to 
examine the impact of this function of ANP32E at DSBs. It was found that ANP32E 
works co-operatively with INO80 to promote RAD51 foci formation by removing 
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H2AZ from damaged chromatin (Figure 4.9), expanding on the finding of Gursoy-
Yuzugullu et al. (2015) that ANP32E is required for the removal of H2AZ at DSBs. 
However, this result raises several additional questions, including the role of INO80 in 
the H2AZ removal reaction considering the established binding of ANP32E, and 
whether INO80 or ANP32E is dependent on the other for recruitment, binding, or 
function. 
4.3.5 Efficient HR requires the removal of H2AZ by INO80 and 
ANP32E 
The SCE data from the current study showed that efficient HR requires the involvement 
of both INO80 and ANP32E. The defect in the number of SCEs in the absence of 
INO80 and/or ANP32E mimics that observed in the number of RAD51 foci; therefore, 
it is highly likely that the SCE deficit is consequent to an upstream defect in RAD51 
foci formation. Furthermore, this finding suggests that the main role for INO80 and 
ANP32E is to remove H2AZ from damaged chromatin to allow the efficient loading of 
RAD51 at its focal sites.  
 
Additionally, this data also indicated that the incorporation of H2AZ is not required for 
HR, although its removal is critical, as the absence of H2AZ alone resulted in the 
establishment of levels of SCE similar to those of the control. However, in the absence 
of INO80 or ANP32E, under which conditions H2AZ cannot be removed, a significant 
reduction in the number of SCEs was observed (Figure 4.10). According to Xu et al. 
(2012), the incorporation of H2AZ is critical for repair by NHEJ, as the depletion of 
H2AZ leads to the abolishment of KU70/80 recruitment at sites of damaged DNA and a 
significant reduction in the level of NHEJ. Notably, the γH2AX data presented herein 
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indicated that after 8 h of DSB induction by IR, cells subjected to knockdown of 
INO80, H2AZ, or both managed to repair the damage to the level of the control, 
suggesting that these cells incorporated a different repair pathway to repair DSBs, such 
as either NHEJ or Alt-NHEJ. As the KU complex is lost in H2AZ-depleted cells and the 
NHEJ pathway is defective, cells would thus be required to utilise the Alt-NHEJ 
pathway to repair DSBs. This was confirmed through the observation of efficient repair 
by Alt-NHEJ in cells lacking H2AZ, approximating the level of repair observed in 
control cells (Xu et al., 2012).  
 
In summary, once DSBs occur, H2AZ is incorporated into damaged chromatin within 
seconds (Alatwi & Downs, 2015), facilitating H4 acetylation and leading to a 
weakening of the histone interactions within nucleosomes by interrupting the interaction 
between H2A and H4, thus resulting in a relaxed, open chromatin configuration (Xu et 
al., 21012). This chromatin relaxation is important to promote KU70/80 complex 
recruitment to sites of DSBs and to facilitate NHEJ (Xu et al., 2012). However, H2AZ 
then needs to be removed shortly thereafter by both INO80 and ANP32E to allow 
accurate loading for the establishment of RAD51 foci and, eventually, efficient HR 
(Alatwi & Downs, 2015). 
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5.1 Introduction 
Chromosomal instability (CIN) represents one of the main causes of genomic instability 
and describes a dynamic state wherein cells continuously gain or lose whole 
chromosomes or chromosomal fragments. CIN has been strongly associated with 
several types of cancer, such as breast, lung and colon cancers (McGranahan et al., 
2012). Appropriate chromosomal segregation is reliant upon the functional and 
structural accuracy of the centromere, a fundamental component of each chromosome 
(Verdaasdonl & Bloom, 2011; Bloom, 2014). In turn, H2AZ, a histone variant of the 
core histone H2A, has been shown to comprise one of the critical factors for 
maintaining centromere structure. Specifically, H2AZ-containing nucleosomes function 
as a boundary between euchromatin and heterochromatin (Meneghini et al., 2003). Loss 
of H2AZ results in the loss of centromere silencing owing to impaired regulation of 
CENP-C expression, a centromere protein required for centromere silencing (Hou et al., 
2010; Greaves et al., 2007).  
 
In a previous publication, our laboratory was the first to identify a role for the INO80 
complex in chromosome segregation in budding yeast (Chambers et al., 2012). In the 
study, yeast strains lacking either Ise6 or Ino80 were found to be defective for 
chromosome segregation owing to the enrichment of H2AZ in pericentric chromatin. 
The authors had also shown that H2AZ overexpression or down-regulation accelerates 
or prevents the development of polyploidy, respectively (Chambers et al., 2012). 
Polyploidy and chromosomal structural abnormality, including chromosome and 
chromatid breaks, have been shown by others to occur subsequent to loss of YY1, a 
human subunit of INO80, as well (Wu et al., 2007). Finally, Cao et al. (2015) have 
recently found that the depletion of INO80 by siRNA resulted in an increase in the 
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number of cells with more than two centrosomes per nucleus, aberrant cytokinesis, and 
multipolar spindle formation. Together, these different lines of evidence indicate the 
association of INO80 with chromosomal stability. 
 
The experiments in this chapter were based on our finding from Chapter 4 that INO80 
plays a role in the removal of H2AZ from chromatin in mammals (Alatwi & Downs, 
2015) and the observation that H2AZ constitutes a major component of human 
centromeres (Greaves et al., 2007), which have been shown to be vital for the fidelity of 
chromosome segregation in yeast (Chambers et al., 2012). Therefore, we hypothesised 
that the loss of INO80 might result in structural centromeric defects owing to the local 
enrichment of H2AZ, eventually leading to chromosomal instability. Accordingly, we 
aimed to address whether human INO80 contributes to the maintenance of faithful 
chromosome segregation, and if so, whether it might be suitable for use as a therapeutic 
target for CIN+ tumours, which may not be able to tolerate further perturbations to 
chromosome segregation pathways. 
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5.2 Results 
5.2.1 Depletion of INO80 results in an increase in the number of 
micronuclei (MN) in CIN+ cells 
MN formation constitutes one of the well-established biomarkers for chromosomal 
instability. MN formation can be initiated from acentric chromosome fragments, 
acentric chromatid fragments, or whole chromosomes that failed to attach properly to 
the spindle microtubule (Fenech et al., 2011). Therefore, we utilised MN to test whether 
the absence of INO80 would lead to or increase chromosomal instability. INO80 was 
depleted by siRNA-mediated knockdown in the CIN+ cell line U2OS and in the CIN− 
cell line BR1-hTERT (a human fibroblast line that is genomically stable). Karyotype 
analysis of U2OS cells confirmed that this cell line is aneuploid, carrying approximately 
65–70 chromosomes and exhibiting both numerical and structural CIN (Janssen and 
Medema, 2012); thus, it has been classified as a CIN+ cell line. After two rounds of 
INO80 knockdown, the cells were allowed to grow for 24 h before they were stained 
with DAPI (Figure 5.1).  
 
The percentage of MN was found to be higher in the CIN+ (U2OS) control compared to 
the CIN− cell line, further confirming that U2OS represents a CIN+ cell line (Figure 
5.1). While not statistically significant, depletion of INO80 in U2OS cells led to an 
increase in the percentage of MN of almost 2-fold compared to the MN percentage in 
the control U2OS cells, suggesting that INO80 may be important to prevent further CIN 
(Figure 5.1). Notably, the absence of INO80 also slightly increased the percentage of 
MN in the CIN− cell line as well; however, the MN percentage in the CIN− cell line 
was still low compared to that in the CIN+ cells (Figure 5.1). 
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Figure 5. 1 Depletion of INO80 results in an increase in the number of micronuclei in CIN+ cells.  
Top panel: representative image showing cells with micronuclei in the U2OS cell line; the arrow indicates 
a micronucleus. Lower panel: quantification of the percentage of cells with micronuclei in the control 
(CONT) and siINO80 cells in the different cell lines. Error bars represent ± SD of duplicate experiments. 
P values were determined by Student’s t-test, and samples were compared with control cells. 
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5.2.2 Depletion of INO80 causes a defect in structural CIN rather than 
numerical CIN in U2OS cells 
To further investigate the role of INO80 in CIN, next we monitored the mitosis 
aberrations in U2OS cells. INO80 was again depleted and the cells subsequently 
allowed to grow for 24 h. Then, the cells were fixed with 4% PFA and stained with 
DAPI. The experiment initially was designed to monitor anaphase bridges, which 
represent another biomarker for CIN that can originate when a dicentric chromosome 
becomes pulled to opposite poles; such dicentric chromosomes can be generated from 
either a misrepair of chromosome breaks or telomere to telomere end fusions (Fenech et 
al., 2011). Anaphase bridges may also result from a failure in resolving the linkage 
between sister chromatids, i.e., failure in resolving cohesion or decatanation via top II 
(Fenech et al., 2011; Tanaka & Hirota, 2016). However, other breakages were also 
observed in U2OS cells, such as uncompleted bridges and acentric or lagging 
chromosomes. Therefore, all types of breakages were included as representing defects 
in mitosis (Figure 5.2). Notably, the percentage of cells with aberrant mitosis was 
substantially higher in INO80-depleted U2OS cells compared to the control. This 
suggests that the INO80 complex plays an important role in ensuring the fidelity of 
mitosis (Figure 5.2). Furthermore, in both control and siINO80-treated 1BR-hTERT 
cells, few mitotic aberrations of any kind could be observed, which might be due to the 
high genomic stability manifested by these cells. 
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Figure 5. 2 Depletion of INO80 causes a defect in structural CIN in U2OS cells.  
Top panel: representative images of the observed mitotic aberrations. Lower panel: quantification of the 
percentage of mitotic aberrations in U2OS cells. Error bars represent ± SD of duplicate experiments. P 
value was determined by Student’s t-test, and samples were compared with control cells. 
 
 
Next, we determined whether the absence of INO80 caused an increase in aneuploidy 
within U20S cells. Aneuploidy or chromosomal number was determined by counting 
the centromere number. Centromeres were labelled by staining with a CENP-A 
antibody, which allows the visualisation and straightforward counting of centromeres 
(Figure 5.3). Although U2OS constitutes an aneuploid cell line and the average number 
of chromosomes in these cells is approximately 65–70 (Janssen and Medema, 2011), a 
further change in chromosome number would be expected following the depletion of 
INO80. However, no difference was observed in the number of chromosomes between 
INO80-depleted cells and the control (Figure 5.3). This finding might suggest that the 
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Alternatively, additional rounds of cell division might be necessary to see significant 
changes in the population.  Unfortunately, due to the transient nature of siRNA 
depletion, this is not easily testable in our system. We note that owing to the low 
number of mitotic 1BR-hTERT cells obtained, no data was generated from this cell line. 
 
 
 
	
Figure 5. 3 Depletion of INO80 does not affect the number of chromosomes in U2OS cells.  
Top panel: representative images showing chromosome segregation in anaphase cells. Lower panel: 
quantification of the average number of chromosomes in U2OS cells. Error bars ± SD of duplicate 
experiments. 
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5.2.3 Loss of INO80 causes cell death in CIN+ cells 
Together, the previous data from yeast (Chambers et al., 2012) and humans (Chapter 4; 
Alatwi & Downs, 2015) respectively suggest that the loss of INO80 causes 
chromosome segregation errors owing to aberrant pericentric H2AZ enrichment and 
that H2AZ removal is partially dependent on the presence of INO80 in response to 
DNA damage. As our findings in U2OS cells further suggested that INO80 plays a role 
in chromosomal stability, we next examined whether the loss of INO80 in CIN+ cells 
led to any lethal effect on their growth. To this end, colorectal cancer cell lines were 
utilised in addition to the CIN+ cell line U2OS (Tanno et al., 2015) as they have been 
intensively analysed and classified as representing CIN+ and CIN− cell lines (Burrell et 
al., 2013). INO80 was depleted as previously described via siRNA in CIN+ cells 
(U2OS, HT29, and NCIH747) and CIN− cells (DLD1 and RKO) (Figure 5.4A). The 
cells were then seeded into 96-well plates, to which CellTiter-Blue reagent was added 
and cell viability was measured at the required time point using a microplate reader.  
 
Theoretically, if the INO80 complex functions in maintaining chromosomal stability, a 
reduction in cell viability in CIN+ cells might be expected as these cells would 
experience further increase in CIN in the absence of INO80 and thus their viability 
would be severely challenged. In support of this, depletion of INO80 caused an increase 
in cell death in CIN+ cell lines compared to the control (untreated cells) (Figure 5.4B). 
Notably, the cell death was more obvious beginning at 48 h in all CIN+ cell lines; 
therefore, this might represent the point at which the cells reach the peak of H2AZ 
enrichment. Subsequently, a higher degree of defective HR and larger number 
structurally defective centromeres would likely occur, negatively impacting viability. It 
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is also possible that H2AZ mislocalisation may impact on transcriptional regulation of 
essential genes. 
 
However, DLD1 CIN− cell line, no difference was observed in cell viability between 
untreated and siINO80-transfected cells. This may suggest that INO80 is required when 
cells experience CIN and therefore could be used to target CIN+ tumours. Conversely, 
RKO cells, which had been classified as a CIN− cell line according to the Burrell et al. 
(2013) study, showed a phenotype similar to that observed for CIN+ cells. This led us to 
further investigate the CIN state of this cell line, as described in the next section (5.4).  
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Figure 5. 4 Loss of INO80 causes cells lethality in CIN+ cells.  
(A) Western blot performed 24 h after the second round of siINO80 transfection in the indicated cell 
lines; tubulin was used as a loading control. (B) Cell viability in CIN+ cell lines (U2OS, HT29, and 
NCIH747) and (C) in CIN− cell lines (DLD1 and RKO) in untreated and siINO80-transfected cells at the 
indicted time points. Viability values reflect the means relative to measurement at 24 h. Each experiment 
was performed in triplicated wells; error bars represent  ± SD from three independent experiments.  
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5.2.4 RKO cells are sensitive to the loss of INO80 
Based on the Burrell et al. (2013) classification RKO constitutes a CIN− cell line; 
however, it exhibited a similar phenotype to that of CIN+ cell lines in response to 
INO80 depletion as measured by the cell viability assay (Figure 5.4B&C). Therefore, 
we checked the chromosomal stability state for this cell line by monitoring MN and 
anaphase bridges as described in sections 5.2.1 & 5.2.2.  
 
Previously, Burrell et al. (2013) reported an approximate rate of 18% anaphase 
segregation errors for RKO cells, which was considered to fall within the range of the 
CIN− cell lines compared to a mean of 38% for the CIN+ cell lines (Burrell et al., 
2013). In comparison, in the present study only approximately 6% of RKO cells were 
found to be MN positive although approximately 19% of cells exhibited anaphase 
bridges (Figure 5.5), in agreement with their classification as a CIN− cell line as 
determined by Burrell et al. (2013). However, depletion of INO80 in these cells 
increased the percentage of cells with MN to approximately 14% and 40% of anaphase 
cells exhibited bridges (Figure 5.5), suggesting that INO80 plays a vital role in 
maintaining chromosomal stability in this cell line. Notably, we determined that the HR 
pathway is defective in RKO cells as BRCA1 and BRCA2 were found to be mutated in 
this cell line according to the COSMIC Cell Line Project database; specifically, 
substitution missense and frameshift deletion mutations were identified in these genes, 
respectively (Wellcome Trust Sanger Institute, 2016). This additional deficit may 
provide clues regarding the importance of INO80 for this cell line; further discussion on 
this topic is provided at the end of section 5.3.1.  
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Figure 5. 5 RKO is sensitive to INO80 loss.  
(A) Right panel: representative image of MN in RKO cells; left panel: quantification of the percentage of 
control and siINO80 RKO cells with micronuclei (red arrowhead). (B) Right panel: representative image 
of an anaphase bridge in RKO cells; left panel: quantification of the percentage of control and siINO80 
RKO cells with anaphase bridges (red arrowhead). Error bars represent ± SD from three independent 
experiments. P values were determined by Student’s t-test, and samples were compared with control cells. 
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5.3 Discussion 
This chapter aimed to investigate the role of INO80 in chromosomal stability within 
human cells and to ascertain the potential for using such a chromatin remodeller in 
targeting CIN+ tumours. Our results showed that the depletion of INO80 caused an 
increase in CIN, which was observed as an increase in the percentages of micronuclei 
and mitotic aberrations. Furthermore, we found that the depletion of INO80 increased 
cell death in CIN+ cells. 
5.3.1 INO80 is likely to be required for chromosomal stability 
Our results confirmed the previously reported role of INO80 in maintaining 
chromosomal stability (Wu et al., 2007; Chambers et al., 2012; Kracker et al., 2014; 
Cao et al., 2015). In particular, here we showed that INO80 is probably required for 
preventing or moderating CIN, as its depletion caused an increase in the percentages of 
MN and mitotic aberrations. This might indicate a primary role for INO80 in 
maintaining chromosomal stability and mitotic fidelity. Furthermore, as MN may arise 
from chromosomal structural or attachment errors in mitosis (Fenech et al., 2011) and 
the observed aberrant mitoses included anaphase bridges and acentric or lagging 
chromosomes in siINO80-U2OS cells, the enrichment of these features suggested that 
INO80 may be important for preventing such mitotic structural and attachment errors. 
Similarly, it has been reported that the depletion of BAF180, a subunit of the BPAF 
chromatin remodelling complex, also caused an increase in the percentages of MN and 
aberrant mitosis in U2OS and BR1-hTERT cells (Brownlee et al., 2014). However, 
whereas our result from U2OS cells showed that no further aneuploidy was caused by 
the depletion of INO80 (Figure 5.3), the depletion of BAF180 resulted in aneuploidy 
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consequent to a subsequent defect in cohesion (Brownlee et al., 2014). This discrepancy 
might be due to the method used to monitor aneuploidy in our study, in particular as the 
premature separation of sister chromatids and an increase in chromosome breaks have 
been reported as a result of down-regulation of INO80 in CH12-F3 cells, a lymphoma 
cell line (Kracker et al., 2015). Therefore, a metaphase spread method should be used in 
future research to provide a precise number of chromosomes and monitor any premature 
separation of sister chromatids. 
 
Notably, a role for INO80 in chromosomal stability in mammals has been reported in 
other studies. For example, it has been shown that loss of YY1, a subunit of INO80, 
causes polyploidy and chromosomal abnormalities including chromosome and 
chromatid breaks and triradial or quadriradial chromosomes. This phenotype was linked 
to the role of YY1 in DNA repair (Wu et al., 2007). Furthermore, Cao et al. (2015) 
reported an increase in the number of cells with large nuclei, cells with more than two 
centrosomes, aberrant cytokinesis, and multipolar spindle formation caused by the 
depletion of INO80. The authors also observed high expression of p21 in siINO80 cells, 
thus attributing these phenotypes to the role of INO80 as a negative regulator of p21 
(Cao et al., 2015). In addition, polyploidy was observed in yeast strains lacking the 
INO80 subunits Ino80 or Ies6 consequent to H2AZ enrichment at pericentric chromatin 
(Chambers et al., 2012). Taken together, these findings indicate that INO80 represents a 
fundamental player in maintaining chromosomal stability and mitotic fidelity. They also 
indicate a high probability that the multiple functions of INO80 including its roles in 
DNA repair, negative regulation of p21 expression, and eviction of H2AZ from 
chromatin work in concert to generate CIN. 
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Although the means by which deficient HR may lead to CIN are not clear, an earlier 
study has shown that mild or severe defects in RAD51, i.e., leading to deficient HR, 
could cause incomplete separation during anaphase, whereas only severe defects would 
lead to a multipolar anaphase state and cell death (Laulier et al., 2011). This differential 
outcome might explain the cell death that was observed in the CIN− colorectal cell line, 
RKO (Figure 5.4), in which we found that HR was defective owing to mutations in the 
key repair proteins BRCA1 and BRCA2, which could be considered to represent a 
severe defect. Therefore, the additional absence of INO80 yielded a phenotype similar 
to that of CIN+ cell lines (Figure 5.4). However, our preferred model to explain the 
overall function for INO80 in maintaining chromosomal stability relies upon its role as 
a chromatin remodeller to remove H2AZ from chromatin. Specifically, in the absence 
of INO80, H2AZ would accumulate to high levels at centromeres, impairing their 
function; in conjunction with an upstream defect in HR, these deficits would eventually 
lead to an increase in CIN. This model will be tested by the Downs laboratory in 
subsequent experiments. We note that it is also possible that all of the described 
functions of INO80 could also be attributed to a role in the maintenance of mitosis 
fidelity. 
5.3.2 INO80 constitutes a proposed therapeutic target for CIN+ 
tumours 
CIN represents one of the hallmark features that are found in most cancers at an 
advanced level and in almost all solid tumours such as colon, lung, and cervical tumours 
(Tanaka & Hirota, 2016). Recently, several therapeutic strategies have been developed 
to target mitosis or, more precisely, CIN+ tumours to suppress cancer by inducing 
mitotic arrest and eventfully apoptotic cell death, such as the use of a microtubule 
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stabiliser and targeting mitotic checkpoints. However, the challenges related to 
controlling the dose of these drugs to allow the disruption of mitosis in tumour cells but 
not in normal cells has limited the use of these strategies to cure cancer in patients 
(Tanaka & Hirota, 2016). Notably, however, it has been found that suppressing CIN in 
colorectal tumour cell lines by increasing the microtubule assembly rate accelerates 
tumour growth in these cells (Ertych et al., 2014). This led to the conjecture that 
increasing CIN beyond the lethal level might induce cell death. In support of this model, 
Zasadil et al. (2016) have recently found that an increase in CIN level was able to 
inhibit tumour cell growth but did not suppress its initiation (Zasadil et al., 2016). This 
observation provides a new therapeutic option by which to preferentially reduce cancer 
cells; however, the main challenge to this strategy lies in identifying the molecular 
target. 
 
In the current study, we have taken advantage of the role of INO80 in maintaining 
chromosomal stability (see 5.3.1) to test its suitability as a therapeutic target that could 
increase the CIN rate and ultimately kill CIN+ tumour cells. Our viability assay data 
showed that the absence of INO80 increased cell death in CIN+ tumour cells, whereas 
this outcome was not observed in the CIN− cell line DLD1 (Figure 5.4). This led us to 
propose INO80 as a promising therapeutic target that might be utilised to increase CIN 
to a lethal level and eventually suppress CIN+ tumour growth. These results may be 
further improved in the future by expanding the panel of tested cell lines (both CIN+ 
and CIN− cells), as our experiments originally included additional colorectal cell lines 
(CIN+: HT55 & T84; CIN−: GP2D) that were not subjected to full testing because of 
difficulties in their culture. Furthermore, subsequent studies to ascertain whether 
targeting INO80 might increase CIN+ cell sensitivity towards chemotherapeutic drugs; 
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e.g., the microtubule stabilisers taxane or paclitaxel, might help to reduce the required 
dose concentration of these agents to a level that would increase their efficiency in 
suppressing tumour growth without affecting healthy cells. 
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The work outlined in this thesis provides a novel characterization of the structure and 
biochemical features of YY1, a human subunit of INO80, which also reveal its ability to 
form multimers in vivo and in vitro and to bind several types of DNA (Chapter 3). 
Furthermore, this study demonstrates a novel mechanism of how human INO80 
promotes HR repair through its ability to remove H2AZ from damaged chromatin. In 
addition, it provides the first evidence related to the dynamics of H2AZ on damaged 
chromatin in human cells. Specifically, H2AZ is incorporated within seconds onto 
induced damage and then rapidly removed, and the removal reaction is partially 
dependent on INO80 (Chapter 4). Moreover, this work confirms the role of INO80 in 
the maintenance of chromosomal stability during mitosis and shows that the loss of 
INO80 is lethal for CIN+ tumour cell lines; thus leading to the proposal of INO80 as a 
therapeutic target for CIN+ tumour cells (Chapter 5). 
 
A major challenge lies in understanding how ATPase chromatin-remodelling complexes 
manipulate the highly compact chromatin structure by effectively evicting, exchanging, 
or sliding histones or nucleosomes along the DNA. Our finding in Chapter 3 expands 
our understanding of how human INO80 efficiently interacts with the DNA through a 
direct association between YY1-RUVBL1/2 and DNA. The established structure of 
YY1 and its multimerisation feature may also assist in understanding how the INO80 
complex performs its remodelling activity. The establishment of the “embryonic” 
structure of yeast INO80 by Tosi et al. (2013) and the identification of all of the 
crosslinks between INO80 subunits and nucleosomes has advanced the field by 
explaining the manner in which INO80 achieves some of its remodelling activities. It 
has been suggested that INO80 can form a flexible cradle between its head, neck, and 
body regions that can accommodate and embrace the nucleosome. It is envisioned that 
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nucleosomal DNA binds to the head, neck, and body, whereas the flexible foot region 
attaches to histones at both sides of the nucleosome. It has also been suggested that the 
large conformational change in INO80 might facilitate the open nucleosome 
conformation, in which H2A-H2B dimers are moderately disassociated from the H3-H4 
tetramer, and that this could subsequently enable the histone-exchange activity of the 
INO80 complex (Tosi et al., 2013). Notably, the head of INO80 is formed from Rvb1/2, 
whereas the body consists of the N-terminal domain and metazoan subunits that 
contribute to high-affinity DNA or nucleosome recognition (Tosi et al., 2013). Chen et 
al. (2011) further showed that YY1 recruitment is dependent on the HSA domain in 
humans, the latter of which, according to Tosi et al. (2013), together with its dependent 
subunits form the foot of the embryonic INO80. In contrast, Wu et al. (2007) found that 
the recruitment of YY1 is dependent on the N-terminal domain and the middle segment 
of mammalian INO80. Our result from Chapter 3, however, suggested that YY1 is 
likely to be located within the body of INO80 as it indicated that YY1 directly 
interacted with the RUVBL1/2 complex and this interaction increased the affinity 
towards binding several types of DNA. Therefore, it is possible that the YY1 functions 
to loosen the interaction between DNA and the nucleosomes, thus for example 
facilitating nucleosomes sliding.  
 
In addition, mislocalized unacetylated H2AZ represents a source of genome instability, 
as in yeast the failure in removing unacetylated H2AZ by INO80 resulted in a 
sensitivity to replication stress and DNA damage-inducing drugs (Papamichos-
Chronakis et al., 2011). Furthermore, overexpression of H2AZ has been found in 
several types of cancer including breast as well as sporadic colorectal and bladder 
cancers (Monteiro et al., 2014). Our finding in Chapter 4 extends our understanding of 
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the dynamic state of H2AZ in human cells, in which H2AZ is transiently and 
immediately incorporated into damaged chromatin and then rapidly removed. Our 
finding also provides novel evidence regarding the dependency of H2AZ removal on 
INO80 in human cells (Alatwi & Downs, 2015); moreover, this removal reaction has 
been shown by others to require ANP32E as well (Gursory-Yuzugullu et al., 2015). 
This identified mechanism will likely be of assistance in future studies investigating the 
regulation of H2AZ enrichment.  
 
With respect to DSB repair, however, the removal of H2AZ from damaged chromatin 
by both INO80 and ANP32E comprises the fundamental mechanism to ensure the 
fidelity of HR. In this situation, failure in removing H2AZ from damaged chromatin 
constitutes a barrier for resection, which leads to the inefficient loading of RAD51 foci 
and ultimately defective HR (Alatwi & Downs, 2015). The Price group showed that the 
incorporation of H2AZ at damaged sites is required for H4 acetylation, which 
eventually leads to open and relaxed chromatin consequent to the destabilisation of 
histone-histone and histone-DNA interactions (Xu et al., 2012). Subsequently, the same 
group has recently reported that it is the removal of H2AZ that is required for H4 
acetylation, suggesting that the binding of ANP32E to H2AZ may free the H4 tail and 
promote its acetylation, which in turn will ultimately relax the chromatin (Gursory-
Yuzugullu et al., 2015). Based on this finding, they hypothesized that the transient 
incorporation of H2AZ at sites of DNA damage may temporarily ‘heterochromatinise’ 
and stabilize the damaged chromatin to allow time for the cell to prepare the chromatin 
for repair, whereas the subsequent removal of H2AZ may lead to relaxed chromatin at 
the site where resection occurs (Gursory-Yuzugullu et al., 2015). In either case, the 
presence of H2AZ results in the DNA at DSBs being inaccessible until the H2AZ is 
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removed, which according to their data requires approximately 10 minutes via ANP32E. 
In contrast, repair is known to be an immediate process as upon inducing DSBs γH2AX 
is rapidly formed to initiate the repair and facilitate the recruitment of repair proteins 
(see 1.3.3.2). Therefore, our favoured model is that the deposition of H2AZ instead 
promotes the formation of open and relaxed chromatin allowing accessibility to the 
damage sites by repair proteins, whereupon H2AZ removal is required to allow for 
resection and ultimately efficient HR. 
 
Finally, recent studies have shed light on the role of INO80 in chromosomal stability 
and the fidelity of mitosis. In yeast, Ino80 regulates chromosomal stability through its 
role in regulating H2AZ removal, as H2AZ enrichment in the pericentric chromatin 
leads to aneuploidy (Chambers et al., 2012). In comparison, in human cells INO80 was 
found to function in mitosis through negatively controlling the expression of the tumour 
suppressor p21. In particular, loss of INO80 increased p21 expression, resulting in a 
significant increase in the number of cells with more than two centrosomes per nucleus, 
aberrant cytokinesis, and multipolar spindle formation (Cao et al., 2015). Our results in 
Chapter 5 confirm the role of INO80 in the maintenance of chromosomal stability. 
Furthermore, they demonstrated that the loss of INO80 induced cell death in CIN+ cell 
lines, which led us to propose that INO80 may be utilised to therapeutically target CIN+ 
tumour cells. Notably, INO80 was recently found to interact with BAP1, a tumour 
suppressor that also stabilizes INO80 during DNA replication in normal cells; 
accordingly, INO80 is downregulated in BAP1-defective cancer cells through its 
destabilization (Lee et al., 2014). Furthermore, very recent studies have found that 
INO80 is highly expressed in cervical cancer cells (Hu et al., 2016), non-small cell lung 
cancer (Zhang et al., 2016), and melanoma (Zhou et al., 2016). Hu et al. (2016) also 
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demonstrated that INO80 regulates the expression of Nanog, a transcription factor 
associated with the self-renewal and pluripotency of embryonic stem cells and which 
was found to be activated in cervical cancer cells. INO80 knockdown in these cells 
arrested cells in G0/G1 phase and suppressed tumour growth (Hu et al., 2016). In lung 
cancer cells (Zhang et al., 2016) and melanoma (Zhou et al., 2016), INO80 has been 
found to promote oncogenic transcription. Conversely, INO80 silencing inhibits tumour 
proliferation in vitro and tumour growth in mice (Zhang et al., 2016; Zhou et al., 2016). 
Taken together, these various lines of evidence strongly indicate a critical role for 
INO80 in guarding genome stability and selectively inhibiting the tumour growth of 
several types of cancers. 
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Structure of Yin Yang 1 Oligomers That Cooperate with
RuvBL1-RuvBL2 ATPases*
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Background:Oligomerization of transcription factor YY1 is not well understood.
Results: YY1 assembles homo-oligomers that bind DNAs without the consensus sequence, whose structure is studied by
electron microscopy.
Conclusion: RuvBL1-RuvBL2 enhances YY1 binding to DNAs without the consensus sequence for the transcription factor.
Significance: YY1-RuvBL1-RuvBL2 complexes could contribute to functions beyond transcription, and we find this occurs
during homologous recombination.
Yin Yang 1 (YY1) is a transcription factor regulating prolifer-
ation and differentiation and is involved in cancer development.
Oligomers of recombinant YY1 have been observed before, but
their structure and DNA binding properties are not well under-
stood. Here we find that YY1 assembles several homo-oligo-
meric species built from the association of a bell-shaped dimer,
a process we characterized by electron microscopy. Moreover,
we find that YY1 self-association also occurs in vivo using bimo-
lecular fluorescence complementation. Unexpectedly, these
oligomers recognize several DNA substrates without the con-
sensus sequence for YY1 in vitro, and DNA binding is enhanced
in the presence of RuvBL1-RuvBL2, two essential AAA!
ATPases. YY1 oligomers bind RuvBL1-RuvBL2 hetero-oligo-
meric complexes, but YY1 interacts preferentially with RuvBL1.
Collectively, these findings suggest that YY1-RuvBL1-RuvBL2
complexes could contribute to functions beyond transcription,
and we show that YY1 and the ATPase activity of RuvBL2
are required for RAD51 foci formation during homologous
recombination.
Yin Yang 1 (YY1)3 is a polycomb group transcription factor
that regulates important cellular events through activation or
repression of transcription. YY1 is ubiquitously expressed in
many tissues and participates in replication, differentiation,
proliferation, embryogenesis, and development (1–4). YY1
overexpression in some tumors correlateswith recurrences and
bad prognosis, and YY1 has been proposed as a marker for
cancer progression (5). Interestingly, recent reports have
broadened the spectrum of processes regulated by YY1 such as
silencing of retro-elements in embryonic cells (6), regulation of
long noncoding RNAs (7), inactivation of the X chromosome in
the females of mammals (4), and a direct role in V(D)J recom-
bination during early B-cell development (8).
Human YY1 is a 414-amino acid protein with a predicted
molecular mass of 44 kDa and highly conserved in eukaryotes
(sequence identity between human and mouse!98%) (1) (Fig.
1A). Putative structural and functional homologs in Schizosac-
charomyces pombe (Iec1) (9) and Drosophila melanogaster
(PHO (pleiohomeotic) and PHOL (pleiohomeotic-like)) (10)
have been studied. YY1 hallmark is four C2H2-type zinc finger
motifs located at its C terminus (residues 298–397), responsi-
ble for the sequence-specific recognition of a consensus DNA
sequence (5"-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3", where
the uppercase letters indicate the preferred base for each posi-
tion) being themost frequent ACAT and CCAT. This C-termi-
nal region harbors part of the transcriptional repression activity
of YY1. The co-crystal structure of residues 293–414 bound to
the adeno-associated virus P5 promoter showed the four zinc
fingers interacting with the DNA major groove. The structure
revealed that the interaction with the consensus sequence is
defined by specific contacts between YY1 side chains and bases
of the DNA (11). Less is known about other segments of the
protein. The N terminus has been implicated in transcriptional
activation, whereas residues 170–201 participate in transcrip-
tional repression (12, 13). Residues 201–226 form the REPO
(recruitment of polycomb) domain, involved in polycomb
group repression (14).
There is evidence that YY1 is important for maintaining
genome stability (15), but this could in part work through its
role as a transcriptional regulator of genes involved in DNA
damage responses (16, 17). Yet YY1 could also have a direct role
in DNA damage responses as it has been shown that YY1-
INO80 complexes may function in DNA repair by homologous
recombination (HR) (15). INO80 is a multisubunit chromatin-
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remodeling complex that includes, in addition to YY1 and the
Ino80 catalytic subunit, RuvBL1 and RuvBL2 (18, 19), two
closely related (65% sequence similarity) AAA! (ATPases
associated with diverse cellular activities) proteins (20, 21).
They share homology with RuvB, the prokaryotic helicase
involved in Holliday junction (HJ) resolution during HR. RuvB
assembles as hexameric rings, and its DNA-dependent ATPase
activity provides the energy for branch migration (22). RuvBL1
and RuvBL2 are essential in multiple processes including tran-
scription, DNA repair, and nonsense-mediated mRNA decay,
and their overexpression is associated with tumorigenesis
(20, 21).
X-ray crystallography (23–25) and electron microscopy
(EM) (26–28) revealed that RuvBL1 and RuvBL2 are organized
in three domains. Domain I (DI) and III (DIII) comprise the
catalytic ATPase core, responsible for the oligomerization in
homo-hexameric rings with a central channel. RuvBL1 and
RuvBL2 also assemble hetero-oligomers with alternating
RuvBL1 andRuvBL2 subunits (23–25). DII is a unique insertion
connected to the ATPase core, resembling an OB-fold, and
recombinant DII domains of RuvBL1 interact with ssDNA,
dsDNA, and ssRNA in vitro (23–25). Using cryo-EM we
recently solved the structure of human RuvBL1-RuvBL2 com-
plexes assembled as hetero-dodecamers composed of two
hexameric rings interacting back-to-back (27). These do-
decamers co-existed in two different conformations whose
functional significance is still unclear. RuvBL1 and RuvBL2
interact with YY1 in vitro (15), but these complexes have not
been characterized in detail.
Although there is evidence that YY1 can oligomerize in vitro
(15), little is currently known about the structure or DNA bind-
ing activity of these oligomeric complexes. Moreover, it is not
known if YY1 forms oligomers in vivo. Here we have analyzed
the assembly of YY1 using EM, and we determine the low res-
olution architecture of these YY1 oligomers, providing new
structural information on full-length YY1. In addition, we also
provide evidence of YY1 self-association in vivo. Interestingly,
we find that YY1 oligomers bind to several DNA substrates
without the consensus sequence for YY1 as a transcription fac-
tor. These oligomers also bind to RuvBL1-RuvBL2 ATPases in
vitro, andwe find that RuvBL1-RuvBL2 enhances DNAbinding
byYY1.These findings help explain someunconventional func-
tions ascribed to YY1 recently that could hardly be understood
only on the basis of its function as a transcription factor. We
explore one of these, and we show that, consistent with previ-
ous results (15), YY1 and RuvBL1-RuvBL2 cooperate during
DNA repair, but in addition our results indicate these proteins
are required for the correct assembly of RAD51 filaments and
that this function is dependent on RuvBL2 ATPase activity.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant Proteins—His-
YY1 was expressed using Escherichia coli Origami (DE3) cells,
and induction was performed by the addition of 0.5 mM isopro-
pyl 1-thio-!-D-galactopyranoside (final concentration) at 37 °C
for 3 h. For Strep-II-YY1, BL21 (DE3) cells were used, and
induction was carried out by the addition of 0.1 mM isopropyl
1-thio-!-D-galactopyranoside (final concentration) at 28 °C for
4 h. In both cases the medium was supplemented with 0.1 mM
ZnCl2 (final concentration) at the time of induction, and cell
lysis was performed by sonication in 100 mM Na2HPO4/
NaH2PO4, 300mMNaCl, 0.1mMZnCl2 containing amixture of
proteases inhibitors (Roche Applied Science). His-YY1 was
purified by affinity chromatography using a HisTrap HP col-
umn (GE Healthcare) equilibrated in 100 mM Na2HPO4/
NaH2PO4, 300 mM NaCl, 50 mM imidazole, 0.1 mM ZnCl2 fol-
lowed by a cationic exchange Mini S PC 3.2/3 (GE Healthcare)
column. Purified His-YY1 was dialyzed against 50 mM Tris-
HCl, pH 7.4, 200 mM NaCl, 10% (v/v) glycerol, 0.1 mM ZnCl2
overnight and stored at "80 °C. Strep-II-YY1 was purified in
one step using a StrepTrap HP column (GE Healthcare) equil-
ibrated in 50 mM Tris-HCl, pH 7.4, 500 mM NaCl, 10% (v/v)
glycerol, 0.1 mM ZnCl2, and eluted using 2.5 mM D-desthiobio-
tin in the same buffer. Purified Strep-II-YY1was dialyzed in the
same buffer as His-YY1 and stored at "80 °C. In all cases, size
exclusion chromatography (SEC) was used as a final step of
purification using a BioSep-SEC-S4000 (Phenomenex) or a
Superdex 200 PC 3.2/30 column (GE Healthcare) equilibrated
in 50mMTris-HCl, pH7.4, 200mMNaCl, 10% (v/v) glycerol, 0.1
mM ZnCl2.
His-RuvBL1 and His-RuvBL2 were expressed in BL21 (DE3)
cells by induction with 0.1 mM isopropyl 1-thio-!-D-galactopy-
ranoside (final concentration) at 28 °C for 4 h. They were puri-
fied by affinity chromatography using a HisTrap HP column
(GE Healthcare) equilibrated in 50 mM Tris-HCl, pH 7.4, 300
mMNaCl, 10% (v/v) glycerol, 20mM imidazole and eluted using
a gradient of 20–500 mM imidazole. Fractions containing the
proteins were pooled and dialyzed overnight at 4 °C in 25 mM
Tris-HCl, pH 7.4, 250mMNaCl. In the indicated cases, SECwas
performed using a Superdex 200 PC 3.2/30 (GE Healthcare) or
Superdex 200 10/300 GL (GE Healthcare) column equilibrated
in 50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 10% (v/v) glycerol.
His-RuvBL1-RuvBL2 and RuvBL1-RuvBL2 were produced as
described (27).
Affinity Purification of YY1-RuvBL1-RuvBL2 Complexes—
Recombinant Strep-II-YY1 was used to test interactions with
His-RuvBL1, His-RuvBL2, His-RuvBL1-RuvBL2, and RuvBL1-
RuvBL2 proteins in vitro. Pulldown assays were performed by
incubation of purified Strep-II-YY1 with a 2-fold molar excess
of the purified partner (His-RuvBL1, His-RuvBL2, His-
RuvBL1-RuvBL2, or RuvBL1-RuvBL2) in 50 mM Tris-HCl, pH
7.4, 500 mM NaCl, 10% (v/v) glycerol, 0.1 mM ZnCl2 for 20 min
on ice followed by the addition of StrepTactin High Perform-
ance Resin (GE Healthcare) and further incubation for 30 min
at 4 °C with agitation. After 3 washes with the reaction buffer,
proteins retained in the resin were elutedwith 50mMTris-HCl,
pH 7.4, 500mMNaCl, 10% (v/v) glycerol, 0.1 mMZnCl2, 2.5 mM
D-desthiobiotin. All purification steps were monitored by SDS-
PAGE, and protein detection was carried out using Oriole!
Fluorescent Gel Stain (Bio-Rad) or silver staining.
Glutaraldehyde Cross-linking—Purified His-YY1 (0.1 "g/"l)
was dialyzed in 100mMNa2HPO4/NaH2PO4, 300mMNaCl, 0.1
mM ZnCl2 for 3 h, and 13.5 "l of the protein were cross-linked
in 15-"l reactions on ice using glutaraldehyde 0.005% (v/v)
(final concentration) for 30 min. The reactions were stopped
using 192 mM Tris-glycine (final concentration). Samples were
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analyzed by SDS-PAGE and Western blotting using the anti-
YY1 antibody.
GraFix—Affinity-purified Strep-II-YY1 (10 !M) was stabi-
lized in a discontinuous glycerol/glutaraldehyde gradient by the
GraFix method (29). 100 !l of the sample were applied on the
top of the tube. As a control, sample was also applied into a
similar glycerol gradient without the cross-linking agent. Sam-
ples were centrifuged at 30,000 rpm, 4 °C for 18 h (rotor SW 55
Ti). After centrifugation, fractions were collected, and reac-
tions stopped by the addition of 192 mM Tris-Glycine (final
concentration).
Electron Microscopy and Image Processing—A few microli-
ters of each of the samples analyzed were deposited on carbon-
coated grids immediately after elution from the SEC column
and stained using 2% (w/v) uranyl acetate. All observations
were performed in a JEOL 1230 transmission electron micro-
scope operated at 100 kV. Images were collected using a low-
dose protocol and a 4k x 4k TVIPS CMOS detector under con-
trol of the EM-TOOLS software (TVIPS). Final magnification
of the CMOS micrographs was 68222.5!. Contrast transfer
function for each micrograph was estimated using CTFFIND3
(30) and corrected using BSOFT (31) before selecting particles.
Particles were boxed and extracted from themicrographs using
e2boxer in EMAN2 (32). 16362 particles for complex A and
52713 particles for complex B were boxed and classified using
reference-free methods in EMAN (33), EMAN2 (32), and
XMIPP (34). Particles were binned at 4.56 Å/pixel before fur-
ther processing. Ab initio structures for each experiment were
obtained by the random conical tilt (RCT) method (35) using
XMIPP (34). RCT was applied on those molecule images clas-
sified as belonging to the same view of the oligomer and using
the images of these same molecules after tilting the specimen
holder by 45°. The resulting volumes were then used as tem-
plates for angular refinement using EMAN (33). The rotational
symmetry of the YY1 complexes was determined by calculating
the power rotational spectra of sections of the RCT structures
generated using SPIDER (36) along the longitudinal axis of the
complex, as implemented in XMIPP (34), as well as for the
reference-free two-dimensional averages. Refinement was per-
formedwithout assuming any symmetry, but after some rounds
of refinement 2-fold rotational symmetry was imposed and
refined further until convergence. The hand selected was that
provided by the RCT structure. The resolution of the structure
(20 Å) was estimated using Fourier shell correlation (FSC) and
a 0.5 correlation coefficient. We verified that the bias of the
template used for angular refinement did not affect conver-
gence significantly. For this, we refined the same dataset from
four independent templates and imposing 2-fold symmetry.
Images were refined from: (i) a RCT structure; (ii) a structure
obtained using the common lines method as implemented in
the startAny command from EMAN (33); (iii) a model gener-
ated using the startcsym program from EMAN (33), searching
for particleswith the best 2-fold rotational symmetry, which are
the defined as top views, and for particles with the best mirror
symmetry and poor 2-fold symmetry, defined as sided views;
class averages from each group and the 2-fold symmetry were
used to generate a three-dimensional model; (iv) a model was
generated using e2initialmodel.py in EMAN2 (32), where a ran-
dom featureless blob model is used to seed a refinement using
reference-free class averages. All structures were filtered
according to the estimated resolution and rendered using
UCSF Chimera (37).
DNA Substrates—DNAs were made by annealing combina-
tions of oligonucleotides (Table 1). In each case one of the oli-
gonucleotides was labeled at the 5"-end by polynucleotide
kinase with ["-32P]ATP before annealing. Holliday junction J3,
which has 40-bp arms, was made from oligonucleotides J3-1 to
J3-4, the duplex dsDNA_no_sp_1 (not containing the consen-
sus sequence) from J3-2 and J3-5, and dsDNA_sp_1 (containing
the consensus sequence) from 43-1 and 43-2. The 80-nt ssDNA
substrate used was labeled J3-2 oligonucleotide. Holliday junc-
tion HJ_25 (with 25-bp arms) was made from oligonucleotides
HJ_1 to HJ_4. Annealing was performed in 100 mM phosphate
buffer, pH 7.5, with the appropriate combinations of oligonu-
cleotides, mixing one radiolabeled oligonucleotide with cold
complementary oligonucleotides in a 1:2 ratio. The annealed
products were resolved on an 8% non-denaturing polyacryl-
amide gel. The bands containing the annealed substrates were
purified as described in Zecchi et al. (38). DNA concentration
was calculated by scintillation counting. DNA substrates
labeled with Cy5 (Sigma) at the 5"-end were annealed as
described for the "-32P-labeled substrates. Holliday junction
HJ_25_sp was made from oligonucleotides HJ_12 and HJ_34_1
andHJ_25_no_sp fromHJ_12 andHJ_34_2. dsDNA containing
(dsDNA_sp_2) or not (dsDNA_no_sp_2) the consensus
sequence for YY1 were made from oligonucleotides DS_1 and
DS_2, and DS_3 and DS_4, respectively.
Electrophoretic Mobility Shift Assays (EMSA)—Binding of
YY1 andRuvBL1-RuvBL2 toDNAwas analyzed throughEMSA
using different radiolabeledDNAsubstrates (0.3 nM). Reactions
were performed in 50mMTris-HCl, pH7.5, 0.05mg/mlBSA, 60
mMNaCl, 10% (v/v) glycerol, 1 mMMgCl2, 0.1 mMZnCl2, 1 mM
DTT for 30 min at 37 °C. Complexes were separated by 8 or 6%
native-PAGE in Tris borate-EDTA 0.5! at 4 °C. Gels were run
at 200 V for 3 h and dried before autoradiography and phos-
phorimaging. Apparent binding constants were determined as
the protein concentration resulting in half binding to a DNA
substrate at 0.3 nM by EMSA. The exact value of the half-bind-
ing point was determined from interpolation on a Hill plot.
Binding constants are the average values obtained from at least
three independent experiments (the results given stand within
a 10% standard error).
For the supershift experiments, reactions were carried out in
the same conditions as those for the binding assays, but after
incubation at 37 °C for 30 min, the indicated amounts of anti-
YY1 antibody or PBS 1! as a controlwas added to reactions and
further incubated for 15 min at 37 °C. Samples were separated
under the same conditions as those described before for the
binding assays. Binding of YY1 fractions from the SEC to Cy5-
labeled DNA (10 nM) substrates was also analyzed through
EMSA. Reactionswere carried out on ice for 30min in buffer 50
mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% (v/v) glycerol, 10 mM
MgCl2, 0.1 mM ZnCl2. Complexes were solved on 6% native-
PAGE gels in Tris borate-EDTA 0.5! at 4 °C. Fluorescence of
the DNA was detected with a Fujifilm FLA-3000 equipment.
Native-PAGE gels were transferred to PVDF membranes, and
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protein was detected by Western blot with the anti-YY1
antibody.
Cell Culture and Irradiation—A549 and U2OS cells were
cultured in Eagle’s minimum essential medium (MEM) or
DMEM (Invitrogen), respectively, supplemented with 10%
FCS, L-glutamine, penicillin, and streptomycin (Invitrogen) at
37 °C in a humidified 95% air and 5% CO2 atmosphere. Cells
were irradiated by exposure to a 137Cs source.
Small Interfering RNA (siRNA) Knockdown Conditions and
Antibodies—siRNA-mediated knockdown was achieved using
HiPerFect Transfection Reagent (Qiagen) following the man-
ufacturer’s instructions. siRNA duplexes were transfected into
4 ! 105 of logarithmically growing cells per condition. Cells
were harvested 24 h later, retransfected with siRNA, and then
seeded and grown for 48 h. The primary antibodies used were:
!H2AX (Millipore) at 1:800 for IF, replication protein A (RPA;
Millipore) at 1:100 for IF, RAD51 (SantaCruzBiotechnology) at
1:200 for IF, CENPF (Abcam) at 1:1000 for IF, YY1 (H-414,
Santa Cruz Biotechnology) at 1:1000 forWB, RuvBL2 (Abcam)
at 1:5000 for WB, and KAP-1 (Abcam) at 1:1000 for WB. Anti-
YY1 antibody (H-10 X, Santa Cruz Biotechnologies) for super-
shift experiments was used. The secondary antibodies used
were: FITC (Sigma) at 1:100 for IF, Cy3 (Sigma) at 1:200 for IF,
AlexaFluor 488/555/350 (Invitrogen) at 1:400 for IF, goat anti-
rabbit HRP at 1:10,000 for WB, rabbit anti-mouse HRP at
1:2,000 for WB. Anti-His-HRP conjugated antibody (Sigma)
was used at 1:10,000 for WB.
Bimolecular Fluorescence Complementation (BiFC)—1.5 !
105 of U2OS cells were co-transfected with 0.25 "g of VN173-
and VC155-derived plasmids using a NanoJuice Transfection
Reagent kit (Novagen). 24 h post-transfection cells were fixed
with 3% (w/v) paraformaldehyde, permeabilized with 0.5% Tri-
ton X-100, and mounted with Vectashield containing 4",6-di-
amidino-2-phenylindole (DAPI; Vector Laboratories Ltd).
Slides were analyzed and imaged using an Applied Precision!
Delta Vision! RT Olympus IX70 deconvolution microscope.
Immunofluorescence—Cells plated on coverslips were fixed
for 10 min with fixative (2% (w/v) paraformaldehyde, 3% (w/v)
sucrose, 1! PBS) and permeabilized for 3minwith 0.2%Triton
X-100 in PBS.When staining for RPA/RAD51 in cells not trans-
fected with plasmid, pre-extraction was performed by treat-
ment with 0.2%Triton X-100 in PBS for 0.5–1min before para-
formaldehyde fixation. Cells were rinsed with PBS and
incubated with primary antibody diluted in PBS # 2% (w/v)
BSA for 1 h at room temperature. Cells were washed 3 times,
incubated with secondary antibody (diluted in PBS# 2% (w/v)
BSA) for 30 min at room temperature in the dark, incubated
withDAPI for 10min, andwashed 3 timeswith PBS. Slideswere
mounted using Vectashield and visualized/analyzed using a
Nikon-e400 microscope and imaged using an Applied Preci-
sion! Delta Vision! RT Olympus IX70 deconvolution micro-
scope and softWoRx! Suite software. For !H2AX, RPA, and
RAD51 foci quantification, a minimum of 30 cells were scored
blindly per experiment, and error bars represent the S.D.
between three experiments.
Plasmids and Constructs for in Vivo Studies—The BiFC plas-
mids pBiFC-VN173 (encoding the N-terminal region of Venus;
Addgene no. 22010) and pBiFC-VC155 (encoding the C-termi-
nal region of Venus; Addgene no. 22011) were obtained from
Chang-Deng Hu (via Addgene (49)). The coding region of YY1
was amplified from the YY1 cDNA (Source BioScience) and
cloned into the BiFC plasmids to create pYY1-VN and pYY1-
VC.TheRuvBL2 complete humanORF cDNA (accession num-
ber NM_006666) was purchased from Origene as GFP-tagged
transfection-ready DNA. To generate siRNA-resistant RuvBL2
expression constructs, the following nucleotides weremutated:
451 G to A, 460 A to T, 466 A to T using QuikChange
site-directed mutagenesis (Stratagene). The GFP-RuvBL2K83A
ATPase mutant construct was generated using QuikChange
site-directed mutagenesis (Stratagene) on the siRNA-resistant
template.
RESULTS
YY1 Assembles Two Distinct Oligomeric Species—Human
full-lengthHis-tagged YY1 (His-YY1)was expressed in bacteria
and purified to homogeneity (Fig. 1B) for structural and bio-
chemical studies. His-YY1migrated with the apparentmobility
of a larger protein ($65–68 kDa) due to its amino acid compo-
sition (39). We analyzed the functionality of the recombinant
protein by testing the ability of His-YY1 to bind DNA using
synthetic 4-way DNA substrates (HJ) by EMSA (Fig. 1C). His-
YY1 bound two types of HJ with arms of 40 bp (Fig. 1C, left
panel) and 25 bp (Fig. 1C, right panel). The shifted band was
specifically super-shifted with an anti-YY1 antibody unable to
shift DNA complexes of the RecU resolvase used as a control
(not shown). Therewere severalHis-YY1DNAcomplexes, sug-
gesting the binding of multiple monomers to each DNA mole-
cule and opening the possibility of YY1 oligomerization (15).
Confirming the work by Wu et al. (15), we found that His-
YY1 behaved as an oligomer in a SEC (Fig. 1D), but in addition
we observed that His-YY1 migrated as two distinct species, an
$100–150-kDa complex (named as complex A) and a larger
oligomer of about 200–300 kDa (complex B). Complex A could
correspond to a 2- or 3-mer according to the calibration of the
column using molecular weight standards (Fig. 1D), and this
complex appeared as square-shaped molecules compatible
with an oligomer by EM (Fig. 1E). Complex B appeared at the
microscope as an elongated molecule with roughly double
length than complex A (Fig. 1E). Some larger species were also
detected eluting from the column (Fig. 1D), but they appeared
as aggregates in the electron microscope (Fig. 1E, inset). Oligo-
merization was also detected by analyzing the electrophoretic
mobility of His-YY1 after a mild cross-linking using glutaralde-
hyde, which showed the presence of multimers containing sev-
eral subunitsmigrating as dimers and also larger oligomers (Fig.
1F). Several lines of evidence revealed that complex B was
assembled by the oligomerization of complex A, as the ratio
between complex B and A in SEC was dependent on the input
sample concentration. When fractions from the SEC corre-
sponding to complex B were re-injected in the same column, a
peak containing His-YY1 that migrates as complex A and con-
taining square-shaped molecules was detected (Fig. 1G). This
was interpreted as resulting from the disassembling of the
larger species, suggesting an equilibrium between the two
oligomers.
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YY1 FormsMultimers in Vivo—Whether the oligomerization
of YY1 found for the recombinant protein also occurs in vivo is
unknown. Thus we used BiFC to detect YY1 self-association in
vivo. We created two YY1 fusion constructs with complemen-
tary fragments (VN orVC) of the YFP fluorescent reporter pro-
tein Venus (Fig. 2A). Fluorescence occurs when the comple-
mentary fragments of Venus are in close proximity, providing
readout of protein-protein interactions in vivo. We co-trans-
FIGURE 1. Purification and characterization of human YY1. A, scheme of
human YY1 primary sequence. Relevant domains andmotifs are indicated. B,
SimplyBlue (Invitrogen) staining SDS-PAGE of purified His-YY1. C, left panel,
His-YY1 was incubated with a synthetic HJ DNA (described as J3 under
“Experimental Procedures”), and reactions were resolved by 6% non-de-
naturating PAGE. 0.3 nM of HJ (J3) (lane 1) was titrated with increasing
amounts of YY1 (lanes 2–7, 1920, 960, 480, 240, 120, and 60 nM, respec-
tively). Right panel, antibody super shift experiments demonstrated the
specificity of the interaction. Lane 1, HJ probe alone (described as
HJ_25_no_sp under “Experimental Procedures”); lanes 2 and 3, 2 and 1 !g
of anti-YY1 antibody (Ab) alone, respectively; lane 4, YY1 protein alone
(100 nM); lanes 5 and 6, incubation of YY1 protein (100 nM) with 2 and 1 !g
of anti-YY1 antibody, respectively. Positions of unboundHJ probe, YY1-HJ,
and YY1-HJ-antibody shifted-bands are indicated. D, SEC of purified His-
YY1 in a BioSep-SEC-S4000 (Phenomenex) column. The column was cali-
brated with molecular weight standards (GE Healthcare), and the elution
volume for some of the standards is shown on the top of the chromato-
gram. E, different fractions from the SEC inDwere observed in the electron
microscope, and fields from representative electron micrographs are
shown. Typical molecule images are highlighted within circles. The inset in
the left panel shows a view of aggregates found to elute first from the SEC
column. The scale bar represents 250 Å. F, Western blot with an anti-YY1
antibody of His-YY1 after cross-linking with glutaraldehyde (GA); lane 1,
molecular weight standards (Bio-Rad); lane 2, control without GA; lane 3,
30 min of incubation with GA. His-YY1 monomer migrates as a 70-kDa
protein in SDS-PAGE (labeled as *). Cross-linked bands, with a relative
molecular weight multiples of the YY1 monomer, are labeled with arrows.
G, SEC of His-YY1 was as in D (black line). The peak fraction corresponding
to complex B was re-injected (gray line) in the same column, and the frac-
tions (F1 to F10) of both experiments were analyzed by silver-stained
SDS-PAGE. The top panel corresponds to fractions from the black line and
bottom panel for the gray line chromatography, respectively. Positions of
the YY1 complexes A and B as well as molecular weight standards (GE
Healthcare) used for column calibration are indicated. Total volume of the
column (Vt) is indicated by an asterisk (*).
FIGURE 2. YY1multimerizes in vivo. A, scheme of the expression constructs
used inBiFCexperiments. The coding sequenceof YY1was fused to either the
N-terminal (YY1-VN) or C-terminal (YY1-VC) domain of Venus. B, U2OS cells
transiently co-transfected with plasmids expressing the fusions in A were
analyzed by microscopy. Co-transfection of YY1-VN with VC or YY1-VC with
VN displayed no difference in pan-nuclear fluorescence compared with cells
co-transfected with the empty vectors (VC and VN). Only cells co-transfected
with both YY1 fusion constructs (YY1-VN and YY1-VC) had distinct foci pres-
ent in the nuclei.
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fected cellswith theYY1-VNandYY1-VC fusion constructs. As
controls, cells were transfected with YY1-VN in combination
with the VC empty vector (YY1-VN and VC), YY1-VCwith the
VN empty vector (VN and YY1-VC), or the two empty vectors
(VN and VC). In all of the control cells, we saw pan-nuclear
fluorescence. However, when the YY1 constructs were co-
transfected, we saw distinct foci present in the cells (Fig. 2B),
suggesting that YY1 forms multimers in vivo.
YY1Assembles a Bell-shapedCoreDimer—To further under-
stand the structure of the YY1 multimers, an homogenous
preparation of complex A from the peak fraction of a SEC
experiment was observed by EM, revealing a square-shaped
molecule with approximate dimensions of 60 ! 50 Å, a low
density region at its center (Fig. 3A), and a clear maximum in
4-fold rotational power spectra compatible with the oligomer-
ization of 2 or 4 identical YY1 subunits (Fig. 3B, left panel).
Several low resolution ab initio structures of YY1 complex A
were obtained for homogenous sub-classes using the RCT
method (Fig. 3C, four representative RCT structures are
shown). Sections along the longitudinal axis of these ab initio
structures revealed a square shape (Fig. 3C), with a 4-fold
maximum in the rotational power spectra (Fig. 3B, right
panel). Given that the SEC experiment suggested that YY1
oligomers are either 2- or 3-mers but never 4-mers, the
FIGURE3.Structureof thehumanYY1dimer.A, singlemolecule images and two-dimensional reference-free averages of complexAofHis-YY1 showa typical
square shape. The scale bar represents 5 nm. B, left panel, analysis of the rotational power spectra of a representative reference-free two-dimensional (2D)
average of YY1. Right panel, rotational power spectra of sections along the longitudinal axis of the YY1 RCT structure. One representative section is displayed
that revealed a strong componentwith 4-fold symmetry compatiblewith a dimeric or tetrameric complex. Scale bars represent 5 nm. C, four representative ab
initio low resolution structures of YY1 complex A obtained by the RCT method. Two-dimensional reference-free averages used for each three-dimensional
reconstruction are shown in the left panels and sections of each of themodels (right panels). The scale bar represents 25 Å.D, angular refinement of YY1 dimer
(complex A). Initial refinement was performedwithout imposing any symmetry (steps 1 and n) using the RCTmodel #01 shown in C as the initial template, and
after convergence, c2 rotational symmetry was imposed and further refined (Final volume). Volumes are shown rendered at a threshold representing around
75% of the protein mass for visualization of structural features. The scale bar represents 25 Å. E, three-dimensional structure of the YY1 dimer (complex A)
obtained after angular refinement. The scale bar represents 25 Å. Characteristic regions of the complex, defined as head and arm, are labeled. The left panel
shows the comparison of the computational projections (Proj.) of the refined volumewith the averages (Aver.) of the singlemolecule images assigned to each
orientation. The scale bar represents 5nm. F, angular refinement of YY1 complexAusing several initial volumes as templates todiscard a significantmodel bias.
Refinementwasperformedapplying 2-fold rotational symmetry andusing as templates: a randomconical tilt structure, a reconstructionobtainedby common
lines, or using the Startcsym command in EMAN (33) and a featureless blob usingmethods defined in EMAN2 (32). In all cases refinements converged to very
similar structures (Refined volume). The scale bar represents 25 Å.
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images in the electron microscope suggested the assembly of
an YY1 dimer.
Dimerization of YY1 was further supported by solving the
structure of these oligomers using 16,362 images obtained in
the electron microscope (Fig. 3E). First, a three-dimensional
reconstruction of YY1was obtained by image processingmeth-
ods and using an ab initio RCT structure as the initial template
(model #01 in Fig. 3C) for refinement and applying no symme-
try constrains (Fig. 3E). The estimated molecular mass of this
non-symmetrized reconstruction, defined by the number of
voxels occupied by the reconstruction and assuming an average
density for proteins, was !100 kDa, which only matched a
dimeric species. Then, 2-fold symmetry was applied to obtain
the structure of YY1 complexA at 20Å resolution (Fig. 3E). The
structure of the YY1 revealed two regions (Fig. 3E). The top
region (“head”) was compact and displayed a square shape and
was therefore responsible for the strong component of 4-fold
symmetry detected in the averages (Fig. 3B). The bottom region
(the “arms”) was slightly elongated and fitted better to 2-fold
symmetry. To rule out a significant bias of the initial template
during image processing, we confirmed that the data converged
to very similar reconstructions when using several initial mod-
els obtained by distinct methods: RCT, common lines, use of
rotational symmetry, and a featureless blob (see “Experimental
Procedures” for details) (Fig. 3F).
YY1 Multimerizes by the Association of Dimers—The struc-
tural characterization of YY1 complex B was first addressed by
concentrating His-YY1 to enrich the complex, but this resulted
in its aggregation. We then produced an N-terminal Strep-II-
tagged version (Strep-II-YY1) that yielded a major peak com-
posed of abundant complex B in SEC (Fig. 4A). Strep-II-YY1
behaved as a discrete high molecular weight band in SDS-
PAGE after stabilization with a mild concentration of glutar-
aldehyde using the GraFix method (29) (Fig. 4B), clearly
indicative of a defined oligomeric species. Images of Strep-
II-YY1 complex B revealed an elongated molecule (Fig. 4C),
and similar images were obtained for the complex after Gra-
Fix (not shown) and for His-YY1 complex B (Fig. 4D). A
minor percentage of Strep-II-YY1 complex A co-existed in
the same micrographs (20% of the data set) (Fig. 4C), and ab
initio RCT structures for each complex were obtained by the
RCT method to deal with this heterogeneity. Complex B
(80% of the data set) appeared as elongated structures of
roughly 100 Å in length, approximately double in size than
the dimers (Fig. 4E). We were unable to refine these struc-
tures to higher resolutions despite rigorous attempts. Major
difficulties were found to assign each molecule image to a
certain conformation as well as the ambiguities to define the
axis of rotational symmetry. Nonetheless, the two-dimen-
sional averages of the complexes and their RCT structures
suggested that these were distinct oligomeric species assem-
bled by the association of dimers, and several models could
be possible (Fig. 4F).
YY1 Oligomers Can Bind DNA with and without the Consen-
sus Sequence—Zinc finger motifs of YY1 define its function as a
transcription factor by recognizing a consensusDNAsequence.
We verified that Strep-II-YY1 oligomeric fractions obtained by
SEC (Fig. 5A) recognize a short dsDNA (20-bp) and 4-way HJ,
containing a consensus sequence (CCAT) by EMSA (Fig. 5, B
and C, Table 1). Unexpectedly, we found that YY1 oligomers
could also bind a 25-bp dsDNA without a consensus sequence
(although with less affinity than the dsDNAwith the consensus
sequence) and a HJ without a consensus sequence (Fig. 5, B–E),
suggesting these oligomers could have acquired new DNA
binding properties. The DNA mobility shifts observed corre-
lated with YY1 present in the fractions as revealed when the
native gels were analyzed by Western blot with an anti-YY1
antibody (Fig. 5, B–E, bottom panels). Maximum binding was
detected for the peak fraction enriched in YY1 oligomers,
mainly complex B. These results revealed that YY1 can bind
DNA after oligomerization, and remarkably these oligomers
seem to have the potential to recognize some DNA sub-
strates even when lacking the consensus sequence.
RuvBL1-RuvBL2 Interacts with YY1 and Enhances DNA
Binding—YY1has been shown to bindRuvBL1 andRuvBL2 (18,
19), and thus we decided to analyze if the oligomeric forms of
YY1 also interacted with these ATPases and how this could
affect DNA binding. RuvBL1 and RuvBL2 assemble homo-
hexameric rings on their own, whereas its co-expression results
in a mixture of hetero-hexameric and dodecameric complexes
that are believed to be functional forms of these ATPases in the
cell (23–25). We purified His-RuvBL1, His-RuvBL2, and His-
RuvBL1-RuvBL2 complexes and also RuvBL1-RuvBL2 where
the tag was removed (27) (Fig. 6A), and the oligomeric state of
each sample was characterized by SEC (Fig. 6B). Purified His-
RuvBL1 was resolved as a mixture of oligomers and free sub-
units, whereas His-RuvBL2 did not oligomerize under our
experimental conditions. On the other hand, His-RuvBL1-
RuvBL2 and RuvBL1-RuvBL2 formed hetero-oligomeric com-
plexes with an approximate 1:1 ratio that we interpreted as
hexamers and dodecamers based on previous information (27).
We found that Strep-II-YY1 interacted with His-RuvBL1 but
not His-RuvBL2 under our experimental conditions after pull-
ing down the Strep-II tag and eluting the retained His-RuvBL1
or His-RuvBL2 with D-desthiobiotin (Fig. 6C, lanes 3 and 5).
Similar experiments performed using purified His-RuvBL1
hexamers ormonomers retrieved identical results (not shown),
indicating that Strep-II-YY1 interacts with these two forms of
His-RuvBL1. Also, we observed that RuvBL1-RuvBL2 (either
containing or not the His tag) was also eluted in complex with
Strep-II-YY1 (Fig. 6D; note that His-RuvBL1 and RuvBL1 run
differently on SDS-PAGE).
We analyzed how the interaction between YY1 and RuvBL1-
RuvBL2 affected DNA binding by EMSA, and we focused on
two dsDNAs, one containing and another onemissing the con-
sensus sequence for YY1 (Fig. 7), and compared its binding
affinity to the binding to a HJ DNA without a consensus
sequence. We first measured the affinity of each protein for
these forms of DNA and included also ssDNA in our analysis
(Fig. 7A, Table 2). The interaction of YY1 with both dsDNAs
mainly revealed two types of complexes, a single band of shifted
DNA and a complex migrating at the gel well at high protein
concentrations (Fig. 7A, left panel). YY1 bound 4–5 times bet-
ter to the dsDNA containing the consensus sequence, but the
difference in binding affinity between the specific DNA and HJ
DNA was only 2–3 times (Table 2). Binding to ssDNA was also
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observed. The analysis of the binding of RuvBL1-RuvBL2 to
DNA showed that the preferred substrate was HJ (J3) followed
by the 80-nt ssDNA (Fig. 7A, right panel; Table 2). RuvBL1-
RuvBL2 bound DNA forming several complexes. Interestingly,
when RuvBL1-RuvBL2 and YY1were incubated together in the
presence of a dsDNA with or without the consensus sequence,
we observed that the top bands corresponding to DNA shifted
by YY1were enhanced significantly (Fig. 7B, compare lane 6 for
FIGURE 4. YY1 multimerizes in larger complexes by the association of YY1 dimers. A, purification of Strep-II-YY1. Left panel, SDS-PAGE and SimplyBlue
(Invitrogen) staining of purified Strep-II-YY1. Right panel, SEC of Strep-II-YY1 using a Superdex 200 PC 3.2/30 (GE Healthcare) column. Molecular weight
standards (GE Healthcare) used for column calibration are indicated on the top of the chromatogram. B, silver staining SDS-PAGE of the Strep-II-YY1 protein
purified and stabilized by the GraFix method in a glycerol/glutaraldehyde (GA) gradient (right panel) and in a glycerol gradient (left panel). C, selected raw
molecule images and reference-free averages of Strep-II-YY1 (complexes A and B). The scale bar represents 10 nm. 2D averages, two dimensional averages. D,
rawmolecule images and reference-free averagesofHis-YY1 (complexesA andB). Images for both samples (His- andStrep-II-taggedYY1)were similar. The scale
bar represents 10 nm. E, representative RCT structures obtained from images and averages of Strep-II-YY1. The peak from the SEC contained a mixture of
complexes A and B. The scale bar represents 25 Å. The two-dimensional averages of the images used for each RCT reconstructions are shown in the left panels.
The scale bar represents 5 nm. F, hypothetical models for the association of YY1. Two potential ways of association of YY1 dimers into larger oligomers, based
on the two-dimensional averages and the RCT structures of complexes A and B, are proposed.
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YY1 alone with lanes 7–9 for YY1 incubated with RuvBL1-
RuvBL2). Experiments were done at a YY1 concentration that
resulted in !10% of DNA shifted in the absence of RuvBL1-
RuvBL2, and at the highest RuvBL1-RuvBL2 concentration
used (700 nM), a 5-fold increase in the amount of YY1 com-
plexes with the consensus sequence and a 7-fold for YY1 com-
plexes with dsDNA without the consensus sequence was
observed. Similar effects were found for ssDNA (Fig. 7C) and a
HJ (Fig. 7D). Control experiments were performed where the
different DNA substrates were incubated with YY1 and an
excess of BSA to demonstrate that the enhancement in binding
is not due to a “protein concentration” stabilizing effect (data
not shown).
Taken together, these results are a strong indication that YY1
and RuvBL1-RuvBL2 can form a complex with increased affinity
for DNA. Interestingly, these effects are found to occur also when
the DNA does not contain the consensus sequence for YY1.
YY1 and RuvBL1-RuvBL2 Cooperate in Vivo to Promote
RAD51 Foci Formation during Homologous Recombination—
YY1 functions in HR as part of the INO80 complex (containing
RuvBL1 and RuvBL2 subunits), and although the mechanism
for this is unknown, it has been suggested that it could occur
FIGURE 5.YY1 oligomers recognize DNAwith andwithout the consensus sequence. A, purified Strep-II-YY1was fractionated as in Fig. 4A and analyzed by
SDS-PAGE and silver-staining. Molecular weight markers used for SEC calibration are indicated above the gel. B, EMSA using the fractions from the SEC
experiment shown inA andadsDNAcontaining the consensus sequence for YY1 (CCAT) (describedasdsDNA_sp_2under “Experimental Procedures”).C, EMSA
as in Bbut using a dsDNA that does not contain the consensus sequence (described as dsDNA_no_sp_2 under “Experimental Procedures”).D, EMSA as in Bbut
using a synthetic 4-way HJ containing the consensus sequence for YY1 (CCAT) (described as HJ_25_sp under “Experimental Procedures”). E, EMSA as in D but
using a synthetic 4-way HJ that does not contain the consensus sequence (described as HJ_25_no_sp under “Experimental Procedures”). Lanes labeled as C
(B–E) show the nucleic acid in each case in the absence of protein. The bottom panels (B–E) show the same gels, run for longer, and where the presence of YY1
in the shifted DNA was detected by Western blot with an anti-YY1 antibody (!-YY1).
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through the recognition of Holliday junction-like structures
(15). Our findings showing that the interaction of YY1 and
RuvBL1-RuvBL2 enhances binding to ssDNA and dsDNA
prompted us to further define their role during HR. We
explored if these proteins cooperate at several stages of the HR
process where HJ substrates are not available and also the
requirement of catalytic activity of the RuvBL1-RuvBL2
ATPases. To investigate this, we transfected cells with siRNA
targetingYY1 and examined themafter treatmentwith ionizing
radiation (IR) (Fig. 8). HR is restricted to the S and G2 phases of
the cell cycle in mammalian cells, so we immunostained for
CENPF to identify G2 phase cells and then measured the accu-
mulation ofDNAdamage response factors into IR induced foci.
We found that the number of phosphorylatedH2AX (!H2AX)-
containing foci at the 2-h time point was unaffected by deple-
tion of YY1 (Fig. 8A), suggesting that the initial detection and
signaling of the DNA breaks are unaltered. At 8 h after treat-
ment, the BRCA2 (breast cancer type 2 susceptibility protein)-
depleted cells, which are HR-defective, showed a modest
increase in foci at this time point (Fig. 8A).
After recognition, DNA breaks are resected to leave 3!
ssDNA overhangs that are bound by RPA. Subsequent to resec-
tion, BRCA2 mediates the replacement of RPA with RAD51
filaments on the ssDNA overhang, and the RAD51 filament
performs the homology search and strand invasion steps (40).
When we examined RPA foci formation in G2 cells, we found
no difference in the number of foci in the cells depleted for YY1
when compared with control cells (Fig. 8B). Whereas it is pos-
sible that the extent of resection is affected, this result suggests
that there is no defect in the number of resected DNA breaks in
these cells. Cells depleted for BRCA2 show normal !H2AX and
RPA foci but defective RAD51 foci after IR (Fig. 8, B and C).
Similar to loss of BRCA2, we found that there were significantly
fewer RAD51 foci in the YY1 and RuvBL2 depleted cells,
although the severity of the defect was not as pronounced as in
the BRCA2-depleted cells (Fig. 8C). Notably, we found that
depletion of RuvBL2 recapitulated HR defects after YY1 deple-
tion. Specifically, the numbers of !H2AX and RPA foci were
largely unaffected by depletion of RuvBL2, but the number of
RAD51 foci was reduced to similar levels as those observed in
YY1-depleted cells (Fig. 8).
These results showed that depletion of YY1 or RuvBL2
resulted in comparable HR defects, suggesting that YY1 and
RuvBL2 could cooperate to promote or stabilize RAD51 fila-
ment formation. To investigate whether this was the case, we
analyzed the formation of !H2AX, RPA, and RAD51 foci in G2
cells following IR exposure after depletion of YY1, RuvBL2, or
both (Fig. 9A). If these subunits were functioning at separate
steps during HR, we would predict an increase in unrepaired
breaks when they are co-depleted, leading to an increase in
!H2AX foci. Furthermore, if YY1 and RuvBL2 were promoting
or stabilizing RAD51 foci formation via distinct mechanisms,
depletion of both proteins would result in a greater defect in
RAD51 foci relative to cells with depletion of a single subunit.
However, we found that both !H2AX and RAD51 foci forma-
tions were similar in cells depleted of both proteins to cells
depleted of either individual subunits (Fig. 9B), indicating that
these genes function on the same pathway to promote HR.
Wemade use of a point mutation within theWalker Amotif
of RuvBL2 that impairs ATP binding but does not disrupt its
folding (41) to determine whether the ATPase activity of
RuvBL2 is required for the observed effect on RAD51 foci
formation after IR exposure. To do this we generated a
siRNA-resistant GFP-tagged RuvBL2 expression construct
and then introduced the K83A point mutation into this con-
struct (Fig. 9C). We then transfected the wild type and
mutant constructs (along with a GFP control) alongside
siRNA directed against RuvBL2 and analyzed !H2AX and
RAD51 foci formation in GFP-positive G2 cells. We found
that the wild type construct was able to complement the
RAD51 foci formation defect of the RuvBL2-depleted cells,
whereas the mutant construct was not able to complement
the defect (Fig. 9D), indicating that the ATPase activity of
RuvBL2 is required during this step of HR. All these data
suggest that the epistatic function of YY1 and RuvBL1-
RuvBL2 during HR requires the catalytic activity of these
ATPases, at least in the case of RuvBL2.
TABLE 1
Sequences of oligonucleotides used for constructing several DNA substrates
Name Sequence 5!-3 5!-Label
J3-1 CGCAAGCGACAGGAACCTCGAGAAGCTTCCGGTAGCAGCCTGAGCGGTGGTTGAATTCCTCGAGGTTCCTGTCGCTTGCG
J3-2 CGCAAGCGACAGGAACCTCGAGGAATTCAACCACCGCTCAACTCAACTGCAGTCTAGACTCGAGGTTCCTGTCGCTTGCG !-32P
J3-3 CGCAAGCGACAGGAACCTCGAGTCTAGACTGCAGTTGAGTCCTTGCTAGGACGGATCCCTCGAGGTTCCTGTCGCTTGCG
J3-4 CGCAAGCGACAGGAACCTCGAGGGATCCGTCCTAGCAAGGGGCTGCTACCGGAAGCTTCTCGAGGTTCCTGTCGCTTGCG
J3-5 CGCAAGCGACAGGAACCTCGAGTCTAGACTGCAGTTGAGTTGAGCGGTGGTTGAATTCCTCGAGGTTCCTGTCGCTTGCG
43-1 ACAGGAATTCCTCGAGGCCGCCATTTTGTGCTGTCTAGAGACT !-32P
43-2 AGTCTCTAGACAGCACAAAATGGCGGCCTCGAGGAATTCCTGT
HJ_1 GACGCTGCCGAATTCTGGCGTTAGGAGATACCGATAAGCTTCGGCTTAA !-32P
HJ_2 CTTAAGCCGAAGCTTATCGGTATCTTGCTTACGACGCTAGCAAGTGATC
HJ_3 TGATCACTTGCTAGCGTCGTAAGCAGCTCGTGCTGTCTAGAGACATCGA
HJ_4 ATCGATGTCTCTAGACAGCACGAGCCCTAACGCCAGAATTCGGCAGCGT
HJ_12 GACGCTGCCGAATTCTGGCGTTAGGAGATACCGATAAGCTTCGGCTTAATTTCTTAAGCCGAAGCTTATCGGTATCTTGC
TTACGACGCTAGCAAGTGATC
Cy5
HJ_34_1 TGATCACTTGCTAGCGTCGTAAGCAGCTCGTGCTGTCTAGAGACATCGATTTATCGATGTCTCTAGACAGCACGAGCCCT
AACGCCAGAATTCGGCAGCGT
HJ_34_2 TGATCACTTGCTAGCGTCGTAAGCAGCTCGTGCTGTCTAGAGTATACGATTTATCGTATACTCTAGACAGCACGAGCCCT
AACGCCAGAATTCGGCAGCGT
DS_1 AGGGTCTCCATTTTGAAGCG Cy5
DS_2 CGCTTCAAAATGGAGACCCT
DS_3 CTGAAGGGGGGCTATAAAAGGGGGT Cy5
DS_4 ACCCCCTTTTATAGCCCCCCTTCAG
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DISCUSSION
Recombinant YY1 was previously shown to behave as an oli-
gomer in SEC and glutaraldehyde cross-linking experiments
(15). Our structural characterization of the transcription factor
YY1 not only confirms those results using His-YY1 and Strep-
II-YY1, but in addition it offers a deeper understanding of the
architecture of these oligomers.We determine that YY1 assem-
bles as dimers that can associate into larger oligomeric com-
plexes, and we characterize the structural organization of these
oligomers using EM. Moreover, we show that the self-associa-
tion of YY1 also occurs in vivo. The most characteristic struc-
tural feature for the transcription factor YY1 is the C-terminal
C2H2-type zinc finger motifs (11). Although the main function
of these motifs is to interact with nucleic acids, they have been
also implicated in protein-protein interactions, including in
some cases homo-dimerization (42–44). One example is
Ikaros, a protein containing six C2H2-type zinc fingers, four of
which are involved in DNA binding and the two C-terminal
fingers are responsible for the assembly of a homodimer (45).
Thus, it is conceivable that YY1 could use, at least in part, these
multifunctional zinc fingers to homo-dimerize. Interestingly,
dimerization of Ikaros dramatically increased its affinity for
DNA, and a similar effect could be taking place in the case of
YY1 (see below).
YY1 zinc finger motifs are responsible for specifically bind-
ing to a consensus DNA sequence (5!-(C/g/a)(G/t)(C/t/a)-
FIGURE 6. Analysis of the interaction of purified YY1 with RuvBL1 and RuvBL2. A, SDS-PAGE and SimplyBlue (Invitrogen) staining of purified His-RuvBL1,
His-RuvBL2, His-RuvBL1-RuvBL2, and RuvBL1-RuvBL2. B, chromatograms and SDS-PAGE analysis of the fractions from a SEC of His-RuvBL1, His-RuvBL2, and
His-RuvBL1-RuvBL2 (solid line) and RuvBL1-RuvBL2 (dash line) using a Superdex 200 PC 3.2/30 (GEHealthcare) column. Proteinswere stained using SimplyBlue
(Invitrogen) (His-RuvBL1,His-RuvBL1-RuvBL2, andRuvBL1-RuvBL2) or by silver staining (His-RuvBL2). Thepositions for thedifferent oligomeric species (12-mer,
dodecamer; 6-mer, hexamer; 1-mer, monomer) are indicated in each case and were determined by comparison with molecular weight standards. The asterisk
(*) in the case of His-RuvBL1 SEC indicates a peak of aggregated material as observed by EM. C, pulldown experiments of Strep-II-YY1 and His-RuvBL1 or
His-RuvBL2. Strep-II-YY1was incubatedwithout (lane 1) or with His-RuvBL1 (lane 3) or His-RuvBL2 (lane 5) and affinity purified using the Strep-II-tag present in
YY1. As a control, His-RuvBL1 (lane 2) or His-RuvBL2 (lane 4) was purified in the same conditions but in the absence of YY1. D, pulldown experiments of
Strep-II-YY1andHis-RuvBL1-RuvBL2orRuvBL1-RuvBL2. Strep-II-YY1was incubatedwithout (lane1) orwithHis-RuvBL1-RuvBL2 (lane3) or RuvBL1-RuvBL2 (lane
5) and affinity-purified as in A. As a control, His-RuvBL1-RuvBL2 (lane 2) or RuvBL1-RuvBL2 (lane 4) was pull downed in the same conditions as those before but
in the absence of YY1.
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FIGURE 7. YY1 and RuvBL1-RuvBL2 cooperate in DNA binding. A, left panel, EMSA assays showing binding of Strep-II-YY1 to several DNA substrates
(described under “Experimental Procedures”) and represented as a schematic in each gel. Binding reactions contained 0, 240, 120, 60, or 30 nM protein
and 0.3 nM DNA species: HJ (J3) (lanes 1–5), dsDNA non-consensus sequence (dsDNA_no_sp_1) (lanes 6–10), 80-nt ssDNA (lanes 11–14), and dsDNA
consensus sequence (dsDNA_sp_1) (lanes 15–19). Right panel, EMSA assays showing binding of His-RuvBL1-RuvBL2 to the sameDNA substrates. Binding
reactions contained 0, 1.4, 0.7, 0.35, or 0.17 !M protein and 0.3 nM DNA species: HJ (J3) (lanes 1–5), dsDNA non-consensus sequence (dsDNA_no_sp_1)
(lanes 6–10), 80-nt ssDNA (lanes 11–14), and dsDNA consensus sequence dsDNA_sp_1) (lanes 15–19). Reactions were performed as described under
“Experimental Procedures,” and protein-DNA complexes were visualized by 6% PAGE and autoradiography. B, RuvBL1-RuvBL2 enhances the binding of
YY1 to dsDNA either containing (right panel, dsDNA_sp_1) or not the consensus sequence (left panel, dsDNA_no_sp_1). Reactions assembled on ice
contained combinations of a decreasing concentration of His-RuvBL1-RuvBL2 (1.4, 0.7, 0.35 or 0.17!M) and a fixed concentration of Strep-II-YY1 (120 nM
in the left panel and 15 nM in the right panel). After DNA addition (0.3 nM), samples were incubated for 30 min at 37 °C before electrophoresis. C, YY1 and
RuvBL1-RuvBL2 also cooperate in ssDNA binding. Shown is a similar experiment as B but using a 80-nt ssDNA (0.3 nM) (lanes 1–9). His-RuvBL1-RuvBL2
concentrations were varied as indicated from 700 to 87 nM, and the fixed concentration of Strep-II-YY1 used was 120 nM. D, EMSA of the enhancement
in binding of Strep-II-YY1 to HJ (J3) (0.3 nM) in the presence of the indicated concentrations His-RuvBL1-RuvBL2 (concentrations are expressed in nM).
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CATN(T/a)(T/g/c)-3!) found at the promoters of target genes
(11). DNA binding by the oligomeric forms of YY1 is not well
characterized, and the work byWu et al. (15) used nucleic acid
substrateswith a consensus sequence for YY1,where it could be
difficult to identify interactions with DNA distinct to those as a
transcription factor. In this context, one significant new finding
of our study is that these oligomers can interact with several
DNAs that do not contain the consensus sequence, at least in
vitro. This is consistent with the finding that YY1 binds to RNA
during inactivation of one X chromosome in mammalian
females independent of a consensus motif (4). What could be
the molecular/structural basis for these unconventional inter-
actions between YY1 and nucleic acids? C2H2-type zinc finger
domains can bind, in addition to DNA, to several nucleic acids
such as ssRNA, dsRNA, and DNA-RNA hetero-duplexes (44),
although the structural basis for these properties are poorly
FIGURE8.YY1andRuvBL2functionduringG2topromoteRAD51foci formation,butnot!H2AXorRPAfoci,afterexposuretoIR.A,A549cellsweretransfected
with scrambledsiRNA (siCTR) or siRNAdirectedagainstYY1,RuvBL2,orBRCA2, irradiated (3Gy)andharvested2or8h later and immunostained for !H2AXandCENPF
(to identify G2 phase cells). Average !H2AX foci per G2 cell were quantified (right panel). B, cells transfected as in Awere irradiated (3 Gy), harvested after 2 h, and
immunostained for RPAandCENPF. AverageRPA foci perG2 cellwerequantified (right panel).C, cells transfected as inAwere immunostained for RAD51andCENPF,
and average RAD51 foci per G2 cell were quantified (right panel). All data (A–C) are themeans of"3 experiments; error bars, S.D.
TABLE 2
DNA binding affinities of YY1 and RuvBL1-RuvBL2
DNA Kd appa YY1 Kd app RuvBL1-RuvBL2
nM "M
dsDNA_sp_1 40 "2b
dsDNA_no_sp_1 170 "2b
80-nt ssDNA 180 1.8
Holliday junction J3 90 1
a The apparent binding constant (Kd app) for each substrate was determined from
a compilation of at least three separate gel shift experiments, each with a dilu-
tion series of protein and a DNA substrate concentration fixed at 0.3 nM.
b The Kd app for this substrate is estimated, because at the maximal protein con-
centration tested (2 "M)#25% of the DNA was retained.
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understood. One hypothesis might be that the oligomerization
of YY1 could expand its properties to bind DNA, RNA, and/or
other proteins by the combination of zinc fingers motifs from
several monomers. This opens the possibility that, when in the
form of larger oligomers and/or as part of larger complexes,
YY1 could contribute to functions unrelated to those of a tran-
scription factor. Interestingly, recent reports describe roles of
YY1 in distinct functions such as proviral silencing in embry-
onic cells (6), the regulation of the expression of long non-
coding RNAs during myogenesis (7), and in V(D)J somatic
rearrangement of Ig loci during B-cell development by a mech-
anism that involves long distance DNA interactions (46).
One of these unconventional functions is the link between YY1
and DNA repair (15, 47). We predict that the functions of YY1 in
DNA repair should be independent of the recognition of specific
sequences, andour results indicate thatYY1has thepotential todo
so. We corroborate that YY1 functions in HR, but in addition,
our data suggest that defects in HR observed in the absence of
YY1 may be due to, at least in part, an inability to efficiently
promote formation or stabilization of the RAD51 filament.
FIGURE 9.RuvBL2 cooperateswith YY1 to promote RAD51 foci formation, and the ATPase activity of RuvBL2 is required for this activity.A, A549 cells were
transfectedwithscrambledsiRNA(siCTR) or siRNAsdirectedagainstYY1,RuvBL2,orBRCA2,as indicated, irradiated (3Gy),harvested2or8h later, and immunostained
for!H2AXandCENPF (to identify G2 phase cells). Average!H2AX foci perG2 cell were quantified (right panel). B, cells treated as inAwere immunostained for RAD51
and CENPF, and average RAD51 foci per G2 cell were quantified (right panel). All data (A and B) are themean of!3 experiments; error bars, S.D. C, top, Western blot
analysis ofwhole cell extractsprepared fromA549cells transfectedwith the indicated siRNA.Bottom,Westernblot analysis ofwhole cell extracts prepared fromA549
cells transfectedwith single or double siRNA constructs as indicated. Anti-KAP1 is shown as a loading control.D, U2OS cells transfectedwith siRNA directed against
RuvBL2 andeitherGFP, GFP-RuvBL2, or GFP-RuvBL2-K83Awere irradiated (3Gy), harvested, and immunostained for RAD51 andCENPF. Average RAD51 foci perGFP
positive G2 cell were quantified and are presented as themeans of three experiments; error bars, S.D.
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A direct interaction of YY1 with RuvBL1 and RuvBL2 has
been previously described (15). These AAA! ATPases are
implicated in several cellular processes as part of large macro-
molecular assemblies, such as INO80, SWR1, TIP60, and R2TP
complexes, among others (20, 21). Despite both proteins being
essential, not much is known about their mechanism of action,
and the functional significance of the several oligomeric forms
of RuvBL1 and RuvBL2 is still unclear (20, 21). We tested the
interaction of YY1 with the RuvBL1 and RuvBL2 ATPases,
showing that this interaction takes place also with purified YY1
oligomers. In addition, we observed that YY1 binds RuvBL1-
RuvBL2 complexes, but YY1 interacts preferentially with
RuvBL1, and it associates to RuvBL2 mostly when this is in
complex with RuvBL1. We cannot rule out that RuvBL2 could
bind YY1 at higher concentrations.
Unexpectedly, we found that when YY1 and RuvBL1-
RuvBL2 are incubated together with several DNA substrates,
they interact with the nucleic acids with enhanced affinity com-
pared with each protein on their own, and this effect is espe-
cially relevantwhen considering thoseDNAswithout a consen-
sus sequence. YY1 forms a complex with DNA that is detected
as a lowermigrating band in EMSA experiments, and the abun-
dance of this complex is enhanced 7-fold in the presence of
RuvBL1-RuvBL2. These results suggest that YY1 and RuvBL1-
RuvBL2 cooperate to enhance binding toDNA. Similar findings
have been recently described for another transcription factor,
GATA-binding protein 3 (Gata3), which controls differentia-
tion of T cells (48). Gata3 forms a complex with RuvBL2, and it
was proposed that the interaction promoted the DNA binding
activity of Gata3.
Thus, the interaction of YY1with RuvBL1 andRuvBL2 either
alone or as part of a larger complex could represent a mecha-
nism to modify the functionality of this transcription factor.
The molecular/structural bases for this remain to be explored,
but RuvBL1-RuvBL2 contains two regions with the potential to
bind nucleic acids. Domain II shows a structure reminiscent of
RPA, and recombinant DII domains from RuvBL1 in isolation
bind ssRNA, ssDNA and dsDNA (24). Similar to other AAA!
family members, RuvBL1 and RuvBL2 assemble hexameric
complexes with a central channel that could potentially bind
ssDNA (24), although this has not been demonstrated experi-
mentally. YY1 could cooperate with any of these two potential
DNA binding sites in RuvBL1-RuvBL2 to enhance the affinity
for nucleic acids, somehowmimicking the behavior of the bac-
terial homolog RuvB, which has poor DNA binding itself and
needs to interact with RuvA to bind DNA structures (22). The
mechanism of how exactly YY1, RuvBL1, and RuvBL2 proteins
cooperate to promote steps during HR and/or other cellular
events needs to be further explored. Here we provide evidence
suggesting an important role of the RuvBL1-RuvBL2 ATPases
in enhancing the DNA binding properties of YY1, which could
be directly linked to the regulation of different cellular pro-
cesses, including transcription and DNA repair.
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Removal of H2A.Z by INO80 promotes
homologous recombination
Hanan E Alatwi & Jessica A Downs*
Abstract
The mammalian INO80 remodelling complex facilitates homolo-
gous recombination (HR), but the mechanism by which it does this
is unclear. Budding yeast INO80 can remove H2A.Z/H2B dimers
from chromatin and replace them with H2A/H2B dimers. H2A.Z is
actively incorporated at sites of damage in mammalian cells, rais-
ing the possibility that H2A.Z may need to be subsequently
removed for resolution of repair. Here, we show that H2A.Z in
human cells is indeed rapidly removed from chromatin flanking
DNA damage by INO80. We also report that the histone chaperone
ANP32E, which is implicated in removing H2AZ from chromatin,
similarly promotes HR and appears to work on the same pathway
as INO80 in these assays. Importantly, we demonstrate that the
HR defect in cells depleted of INO80 or ANP32E can be rescued by
H2A.Z co-depletion, suggesting that H2A.Z removal from chromatin
is the primary function of INO80 and ANP32E in promoting homolo-
gous recombination.
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Introduction
The INO80 family of chromatin remodelling enzymes is defined by
an insertion in the ATPase domain and, in addition to INO80,
includes yeast Swr1 and human p400 and SRCAP. Evidence suggests
that members of this family are capable of histone exchange reac-
tions (for review, see [1]). Swr1, as part of the SWR complex,
removes H2A/H2B dimers and replaces them with H2A.Z/H2B
[2,3]. Mammalian SRCAP and p400 (as part of TIP60) are related to
yeast SWR and perform the same function [4,5]. The budding yeast
INO80 complex has been shown to catalyse the reverse reaction and
replace H2A.Z/H2B dimers with H2A/H2B [6]. In mammalian cells,
the histone chaperone ANP32E has been shown to remove H2A.Z
from chromatin [7,8], but it has not been investigated whether
mammalian INO80 contributes to this activity.
INO80 has been widely implicated in homologous recombination
[9–20]. There is evidence in both yeast and mammalian cells that
INO80 functions to promote resection [9,15,18,19], and although
the defect in mammalian cells depleted of INO80 is relatively mild,
this may be sufficient to impair efficient HR.
Recently, incorporation of H2A.Z by TIP60 at damaged chroma-
tin was found to restrict resection [5]. In the absence of H2A.Z,
recruitment of the non-homologous end-joining (NHEJ) complex
Ku70/Ku80 to DNA breaks is impaired, and this appeared to be a
consequence of unrestricted resection [5]. Taken together, these
data raise the possibility that INO80 may promote HR by removing
H2A.Z to allow resection. We investigated this possibility and found
that H2A.Z is incorporated and then very rapidly removed from
chromatin following DNA damage. We found that the removal of
H2A.Z from chromatin is dependent on INO80. Notably, while the
depletion of H2A.Z does lead to increased RPA foci, consistent with
a role in preventing unrestricted resection, we find that the deple-
tion of INO80 has only marginal effects on resection. Instead, we
find that cells are unable to efficiently replace RPA with RAD51, and
consequently, the formation of sister chromatid exchanges is
impaired in the absence of INO80. These data suggest that H2A.Z
removal performs an additional function during HR that is separated
from regulating resection. We also investigated the potential role of
ANP32E in mediating HR and found that its depletion results in a
similar defect as loss of INO80, and they appear to function together
in mediating HR. Strikingly, we find that the co-depletion of H2A.Z
and either INO80 or ANP32E fully rescues the defects in RAD51 foci
and SCE formation of siINO80 or siANP32E cells, suggesting that the
primary function of INO80 and ANP32E in promoting HR is the
removal of H2A.Z from damaged chromatin.
Results and Discussion
H2A.Z dynamics at damaged chromatin
To investigate the possibility that H2A.Z is removed from chromatin
subsequent to its incorporation after DNA damage, we introduced a
GFP-tagged expression construct into cells. Using live cell imaging,
we monitored H2A.Z accumulation at DNA damage sites induced by
laser micro-irradiation. Consistent with previous findings [5], we
found that H2A.Z is incorporated after damage (Fig 1A). Strikingly,
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Figure 1. H2A.Z dynamics at damaged chromatin.
A H2A.Z is rapidly incorporated and removed from chromatin in the vicinity of damaged DNA. U2OS cells transfected with GFP-H2A.Z were laser micro-irradiated and
monitored by live cell imaging. Representative images taken at indicated time points are shown.
B The RuvBL2 subunit of INO80 accumulates at sites of damaged DNA. U2OS cells transfected with EGFP-RuvBL2 were laser micro-irradiated and monitored by live
cell imaging. Representative images taken at indicated time points are shown.
C Quantification of mean fluorescence intensity at sites of micro-irradiation ! SE (n = 3).
D Removal of H2A.Z from chromatin in the vicinity of damaged DNA is at least partly dependent on INO80. USOS cells treated with siINO80 were transfected with
GFP-H2A.Z, laser micro-irradiated and monitored by live cell imaging. Representative images taken at indicated time points are shown.
E Quantification of relative mean fluorescence intensity ! SD at sites of micro-irradiation in control (U2OS; n = 3) and siINO80 cells (n = 3) in a minimum of 10 cells
per experiment.
Data information: Scale bars represent 10 lm.
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we found that it is subsequently very rapidly removed from
chromatin, with signal intensity returning to pre-damage levels
within 3 min (Fig 1A and E). This is distinct from the behaviour of
GFP-tagged core histone H2B, which we find shows no detectable
patterns of movement under these conditions (Fig EV1A). This
result suggests that H2A.Z is actively removed from damaged
chromatin after it is incorporated.
While budding yeast INO80 is capable of removing H2A.Z from
chromatin and replacing it with H2A [6], this has not been investi-
gated for mammalian INO80. INO80 has previously been shown to
accumulate at DNA DSBs when analysed using chromatin immuno-
precipitation [15]. We analysed the dynamics of the RuvBL2 subunit
of INO80, and in agreement with the ChIP data [15], we find that it
accumulates in chromatin in proximity to damage induced by laser
micro-irradiation, but then remains in the vicinity of damaged chro-
matin until at least 15 min after damage (Figs 1B, C and EV1B).
To determine whether H2A.Z removal following damage is
dependent on INO80, we analysed GFP-H2A.Z dynamics after
depleting INO80 (siINO80). We found that the accumulation of
H2A.Z in laser-irradiated chromatin is unaffected by depletion of
INO80. In contrast, the removal of accumulated H2A.Z in damaged
chromatin is significantly slower in cells depleted of INO80 when
compared with control cells (Fig 1D and E), indicating that INO80
contributes to the removal of H2A.Z from chromatin in mammalian
cells.
INO80 facilitates multiple steps during HR
There is evidence that INO80 contributes to HR in mammalian cells.
In order to investigate the contribution of INO80 and H2A.Z to this
pathway, we restricted our analyses to G2 cells using CENP-F,
whose expression is limited to late S and G2 phases of the cell cycle
[21], as a marker. There is evidence that the resection step of HR is
defective in mammalian cells lacking INO80 [15,18]. We therefore
monitored the appearance of RPA foci following irradiation as a
readout of single-stranded DNA formation. We did not detect a
difference in the number of RPA foci in cells treated with siINO80
when compared with control cells (Fig 2A). In contrast, and consis-
tent with a previous report [22], we find that the depletion of SRCAP
has an obvious impact on the number of IR-induced RPA foci
(Fig EV2). The absence of an obvious defect in RPA foci formation
is consistent with our previous work investigating the YY1 and
RuvBL2 subunits of INO80 [17], but is apparently at odds with other
reports [15,18]. We considered that one possibility for the discrep-
ancy between these findings is the different methodologies and
conditions used to monitor resection. We therefore used a different
approach and monitored the number of cells with RPA foci follow-
ing treatment with camptothecin (CPT), and, in doing so, found a
modest but statistically significant defect in cells treated with siRNA
targeting either the INO80 or YY1 subunits of the INO80 complex
(Fig 2D), suggesting that INO80 does function to promote resection
following DNA double strand breaks.
We next monitored the accumulation of RAD51 foci following
irradiation and found a more substantial defect in INO80-depleted
cells (Fig 2B). It seems unlikely that this is entirely a consequence
of the minor resection defect in siINO80 cells, and it therefore
suggests that INO80 has an additional function in promoting RAD51
foci formation during HR.
Depletion of H2A.Z rescues the RAD51 foci formation defect of
cells depleted of ANP32E and INO80
We hypothesised that the removal of H2A.Z from damaged chroma-
tin by INO80 may be an important aspect of the ability of INO80 to
promote RAD51 foci formation. To test this, we co-depleted H2A.Z
and INO80 (Fig 2C) and analysed the accumulation of RPA and
RAD51 foci following DNA damage. We found that, while the deple-
tion of H2A.Z alone had no detectable effect, the depletion of H2A.Z
rescued the defect in RAD51 foci accumulation in siINO80 cells
(Fig 2B). Using the assay in which we can uncover defect in RPA
foci formation in siINO80 cells, we find that the depletion of H2A.Z
also rescues this defect (Fig 2D). Loss of H2A.Z alone results in a
greater number of RPA foci following irradiation (Fig 2A), consistent
with a previous report showing that H2A.Z is a barrier to resection
[5]. Interestingly, the number of RPA foci appears to be reduced
when INO80 is also depleted back to wild-type levels (Fig 2A),
suggesting there may be crosstalk between the resection machinery
and INO80.
Very recently, the histone chaperone ANP32E was shown to
remove H2A.Z from chromatin in mammalian cells, both globally
[7,8] and from chromatin at sites of damage [23]. We were therefore
interested in understanding whether ANP32E might contribute to HR
in a similar manner to INO80. We depleted ANP32E and monitored
RPA and RAD51 foci formation as previously, and we found that loss
of ANP32E results in a similar defect in RAD51 foci formation follow-
ing irradiation as we find with the depletion of INO80 (Fig 3B). Nota-
bly, the depletion of both ANP32E and INO80 results in no further
defects in RAD51 foci accumulation following irradiation (Fig 3A–C),
suggesting that they are working together to facilitate this step in
HR. Most importantly, the co-depletion of H2A.Z in cells lacking
ANP32E rescues the defects in foci formation of the siANP32E cells
(Fig 3B and C).
Figure 2. Cells lacking INO80 have a modest resection defect and a more significant defect in RAD51 foci accumulation, and these defects are rescued by
depletion of H2A.Z.
A IR induced RPA focus formation in A549 cells treated with siControl, siINO80, siH2A.Z or siINO80/siH2A.Z. Left hand panel: representative images. Right hand panel:
quantification of foci.
B IR induced RAD51 focus formation in A549 cells treated with siControl, siINO80, siH2A.Z or siINO80/siH2A.Z. Left hand panel: representative images. Right hand panel:
quantification of foci.
C Western blot analysis showing efficiency of siRNA depletion. KAP1 is used as a loading control.
D Quanitification of RPA foci following 1 h of treatment with camptothecin (CPT).
Data information: Scale bars represent 5 lm. Data represent the mean of 4 (A, B) or 3 (D) independent assays ! SD. NS, not significant; *P ≤ 0.05; **P ≤ 0.01;
***P ≤ 0.001 by Student’s t-test.
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Figure 3. INO80 and ANP32E work together to promote RAD51 foci formation following irradiation, which is rescued by the depletion of H2A.Z.
A IR induced RPA focus formation in A549 cells treated with siControl, siANP32E, siANP32E/siINO80 or siANP32E/siH2A.Z. Left hand panel: representative images. Right
hand panel: mean number of foci ! SD.
B IR induced RAD51 focus formation in A549 cells treated with siControl, siANP32E, siANP32E/siINO80 or siANP32E/siH2A.Z. Left hand panel: representative images.
Right hand panel: mean number of foci ! SD.
C Western blot analysis showing efficiency of siRNA depletion. Ku80 is used as a loading control.
Data information: Scale bars represent 5 lm. All data (A, B) are from a minimum of 3 independent assays. NS, not significant; *P ≤ 0.05; ***P ≤ 0.001 by Student’s t-test.
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Figure 4. Wild-type levels of sister chromatid exchanges (SCEs) are dependent on H2A.Z removal by INO80 and ANP32E.
A SCEs were monitored in HeLa cells treated with siControl, siINO80, siH2A.Z or siINO80/siH2A.Z following treatment with mitomycin C (MMC). The reduction in SCEs in
cells lacking INO80 is rescued by the co-depletion of H2A.Z. Upper panel: representative images. Lower panel: mean number of SCEs ! SD. SCEs were scored in at
least 1,000 chromosomes from three independent experiments.
B SCEs were monitored in HeLa cells treated with siControl, siANP32E, siANP32E/siINO80 or siANP32E/siH2A.Z. There is no further reduction in SCEs in cells depleted of
both ANP32E and INO80 when compared with ANP32E alone. As with siINO80, the reduction in SCEs in cells lacking ANP32E can be rescued by the co-depletion of
H2A.Z. Upper panel: representative images. Lower panel: mean number of foci ! SD.
Data information: Scale bars represent 50 lm. All data are from a minimum of 3 independent assays. NS, not significant; *P ≤ 0.05; **P ≤ 0.01 by Student’s t-test.
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Depletion of H2A.Z rescues the sister chromatid exchange (SCE)
defect of cells depleted of ANP32E and INO80
The reduction in RAD51 foci formation in cells lacking INO80 or
ANP32E suggests that HR is impaired in these cells. However, the
reduction is modest when compared with cells lacking core HR
proteins, such as BRCA2. We therefore monitored sister chromatid
exchanges (SCEs) as a measure of HR completion. To do this, we
treated cells with mitomycin C (MMC) because this results in a very
substantial increase in SCEs, giving us the best possibility of detect-
ing defects in the pathway. Additionally, unlike IR, MMC-induced
lesions are repaired predominantly by HR.
We found that cells lacking either INO80 or ANP32E show
reduced numbers of SCEs when compared with control cells (Fig 4A
and B). Depletion of H2A.Z alone had no detectable effect on SCE
numbers after MMC treatment (Fig 4A). Similar to our results moni-
toring RAD51 foci formation, we found that the co-depletion of
H2A.Z rescued the defects in SCEs in cells lacking either INO80 or
ANP32E (Fig 4A and B). In addition, the depletion of both INO80
and ANP32E yielded similar levels of SCEs to cells lacking either
INO80 or ANP32E (Fig 4B), suggesting, as above, that they are
working together to facilitate HR.
Collectively our data suggest that H2A.Z is removed from chro-
matin after DNA damage by ANP32E and INO80, and this removal
—either from the chromatin flanking the DSB, or from the sister
chromatid, or both—is required for HR. Very recently, Price and
colleagues also found that H2A.Z is removed from chromatin at
sites of DNA damage in an ANP32E-dependent manner [23].
Interestingly, they found that failure to remove H2A.Z from chroma-
tin in the vicinity of damage results in reduced Ku70/Ku80 binding,
which impairs NHEJ activity. Loss of H2A.Z leads to similar
impairment of Ku70/Ku80 binding and NHEJ activity [5] and is
consistent with a model in which the coupled incorporation and
removal of H2A.Z is required to prevent promiscuous resection and
promote NHEJ. While INO80 has been implicated in mediating
resection, our data suggest that this is a minor role and that it has a
greater impact on facilitating HR at a step downstream of resection.
Taken together with the data from the Price laboratory, we
speculate that H2A.Z removal has multiple roles in DSB responses.
As we were restricting our analyses to late S and G2 cells, one
intriguing possibility is that H2A.Z dynamics are used differentially
throughout the cell cycle to promote distinct steps in both major
DSB repair pathways. Importantly, if H2A.Z is not deposited into
chromatin in the vicinity of DNA damage in the first place, then
INO80 and ANP32E are no longer required for wild-type levels of
RAD51 foci or SCE formation in these assays, indicating that the
removal of H2A.Z from chromatin in the vicinity of DNA damage is
their primary function in HR.
Materials and Methods
Cell culture and irradiation
A549, HeLa or U2OS cells were cultured in MEM or DMEM (Gibco),
respectively, supplemented with 10% FCS, L-glutamine, penicillin
and streptomycin (Gibco) at 37°C in a humidified 95% air and 5%
CO2 atmosphere. Cells were irradiated by exposure to a
137Cs source.
Small interfering RNA (siRNA) knockdown conditions
siRNA-mediated knockdown was achieved using HiPerFect
Transfection Reagent (Qiagen) following the manufacturer’s instruc-
tions. siRNA duplexes (Dharmacon SMARTpool) were transfected
into 4 × 105 of logarithmically growing cells per condition. Cells
were harvested 24 h later, retransfected with siRNA and were then
seeded and grown for 48 h. The siRNA oligonucleotide used for
ANP32E was 50-CGGCUUCCCAGCUUAAAUA-30 (Dharmacon).
Antibodies
The primary antibodies used were as follows: cH2AX (Upstate Tech-
nology; 05-636) at 1:800 for IF, RPA (Merck Millipore; LS-C38952)
at 1:100 for IF, RAD51 (Santa Cruz Biotechnology; SC-8349) at
1:200 and CENP-F (Abcam; ab108483) for IF, INO80 (Abcam;
ab118787, and Bethyl; A303-371A) at 1:2,000 for WB, H2A.Z (Cell
Signaling Technology; 2718S) at 1:1,000 for WB, ANP32E (Sigma-
Aldrich; SAB2100124) at 1:1,000 for WB, KAP1 (Abcam; ab22553)
at 1:1,000 for WB and KU80 (Abcam; ab33242) at 1:1,000 for WB.
The secondary antibodies used were as follows: FITC (Sigma-
Aldrich; F0257) at 1:100 for IF, Cy3 (Sigma-Aldrich; C2306) at 1:200
for IF, AlexaFluor 488 (Invitrogen; A21206) at 1:400 for IF, Goat
Anti-Rabbit Immunoglobulin/HRP (Dako; P0449) at 1:2,000 for WB,
Rabbit Anti-Mouse Immunoglobulins/HRP (Dako; P044801-2) at
1:2,000 for WB.
Immunofluorescence
A549 cells plated on glass slides were fixed for 10 min with fixative
(2% (w/v) PFA, 3% (w/v) sucrose, 1× PBS) and permeabilised for
3 min with 0.2% Triton X-100 in PBS. When staining for RPA/
RAD51, pre-extraction was performed by treatment with 0.2%
Triton X-100 in PBS for 0.5–1 min prior to PFA fixation. Cells were
rinsed with PBS and incubated with primary antibody diluted in
PBS + 2% (w/v) BSA for 1 h at room temperature (RT). Cells were
washed three times, incubated with secondary antibody (diluted in
PBS + 2% (w/v) BSA) for 30 min at RT in the dark, incubated with
40,6-diamidino-2-phenylindole (DAPI) for 10 min and washed
three times with PBS. Slides were mounted using Vectashield and
visualised/ analysed using a Nikon-e400 microscope and imaged
using an Applied Precision! Delta Vision! RT Olympus IX70
deconvolution microscope and softWoRx! Suite software. For
cH2AX, RPA, and RAD51 foci quantification, a minimum of 30 cells
per experiment was scored blindly and error bars represent the SD
between three experiments.
For analysis in Fig 2D, cells were treated for 1 h with 1 mM
camptothecin (CPT; Sigma-Aldrich) and left to recover for 1 h.
Recovered cells were then stained, and cH2AX-positive cells were
scored as above in a minimum of 100 cells per experiment.
Sister chromatid exchange (SCE) assay
Analysis of SCEs was carried out as described previously [24].
Briefly, HeLa cells were grown for 48 h in BrdU and treated with
100 lg mitomycin C (MMC) for 16 h; then, 10 lg/ml colcemid was
added for 2 h to collect cells in mitosis. SCEs were scored in at least
1,000 chromosomes from three independent experiments.
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Laser micro-irradiation
Exponentially growing human U2OS cells were plated onto 35-mm
glass-bottom dishes (MatTek) and transfected with the pTGFP-H2AZ
construct, pEGFP-RUVBL2 (Origene) or pEGFP-H2B using Nano-
Juice according to the manufacturer’s protocol. The cells were
allowed to express the construct for 24 h and were then incubated
with 10 lg/ml Hoechst 3458 for 30 min at 37°C before irradiation.
The microscope system used was an Intelligent Imaging Innovations
spinning disc confocal with a Yokogawa CSU-X1 on an Olympus
IX-71. GFP-positive cells were irradiated with 405-nm ultraviolet
laser set at power of 7:1,000 for either H2AZ or H2B and at 30:1,000
for RUVBL2 and channelled through a 60× objective. Images were
captured at 10-s intervals following laser damage for a total time of
5 min for H2AZ or H2B and 30 min for RUVBL2. Images generated
were acquired on a Photometrics Evolve 512 × 512 EMCCD using
Slidebook 6 software. In protein recruitment experiments, signal
intensity was quantified along the laser path, using Slidebook 6 soft-
ware, in a minimum of 10 cells and error bars represent the SD
between three independent experiments.
Expanded View for this article is available online:
http://embor.embopress.org
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